incivo works by stopping the virus from multiplying and multiplying in the body . incivo is used to treat hepatitis c infection in adults and children aged 18 years and older . it is used in combination with peginterferon alfa , ribavirin and telaprevir , which are medicines called ns3 - 4a protease inhibitors . the ns3 , 4a protein inhibitor stops hepatitis c virus from growing and multiplying . it also inhibits the activity of peginerferonalfa and ribavir . incovibil is used for the treatment of adult patients with chronic hepatitis c disease . it may be
do not take incivo if you are allergic to telaprevir or any of the other ingredients of this medicine ( listed in section 6 ). if you have been taking peginterferon alfa or ribavirin . warnings and precautions talk to your doctor or pharmacist before taking incivo . if you take any of these medicines : if you think you may be taking one of them , ask your doctor for advice . if any of them are not sure , talk to the doctor or nurse before taking this medicine . if your doctor has told you that you may need to take peginerferon avfa or /
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose regimen is one tablet once a day . the recommended dosage regimen is 3 tablets once a morning , 6 tablets once in the evening , 2 tablets once an evening , 8 tablets once or every day for 6 weeks . patients with both hepatitis c virus infection and human immunodeficiency virus infection , efavirenz , the recommendeddose regimen is three tablets once daily , 3 tablets twice a day , 8 times a day for the first 6 weeks of treatment . if you have both hepatitis
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you develop rash , an itchy skin rash , or any of the other signs of the rash . other symptoms of the skin may be : a severe skin reaction . tell a doctor immediately about a skin rash . if your rash does not go away or other symptoms get worse , tell your physician . a severeskin reaction can occur . tell the doctor immediately of any signs of a skin rash . your doctor may decide to treat your rash with other treatments . a rash may include fever , tiredness , swelling of the face
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . incivo tablets should be kept in the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what incivo contains - the active substance is telaprevir . each tablet of incivo contain 375 mg telaprentir . - the other ingredients are tablet core hypromellose acetate succinate , calcium hydrogen phosphate ( anhydrous ), microcrystalline cellulose , silica colloidal anhydrated , sodium lauryl sulphate , croscarmellose sodium , sodium stearyl fumarate . film - coat polyvinyl alcohol , macrogol , talc , titanium dioxide ( e171 ), iron oxide yellow ( e172 ). what incivo looks like and contents of the pack
what zinbryta is zinbulta contains the active substance daclizumab beta , a monoclonal antibody . what zinborryta looks like and contents of the pack zinberryta belongs to a group of medicines called cytokines . it is used to treat multiple sclerosis in adults . it can be used as therapy or as two ms treatment ( two other treatments ). inflammation destroys the protective sheath around the nerves in the central nervous system ( brain and spinal cord ). this loss of myelin ( demyelination ) can lead to relapsing ms ( repeated attacks ( rel
do not take zinbryta if you have previously had a serious allergic reaction to daclizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking zinibryta : if you suffer from liver problems . this is because zinabryta may not be suitable for you . if you are suffering from any other autoimmune disorders . if any of these apply to you , tell your doctor . if your doctor has told you to take any other medicines , including herbal supplements . if this applies to you ( or you
your doctor will decide how much zinbryta you need and how often you need to take this medicine . the recommended dose of zinbaq is 150 mg . your doctor will ask you to have a blood test to check how well your liver is working . the usual dose of your dose of one vial of zinfbrya is 40 mg . this blood test is done every three weeks . your dose may be adjusted . your next dose may need to be adjusted by your doctor . your blood test will be repeated every three months . your liver will be checked regularly . your recommended dose is one vials of
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with zinbryta : tell your doctor straight away if you notice any of the following serious side effects : liver problems : very common ( may affect more than 1 in 10 people ) unexplained nausea ( feeling sick ) vomiting ( being sick ) stomach pain increased tiredness loss of appetite ( anorexia ) your skin and whites of your eyes turn yellow dark ( tea - coloured ) urine 41 uncommon ( may affects up to 1 in 100 people ) severe inflammation of the liver may lead to death . tell your liver
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the zinbryta pre - filled syringe in its original package in order to protect from light . before you start a new syringe / pen , use a refrigerator to record the date the syringes / pens are removed from the refrigerator . zinbaq may be stored at room temperature (
what zinbryta contains the active substance is daclizumab beta . each pre - filled syringe contains 150 mg of dacluzumabbeta . 1 ml of solution for injection contains 150mg of dlizumb beta . 1ml of solution contains sodium succinate , succinic acid , sodium chloride , polysorbate 80 ( see section 2 ' zin bryta contain sodium '). what zinbaryta looks like and contents of the pack zinabryta is a clear to slightly yellow solution for injecting into a syringe / pen . it is supplied in a
wilzin belongs to a group of medicines called metabolism products . wilson ' s disease is due to a rare inherited defect in copper excretion from the liver to the eyes and brain . this defect causes liver damage and neurological disorders . wilzin works by attaching to copper in the intestine and allowing its further accumulation in the body . wilston ' s diseases is not a cure for wilson '. your doctor will discuss with you the benefits of this treatment .
do not use wilzin if you are allergic ( hypersensitive ) to zinc or any of the other ingredients of wilzin ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using wilzin wilzin should be used during initial therapy . if you have signs and symptoms of wilson ' s disease , you are currently being treated with another anti - copper agent , penicillamine . wilzin may be used for the initial treatment in combination with other anti - copper agents , penICillamine , but your symptoms will improve over time . your doctor will monitor the treatment closely , especially
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the different dose regimens are as follows : the usual dose is 25 mg twice a day . this means that you will take either 50 mg twice or 1 mg wilzin twice a morning . this will mean that you take either 25 mg once a day or 1mg wilzin once a morning ( morning ). this will also mean that your daily dose is 50 mg once in a morning and 2 mg wilz twice a afternoon . this adds up to a daily dose of 25 mg . this is equivalent to 1
like all medicines , wilzin can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ) not recommended ( frequency not known ) for wilzin intake may cause gastric irritation during treatment . changes in blood tests may show an increase in some liver and
keep out of the reach and sight of children . do not use wilzin after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what wilzin contains the active substance is zinc . each hard capsule contains 25 mg of zinc ( equivalent to 83 . 92 mg of z zinc acetate dihydrate ). each capsule contains 50 mg of the active substances ( equivalent of 167 . 84 mg of oz zinc acetates dihydrated ). the other ingredients are magnesium stearate . the capsule shell is composed of gelatin , titanium dioxide ( e171 ) and brilliant blue fcf ( e110 ). what wilzin looks like and contents of the pack wilzin 25 mg hard capsules are white to off - white , oblong , printed with " wilzin 50 mg " on
biktarvy contains the active substances bictegravir , an antiretroviral medicine known as an integrase strand transfer inhibitor . emtricitabine , an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir alafenamide , an antiiretviral medicine named a nucleotide reverse transcriptases inhibitor ( trti ). biktarv is used for the treatment of human immunodeficiency virus 1 ( hiv - 1 ) infection in adults . biktrelir reduces the amount of hiv in your body
do not take biktarvy if you are allergic to bictegravir , emtricitabine , tenofovir alafenamide or any of the other ingredients of this medicine ( listed in section 6 ). if you take any of these , tell your doctor . if you have taken any of any of your following medicines : - rifampicin used to treat some bacterial infections such as tuberculosis - st . john ' s wort ( hypericum perforatum ) a herbal remedy used to help you sleep and / or relieve depression and anxiety . warnings and precautions talk to your doctor before
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . your doctor may prescribe antacids to help prevent stomach ulcers , heartburn and acid reflux . your dose may need to be adjusted by your doctor . your diet should be taken in combination with aluminium and magnesium hydroxide mineral supplements . your daily dose should be adjusted in combination to include vitamins , magnesium and iron . see section 2 " taking these medicines with biktarvy ". if you take more biktorvy than you should if you accidentally
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following : inflammation or infection in patients with advanced hiv infection ( aids ) or opportunistic infections ( infections caused by a weak immune system ). symptoms of inflammation from previous infections may occur during hiv treatment . these symptoms are usually due to an improvement in the body ' s immune response , which helps fight infections . there are no obvious symptoms of autoimmune disorders , which occur when the immune system attacks healthy body tissue . medicines given to treat hiv infected people with autoimmune disorders may not work as well as
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the seal tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what biktarvy contains the active substances are bictegravir , emtricitabine and tenofovir alafenamide . each biktravir sodium equivalent to 50 mg bic tegravira , 200 mg emtritabine , tenofovec ( as tenofoviir alufenamide fumarate equivalent to 25 mg tenofofovira alafene ). the other ingredients are tablet core microcrystalline cellulose , croscarmellose sodium , magnesium stearate . film - coating polyvinyl alcohol , titanium dioxide ( e
novarorm is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . novonorm helps control type 2abetes by helping your body to increase the amount of sugar it produces , and to lower the amount that your body can make . diet and exercise can help to control your blood glucose . novororm can be used alone or in combination with metform
do not take novonorm if you are allergic to repaglinide or any of the other ingredients of novonor . if you have type 1 diabetes . your doctor will monitor the acid level in your blood regularly to avoid diabetic ketoacidosis . if your doctor has told you that you have a severe liver disease . if this applies to you , tell your doctor . if any of these apply to you ( or you are not sure ), talk to your doctor before taking novonors . warnings and precautions talk to you doctor before you take no vonorm : if you currently take gemfibrozil ( a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . you can take novonorm with or without food . the maximum recommended dose for adults is 30 mg once daily for 4 weeks . the dose may be increased to 30 mg twice daily for 16 weeks . your doctor may increase your dose if your blood sugar is too high ( see section 2 ). if you take more novonor than you should if you accidentally take too many tablets , contact your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia the most common side effect of hypoglycasemia is : common ( may affect up to 1 in 10 people ): a hypo in section 2 hypoglycemic reactions are generally mild / moderate . hypoemic unconsciousness ( coma ) may occur . allergy allergy ( rare ( may affects up to1 in 10 , 000 people ): symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be a sign of anaphylactic reaction . other side effects include : common : may affect
what novonorm contains - the active substance is repaglinide . - the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate anhydrous , maize starch , polacrilin potassium , povidone ( polyvidone ), glycerol , magnesium stearate , meglumine , poloxamer , iron oxide yellow ( e172 ), iron oxide red ( e 172 ) ( see section 2 " novonorg contains sodium "). what novonor looks like and contents of the pack novonar tablets are white to off - white , round , flat , with " 0 .
pumarix is a vaccine used to protect adults ( aged 18 years and older ) against pandemic flu ( influenza ). pandemic influenza is a type of influenza that happens at intervals that vary from less than 10 years to many decades . it spreads rapidly around the world . pandemicflu is similar to ordinary flu but may be more serious . the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease . none of the ingredients in the vaccine can cause flu . as with all vaccines , pumarix may not fully protect all persons who are vaccinated .
do not use pumarix : if you have had a sudden life - threatening allergic reaction to any ingredient of this vaccine ( listed in section 6 ) or to any of the ingredients that may be present in trace amounts as follows : egg , chicken protein , ovalbumin , formaldehyde and sodium deoxycholate . signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of the face or tongue . if you think any of these apply to you , tell your doctor or nurse immediately . the vaccine may not fully protect all persons who are vaccinated . medical treatment should be immediately available if you experience
pumarix is for use in adults aged 18 years and over . pumarix contains a similar h5n1 as03 as03 . pumix is not a vaccine for use by children aged 3 - 9 years . pumanix is also available in children aged 10 - 17 years . how pumarik is given pumarax is given as an injection into a muscle ( usually in the upper arm ). if you have any further questions on the use of this vaccine , ask your doctor or nurse .
like all medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions allergic reactions may lead to dangerously low blood pressure , shock and need emergency treatment . the following side effects have been reported with pumarix : very common ( may affect more than 1 in 10 people pain where the injection is given headache feeling tired aching muscles joint pain common ( might affect up to 1 in every 10 people ) redness or swelling where the area of the injection was given fever sweating shivering diarrhoea feeling sick uncommon ( may affects up to1 in every 100 people ) bruising where thejection was given bruising a hard
keep this vaccine out of the sight and reach of children . do not use this vaccine after the expiry date which is stated on the carton and the suspension after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . after preparation of the vaccine , the vaccine should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at ≤ 30 . do away with pumarix if you notice any particles in the solution . do throw away any
what pumarix contains the active substance is split influenza virus ( inactivated ) of the type 5 / 2005 ( pr8 - ibcdc - rg2 ) in 0 . 5 ml . the other ingredient is haemagglutinin , which is used to prevent the pandemic . the vaccine contains an ' adjuvant ' as03 . this adjuvant contains squalene , dl - α - tocopherol , polysorbate 80 and is one of the many ingredients that can be present in adjuvants that can occur in the vaccine . the ingredients are : sodium chloride ,
somakit t is a radiopharmaceutical product containing the active substance edotreotide . the powder contains a radioactive substance called gallium ( 68ga ) chloride . the active ingredient is gallium (" 68ga ") edotreaotide . during this procedure , the doctor will dissolve the powder in a liquid called gallia ( 68g ) edotREotide and inject it into a vein . this is to be injected into your body areas as part of a medical imaging procedure called positron emission tomography ( pet scan ). this medical procedure is to obtain images of the abnormal cells and tumours in your disease
do not take somakittoc if you are allergic to edotreotide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had allergic reaction to any ingredient ( listed under section 4 ) of somakitontoc . if you suffer from kidney or liver problems . if your liver is not working properly . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking somakttoc if : you have renal or hepatic disease . this is because somakattoc may affect the way some other medicines work . children and adolescents somaknit
there are strict laws on the use , handling and disposal of radiopharmaceutical products . somakittoc will only be handled and given to you by people who are trained and qualified to use it safely . they will keep you informed of their actions . they are responsible for the correct disposal of the product and for the safe disposal of any unused product . they should not use somakitontoc more than 29 hours after the start of the procedure . somackittoc is given as a single injection . it is not known how much medicine is given by injection . the test will be repeated at intervals during the procedure and may be
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with somakit : allergic reactions ( hypersensitivity ) have been reported with somackittoc . symptoms include warm flush , redness of the skin , swelling , itching , nausea and difficulty breathing . allergic reactions may also include stinging at the injection site . the injection area is exposed to ionising radiation ( which can cause cancer and hereditary abnormalities ). reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not listed in this leaflet . you can also
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials and radiolabelling . the following information is intended for the specialist only : somakit t will be stored at a temperature below 4 ºc and below 25 ºcs . do not freeze . do away with the solution if you notice any visible signs of deterioration . radioactive products should be disposed of in accordancewith local requirements .
what somakit t contains - the active substance is edotreotide . one vial of powder contains 40 mg of edotereotide ( as 10 - phenanthroline ). - the other ingredients are gentisic acid , mannitol , formic acid ( e421 ), sodium hydroxide and water for injections . - the solvent is sodium - free ( e507 ). - after radiolabelling , the solution contains hydrochloric acid . what somakIT t looks like and contents of the pack somakiton t is presented as a kit for radiopharmaceutical preparation . it is supplied as
afinitor is an anticancer medicine that contains the active substance erolimus . everolimus stops the growth and spread of cancer cells . afinitor acts on a hormone receptor called her2 - positive advanced breast cancer ( postmenopausal women ) that has not responded to non - steroidal aromatase inhibitors , which have not been tried or are not suitable for patients with the disease under control . afinavitor is used : - to treat hormone receptor - positiveadvanced breast cancer in postmenopause women who are not taking non - somoidal aromase inhibitors and whose disease is under control ; -
do not take afinitor if you are undergoing cancer treatment . warnings and precautions talk to your doctor or pharmacist before taking afincer : if you think you may be allergic to everolimus , sirolimus , temsirolimuses or any of the other ingredients of this medicine ( listed in section 6 ). if you suspect you may also be allergic , ask your doctor for advice . warnings , precautions talk with your doctor before taking this medicine : if any of these apply to you , tell your doctor . if you have been allergic to any of your other ingredients , or if you develop any problems with your liver
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 10 mg tablet once a day . if you take more afinitor than you should if you have liver problems , your doctor may prescribe a lower dose of afincer . the dose may be increased to 5 mg once a week . the usual dose is between 5 mg and 7 . 5 mg . if certain side effects occur , your dose may have to be reduced . if possible , your physician may reduce your dose of Afinitor or stop treatment completely . if necessary , your
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking afinitor and tell your doctor immediately if you experience an allergic reaction including : difficulty breathing or swallowing swelling of the face , lips , tongue or throat severe itching of the skin with a red rash or raised bumps . the following side effects have been reported with afininitor : very common ( may affect more than 1 in 10 people ): increased temperature ( common ) chills ( common signs of infection ) fever , coughing , difficulty breathing , wheezing ( common ). inflammation of the lung ( pneumonitis 46 common ( might affect
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . donot open the blister . store in the original package in order to protect from moisture . the tablets should be used immediately after opening . do this medicine if you notice any visible sign of tampering . do so , and throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment
what afinitor contains the active substance is everolimus . afincer 2 . 5 mg : each tablet contains 2 . 75 mg of everolim . afinnitor 5 mg tablet : each tablets contains 5 mg of Everolimus. afininitor 10 mg tablet ): each tablet contain 10 mg of of everlimus . the other ingredients are butylhydroxytoluene ( e321 ), magnesium stearate , lactose monohydrate , hypromellose , crospovidone , lactase anhydrous . what afinitors looks like and contents of the pack afiniter
what laventair ellipta is the active substance of lavent air ellipta contains two active substances called umeclidinium bromide and vilanterol . these belong to a group of medicines called bronchodilators . what laventAIR ellipta looks like and contents of the pack laventairy ellipta comes as a clear , colourless inhalation . it is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long - term condition characterised by breathing difficulties that slowly get worse . in copd the muscles around the airways tighten . this medicine works by tightening
do not use laventair ellipta 31 if you are allergic to umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine : if you have asthma . warnings and measures talk to the doctor or nurse before using lavent air ellipta : if your asthma is getting worse . if you suffer from heart problems . if your doctor has told you that you have high blood pressure . if any of these apply to you , tell your doctor . if there is an eye problem called narrow - angle
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use laventair ellipta every day . try to use it at the right time each morning and evening . it is important that you use lavantair ellipte every day until your doctor tells you otherwise . if you have symptoms of lavent air ellipta such as a sudden attack of breathlessness or wheezing , you should seek advice from a doctor or seek
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions if you experience any of the following symptoms stop using laventair ellipta and contact your doctor immediately : uncommon side effects ( may affect up to 1 in 100 people ): skin rash ( hives ) redness rare side effects : ( may affects up to1 in 1 , 000 people ): swelling mainly of the face or mouth ( angioedema ), which may make you feel very wheezy , coughing , having difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ). immediate breathing difficulties
what laventair ellipta contains - the active substances are umeclidinium bromide and vilanterol . each delivered dose contains 55 micrograms umeklidinia and 65 microgramms umecylidinIUM bromides . - the other ingredients are 22 microgram ( 0 . 5 millilitre ) vilancerol and trifenatate . - each inhalation powder contains lactose monohydrate ( see section 2 under ' lavent air ellipta contain lactose ') and magnesium stearate . what laventAir ellipta looks like and contents of
the active substance of tremfya is guselkumab , a monoclonal antibody . this medicine contains the active substance " il - 23 ". this belongs to a group of medicines called cytokines , and is used to treat psoriasis in adults with moderate to severe " plaque psorism ". plaque psoreiasis is an inflammatory condition that affects the skin and nails . tremfYA works by helping improve the condition on the skin , and the appearance of nails . it is used in adults to reduce symptoms such as scaling , shedding , flaking , itching , pain , and burning .
do not use tremfya if you are allergic to guselkumab or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using tremfia if you have an active infection or active tuberculosis warnings and precaution talk to the doctor or nurse before using or using tremfaya if : you have ever had an infection or an infection with tuberculosis . tuberculosis is a serious , sometimes life - threatening condition that can affect up to 36 people . if you develop an infection , your doctor may
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of tremfya is 100 mg ( 1 pre - filled syringe ) given once daily under the skin ( subcutaneous injection ). you may take tremfYA for 4 weeks or 8 weeks after your last injection . if you use more tremffa than you should tremfyna should be used only once . if possible , you should contact your doctor . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side effect : serious allergic reaction : difficulty breathing or swallowing , swelling of the face , lips , tongue or throat , severe itching of the skin , a red rash and raised bumps other side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . some side effects may be serious : common ( may affect up to 1 in 10 people ): upper respiratory infections common ( might affect up in 1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . do do not take this medicine if you notice that the solution is cloudy or contains large particles . do away with the pre -- filled syringes and allow it to reach room temperature ( up to 30 ) before use . do this medicine once it
what tremfya contains - the active substance is guselkumab . each pre - filled syringe contains 100 mg of gusel kumab in 1 ml solution . - the other ingredients are histidine , histidine monohydrochloride monohydrate , polysorbate 80 , sucrose , water for injections . what tremfYA looks like and contents of the pack solution for injection in a vial is clear and colourless . tremffa is supplied as a carton pack containing one single - dose glass syringe and a multipack containing 2 packs of 1 vial of single - dosing sy
the active substance of trepulmix is treprostinil . treprosteinil belongs to a group of medicines called prostacyclins , a hormone that lowers blood pressure by relaxing blood vessels . prostacycylins prevent blood from clotting . trepulemix is used to treat inoperable chronic thromboembolic pulmonary hypertension ( cteph ) in adult patients with persistent or recurrent ctph who are unable to exercise properly due to surgical treatment . it is used in adult adult patients whose condition is not well controlled by exercise capacity . symptoms of the disease are similar to those of chronic th
do not take trepulmix - if you are allergic to treprostinil or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a disease called " pulmonary veno - occlusive disease ". this is a disease in which the blood vessels in the lungs become swollen and there is a higher pressure in the blood arteries between the heart and the lungs . - if the child has severe liver disease . - tell your doctor if the patient has a heart problem . - have had a heart attack ( myocardial infarction ) in the last six months . - suffer from
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . trepulmix is given as a continuous subcutaneous infusion ( subcutaneously ) under the skin through a small tube ( cannula ) in the abdomen or thigh . trepanmix is only available in packs containing a spare pump . you should use your treprostinil only if your doctor tells you to . the pump is designed to be used within the infusion line . accidental overdose is not recommended . the recommended dose is 1 mg , 2 . 5 mg , 5 mg or 10 mg per
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): widening of blood vessels pain at the infusion site reaction at the site bleeding or bruising at the injection site headaches nausea diarrhoea jaw pain common ( might affect up to 1 in every 10 people ) dizziness light - headedness fainting low blood pressure skin rashes muscle pain ( myalgia ) joint pain ( arthralgia ) swelling of feet , ankles , legs ( fluid retention ) hot flush pain in arms and / or legs 36 uncommon ( may effect up to1
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with the vials . trepulmix vial may be stored at room temperature ( up to 30 ) for continuous subcutaneous infusion in a single reserve ( syringe ) of undiluted trepulemix for up to 72 hours . do this medicine if you notice any visible sign of damage such
what trepulmix contains - the active substance is treprostinil . trepulemix 1 mg : each vial contains 1 mg treproprostineil ( as sodium salt ). each 10 ml vial of 10 ml solution contains 10 mg trepristinila ( as water for injections ). each 2 . 5 ml vials of 2 . 25 ml solution contain 10 mg of treprosticinil ( ( as salt ). trepulesmix 2 . 75 mg :each vial produces 2 . 50 mg treProstinIL ( as saline salt ). one 10 ml ampoule of 50
the active substance of thorinane is enoxaparin sodium . it is a low molecular weight heparin ( lmwh ). the active substance in thorinanes is enocriptine . it works in two ways : 1 ) to prevent existing blood clots from forming . 2 ) to stop blood clubs from forming in your blood . thorinne is used to prevent blood clumps from forming within your blood during or after an operation . it can be used : - if you have an acute illness called unstable angina ( problems with your heart ). - if your heart is working normally . - if blood cl
do not use thorinane if you are allergic to enoxaparin sodium or any of the other ingredients of this medicine ( listed in section 6 ). signs of an allergic reaction may include rash , swallowing or breathing problems , swelling of your lips , face , throat or tongue . if you think you may be allergic to heparin or other low molecular weight heparins ( e . g . nadroparin , tinzaparin , dalteparin ), tell your doctor immediately . if a reaction occurs with heparrin , it can lead to a severe drop in the number of your clotting cells ( plate
like other similar medicines ( medicines to prevent blood clotting ), thorinane is used to prevent bleeding . it is used when the bleeding is not controlled . if you experience any bleeding event that does not stop by itself ( exceptional weakness , tiredness , paleness , dizziness , headache , unexplained swelling ), stop taking your medicine and contact your doctor immediately . if any of these apply to you , tell your doctor or nurse immediately . your doctor may decide to stop your medicine temporarily or permanently . if your doctor has told you that you have a severe allergic reaction , which may include difficulty breathing , swelling of the lips , mouth , throat
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe label after exp . the exp date refers to the last day of that month . store below 25 . after dilution the solution should be used within 8 hours . do this medicine if you notice that the thorinane pre - filled syringes are damaged or have not been stored correctly . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what thorinane contains the active substance is enoxaparin sodium . each pre - filled syringe contains 100 mg of enoxapearin sodium in 0 . 2 ml solution . each vial contains 2 , 000 mg of the active ingredient enoxafarin sodium and is for single use only . the other ingredients are water for injections . what thorinanes looks like and contents of the pack thorinan is a clear , colourless type i neutral glass syringe barrel with fixed needle and needle shield , with chlorobutyl rubber stopper and a blue polypropylene plunger rod . pack size of 2 or
senstend contains the active substances lidocaine and prilocaine , which are local anaesthetics . senstend is used to prevent lifelong premature ejaculation in adult men . it works by attaching itself to the head of the penis , which allows ejaculation to last longer .
do not use senstend if you are allergic to lidocaine , prilocaine or any of the other ingredients of this medicine ( listed in section 6 ). if you have a history of allergy or sensitivity to local anaesthetics ( amide - type local anaesthesia ). if your doctor has told you that you have or have had a genetic disease or other condition affecting your red blood cells ( glucose and phosphate deficiency ), such as anaemia ( methaemoglobinaemia ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you : have a genetic condition that affects your redblood cells
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of senstend is 3 sprays ( 3 sprabs per day ). use in children 3 months of age and older the recommended starting dose is 1 spray ( 1 spray ) per day on the head of your penis . use in adolescents 3 months to 24 months of old the recommended maintenance dose is 4 sprays per day . use the spray container to adjust the pump mechanism . avoid contact with eyes , nose , mouth and ears . the pump should be rotated 1 - 2
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : common ( may affect up to 1 in 10 people ) inability to develop or maintain an erection in the penis feeling of burning in the area of the penis uncommon ( may effect up to1 in 100 people ) headache local irritation of the throat , irritation of any part of the skin redness failure to ejaculate during sexual intercourse abnormal orgasm tingling in the part of your penis pain or discomfort in the pris itching in the centre of your erect penis a high temperature . other side effects include :
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the metal container after exp . the exp date refers to the last day of that month . store below 25 and use within 12 months . do away with the metalcontainer . donot puncture or burn it . do this if you notice any particles in it . these measures will help to protect the environment .
what senstend contains - the active substances are lidocaine and prilocaine . each ml of solution contains 150 mg lidocain and 50 mg prilucaine . one spray provides 50 ml solution , delivering 7 . 5 mg lidOCaine and 2 . 5mg prilacaine . - each spray container contains 6 . 5 ml solution . - the other ingredients are 20 micrograms / ml . - one spray container provides 5 ml ( 0 . 5 %) solution , providing 12 doses . what senstends looks like and contents of the pack senstent is a clear , colourless to light
opdivo is a medicine used to treat advanced melanoma ( a type of skin cancer ) in adults . in adults melanoma is advanced after complete resection in adults ( treatment without surgery or adjuvant therapy ). advanced non - small cell lung cancer ( advanced renal cell carcinoma ) advanced kidney cancer in adults classical hodgkin lymphoma if previous therapies have not worked or you cannot have an autologous stem - cell transplant ( a transplant ). advanced cancer of the head and neck in adults advanced urothelial carcinoma ( bladder and urinary tract cancer ) a medicine called nivolumab , which is
do not take opdivo if you are allergic to nivolumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking opdivone if you : - have problems with your heart , such as a change in the rhythm or the heartbeat of your lungs ( an abnormal heart rhythm ) - have any problems with any of your lung systems , such breathing difficulties or cough - have inflammation of the lungs ( pneumonitis or interstitial lung disease ) - diarrhoea , watery , loose or soft stools - have or have had any symptoms of inflammation
always take opdivo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of opdivone is 240 mg ( 2 tablets ) once daily , with a total of 480 mg per 4 weeks . opdivao must always be taken in combination with ipilimumab . the treatment will be started by a doctor who is experienced in the treatment of skin cancer . the usual dose of the combination of op divo and 1 mg of nivolumab is based on kilogram of your body weight . the daily dose is 4 tablets of opilimumib
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store below 25 and freeze . store in a refrigerator ( 2 to 8 ). do not freeze . after dilution , the infusion solution should be used immediately . any unused medicine or waste material should be disposed of in accordance with local requirements .
what opdivo contains the active substance is nivolumab . each ml of concentrate for solution for infusion contains 10 mg of nivlumab ( as 40 mg / ml ). each 4 ml vial contains 100 mg of 10 mg or 240 mg of 24 mg of the active ingredient nivulumab as 40mg / ml . the other ingredients are sodium citrate dihydrate , sodium chloride ( see section 2 " opdivoa contains sodium "), mannitol ( e421 ), pentetic acid , polysorbate 80 , sodium hydroxide , hydrochloric acid and water for injections
clopidogrel tad contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrel tetad is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic events (
do not take clopidogrel tad 30 if you are allergic to clopipidogel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , or if you think any of this applies to you ), tell your doctor before taking clopridogrelTad . warnings and precautions the warning and precautions of clopidineogrel tetad are as follows : if you : have a risk of
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clubidogl tad ( 4 tablets of 75 mg ) once at the start of treatment . then
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel tad contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopidaogrel ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone , macrogol 6000 and hydrogenated castor oil in the tablet core and polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogrol 3000 in the film - coating . what clopIDogrel tetad looks like and contents
tacrolimus contains the active substance tacrolimos . tacforius is an immunosuppressant . after your organ transplant , your liver and kidney will be removed . this will be in accordance with your body ' s immune system . tacfortius will only work when your body is fully adapted to the new condition . it will only be used when the transplanted organ is ready to be given to you . tacvorius is used to prevent rejection of the transplants by the liver , kidney and heart in patients who have received any previous treatment after your transplantation .
do not take tacforius if you are allergic to tacrolimus or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before taking tacforus if you : - are allergic , to sirolimus , to any macrolide , antibiotic , erythromycin , clarithromycin or josamycin . tacrolamus immediate release capsules ( e . g . tacforia prolonged - release capsules ) are not recommended for patients who are unable to swallow
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . this medicine should only be prescribed by a doctor experienced in the treatment of transplant patients . the doctor will prescribe the same tacrolimus medicine as before . if you have had a transplant , your doctor will give you a different tacroleus medicine . always take this medication exactly as described in this leaflet . check your doctor if you do not have the right medicine . the rejection of your transplanted organ will be determined by your doctor . the usual dose for adults , adolescents and children is based on
like all medicines , this medicine can cause side effects , although not everybody gets them . infections can be serious and you must stop taking tacforius and seek medical attention immediately if you experience any of the following severe effects : allergic and anaphylactic reactions ( benign or malignant tumours ) which have been reported during tacforus treatment . pure red cell aplasia ( a very severe reduction in red blood cell counts ). agranulocytosis ( a severely lowered number of white blood cells ). haemolytic anaemia ( decreased number of red blood cells due to abnormal breakdown ). febrile neutrop
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). discard all the prolonged - release hard capsules within 1 month of opening the aluminium wrapping . do away with the foil . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what tacforius contains the active substance is tacrolimus . tacforus 0 . 5 mg prolonged - release hard capsules hard gelatin capsules : tacforia 1 mg prolonged release hard gelatin capsule : tacfius 3 mg prolonged , capsule : 1 mg tacrolamus ( as monohydrate ) tacforio 3 mg long - release soft gelatin capsules: tacfus 5 mg long and prolonged -release hard gelatin hard gelatin : tacrolemus ( monohydrate ). capsule content hypromellose 2910 , ethylcellulose , lactose , magnesium stearate . capsule shell tacforis 0 .
clopidogrel zentiva contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrelzentiva is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic
do not take clopidogrel zentiva : if you are allergic ( hypersensitive ) to clopipidogl or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelzentiva . warnings and precautions the warning and precautions of clopidineogrel ventiva are as follows : if any part of your body is at risk of bleeding
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel zentiva per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl zenta ( 4 tablets of 75 mg ) once at
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with clopidogrel zentiva if it is accidentally frozen in aluminium blisters . do this after the first 30 . do do not take clopridogrelzentiva in all aluminium blacks . donot use this medication if you notice any visible sign of deterioration . do throw away any medicines via wastewater or
what clopidogrel zentiva contains the active substance is clopridogrel . each tablet contains 75 mg of clopidoogrel ( as hydrogen sulphate ). see section 2 ' clopiderel zenta contains lactose ' and ' clapidogl zentive contains hydrogenated castor oil '. the other ingredients are mannitol ( e421 ), hydrogenatedcastor oil , microcrystalline cellulose , macrogol 6000 , low - substituted hydroxypropylcellulose , lactose monohydrate ( milk sugar ), hypromellose ( e464 ), triacet
yttriga is a radioactive medicine that is used in hospital only . it is stored in a refrigerator ( 2 - 8 ). it is not to be used in combination with another medicine . it must be used immediately . it does not require any special storage conditions . it should only be used with tiny radiation doses . the treatment with yttrigda is a radiolabelled medicinal product .
do not use yttriga - if you are allergic ( hypersensitive ) to chloride or any of the other ingredients of yttiga - you must not be pregnant or breast - feeding if you think you may be pregnant . warnings and precautions talk to your nuclear medicine doctor before using yttrada - yttrida is a radioactive medicine . it is used in combination with another medicinal product called radiopharmaceuticals . yttarga contains radioactive material . radioactive medicinal products are stored at 2 to 16 in the outer layer of the outer layers of the protective layer . other medicines and yttoga tell
the treatment is supervised by a doctor experienced in the diagnosis and treatment of medicinal products . method of administration yttriga is for radiolabelling of medicinal product for specific diseases . yttiga is intended for administration by adults only . if you are given more yttrada than you should in the event of overdose , you will receive appropriate treatment .
like all medicines , yttriga can cause side effects , although not everybody gets them . if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
yttriga will be stored under the responsibility of the specialist in appropriate premises and local regulations . the storage details are as follows : keep out of the sight and reach of children . do not use yttrigda after the expiry date which is stated on the label and carton after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . store the vial in the original package in order to protect from light . radioactive substances are excreted as waste material .
what yttriga contains - the active substance is chloride . 1 ml sterile solution contains 1 mg of hydrochloric acid ( equivalent to 3 mg / ml ). what yttiga looks like and contents of the pack yttrida is a clear , colourless type i glass vial with a flat bottom and a silicon stopper and an aluminium seal .
ciambra is a medicine used in the treatment of cancer . ciambra contains cisplatin , another anti - cancer medicine , which is used as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , which has not received prior chemotherapy . cinembra is also used in combination with cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will determine how much ciambra you should receive depending on the severity of lungcancer and on the worsening of your disease . treatment with initial chemotherapy ciamba is a treatment for
do not use ciambra : if you are allergic ( hypersensitive ) to pemetrexed or any of the other ingredients of ciamb ( listed in section 6 ). if you plan to stop breast - feeding during treatment with ciamba . if you have recently received or are about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using ciamBra if you or your family has or have had problems with your kidneys . before each infusion , your doctor will check your blood , kidney and liver function to make sure that you have enough blood cells and that you are receiving c
the recommended dose of ciambra is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your whole body . your doctor will work out this body surface area based on your weight and on your response to treatment , and on the results of your blood cell counts . your healthcare professional will have mixed the ciamra powder with 9 mg / ml ( 0 . 9 %) sodium chloride solution before it is given to you . ciamba will be given to your doctor by infusion into one of your veins . the infusion will last approximately 10 minutes .
like all medicines , this medicine can cause side effects , although not everybody gets them . 52 tell your doctor immediately if you experience : fever or infection ( common ) with a temperature of 38ºc or greater sweating ( common ). infection may occur if you have less white blood cells than normal which is very common . infection , sepsis , may be severe and could lead to death . if you get chest pain ( common ), or a fast heart rate ( uncommon ). if you are having pain , redness , swelling or sores in your mouth ( very common ). allergic reaction ( common ): if you develop skin rash ( common ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the expiratory date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do away with the vial after reconstitution . the reconstituted solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 - 7 , 8 , 15 or 25 .
what ciambra contains the active substance is pemetrexed . each vial of ciamra 100 mg contains 100 mg of pemetreed ( as pemetereed disodium hemipentahydrate ). each vials of cembra 500 mg contains 500 mg of the active ingredient pemetired (as pemetareed dis sodium hemipontahydrates ). after reconstitution , the solution contains 25 mg / ml of pemphigus . further dilution by a healthcare provider is required prior to administration . the other ingredients are mannitol ( e421 ), hydrochlor
immunogam belongs to a group of medicines called immunoglobulins ( antibodies ) which help to control certain infections in your blood . immunogam can be used to prevent increased levels of human hepatitis b immunoglubulins , such as immunoglofulin g ( ig ), in the blood plasma of healthy adults . immunoglogam is used to treat adults who have not previously been vaccinated against hepatitis b virus . immunogenam is for use in haemodialysed patients . vaccination is a precautionary measure in which a hepatitis birus carrier ( i ) stimulates an immune response and develops measurable hepatitis
immunogam should not be given if you have an allergic reaction to human immunoglobulins or other blood products . if you suffer from an iga deficiency , you may be at increased risk of an allergic response to iga containing products . children and adolescents immunogam is not recommended for use in children and teenagers under 18 years of age . immunoglubulins have not been studied in this age group . adverse reactions such as chills , headache , fever , vomiting have been reported . allergic reactions such nausea ( arthralgia ), joint pain , low blood pressure and moderate low back pain have also
immunogam will be given to you by a doctor or nurse who is experienced in the care of patients with vaccination against hepatitis b virus . the first vaccine dose will be administered in accordance with human hepatitis b immunoglobulin ( hbv ). administration prevention the recommended dose for hepatitis b in individuals with at least 500 hbvs is 24 to 72 micrograms / kg body weight per day . the recommended dosage for hepatitis c in haemodialysed patients is 500 hbav / kg per day ( 2 doses ) administered by seroconversion . vaccination against patients with hepatitis b will be initiated by a
like all medicines , immunogam can cause side effects , although not everybody gets them . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ): very rare ( affecting less than1 user in 1, 000 ) not known ( frequency cannot be estimated from the available data ): undesirable effects during clinical trials with immunogaman , the muscle was damaged ( common ) ( affects up to 1 user of 10 ,000 ) very rare
keep out of the reach and sight of children . do not use immunogam after the expiry date which is stated on the carton and on the label of the vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in the outer carton in order to protect from light . donot use immunOGam if the solution is cloudy or contains deposits . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the
what immunogam contains - the active substance is human hepatitis b immunoglobulin . immunogaman 1 mg / ml solution for injection contains 5 mg of human plasma protein ( equivalent to 96 mg / m2 ). - the other ingredients are polysorbate 80 . what immunogams looks like and contents of the pack immunogamer is a solution forjection in a glass vial . it is a clear to slightly opalescent , colourless to pale yellow liquid . each pack contains 1 vial of immunogamation .
remicade contains the active substance infliximab . inflixumab is a monoclonal antibody a type of protein that recognises and attaches to a specific target in the body called tumour necrosis factor ( tnfα ). remicade belongs to a group of medicines called ' tnfs blockers '. it is used to treat the following inflammatory diseases : rheumatoid arthritis psoriatic arthritis ankylosing spondylitis ( bechterew ' s disease ) psoriasis . remicades is used in adults , adolescents and children aged 6 years and older with crohn
do not take remicade if you are allergic to infliximab or any of the other ingredients of remicades ( listed in section 6 ) if you think you may be allergic ( hypersensitive ) if your doctor has told you that you have tuberculosis ( tb ) if this applies to you , tell your doctor . if you have another serious infection such as pneumonia , sepsis or heart failure if you drink alcohol before or during remicada . if any of these apply to you ( or you are not sure ), talk to your doctor before taking remicad . warnings and precautions talk to you doctor or pharm
the recommended dose is : rheumatoid arthritis 3 mg / kg body weight for psoriatic arthritis , ankylosing spondylitis ( bechterew ' s disease ), psoriasis , ulcerative colitis and crohn ' s diseases . the recommended dose for adults is 5 mg / m body weight . how remicade is given remicine will be given to you by your doctor or nurse . how it is given the medicine will be prepared and given to your doctor by a healthcare professional . it will be administered as an infusion ( drip ) over 2 hours into one of your veins (
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some patients may experience serious side effects and may require treatment . if you notice any of the following side effects you should stop your treatment with remicade and seek medical help immediately : - an allergic reaction ( swelling of your face , lips , mouth or throat , which may cause difficulty in swallowing or breathing , skin rash , hives and swelling of the hands , feet or ankles ). these reactions are rare but could be life - threatening . an allergic allergic reaction may occur within 2 hours of the injection
keep this medicine out of the sight and reach of children . do not use remicade after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . store in a refrigerator ( 2 8 ). do not freeze . remicad can be used for infusion if it has been stored at room temperature ( up to 3 ) for a single period of up to 8 days ( but not above 28 ). this period may be extended by an additional 24 hours ( up from 25 ) without removal from the
what remicade contains the active substance is infliximab . each vial contains 100 mg of inflixumab . after preparation each ml contains 10 mg of infiximb . the other ingredients are sucrose , polysorbate 80 , monobasic sodium phosphate , dibasicodium phosphate . what remicades looks like and contents of the pack remicada is supplied as a glass vial containing a powder for concentrate for solution for infusion . the powder is white to off - white . remicaded is available in packs containing 1 , 2 , 3 , 4 or 5 vials .
rasagiline mylan is used to treat parkinson ' s disease in adults . it is used in combination with levodopa ( another medicine used to control parkinson's disease ). with parkinson ', s disease there is a loss of cells that produce dopamine in the brain . dopamine is a chemical in the body that is important for movement control . rasagilinea mylan increases the amount of dopamine in your brain .
do not take rasagiline mylan - if you are allergic to rasaggiline or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have severe liver problems . warnings and precautions talk to your doctor or pharmacist before taking the following medicines : rasaline mylan may affect the way some other medicines work : monoamine oxidase ( mao ) inhibitors ( used to treat depression and parkinson ' s disease ) medicinal and natural products such as st . john ' s wort or pethidine ( a strong pain killer ). children and
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day by mouth . take rasagiline mylan at about the same time each day . you should take rascagilrine mylan every day until your doctor tells you otherwise . if you take more rasgiline than you should if you accidentally take too many tablets of rasgailine , contact your doctor immediately . you may require medical attention . keep the rasaga mylan carton with you so that you can easily describe
like all medicines , this medicine can cause side effects , although not everybody gets them . the majority of side effects have been seen with the use of the active substance ( placebo ). the frequency of possible side effects listed below is defined using the following convention : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to 1 user of 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ): very common abnormal movements ( dyskinesia ) headache common abdominal pain fall allergy fever flu ( influenza ) feeling of being unwell neck pain chest pain
what rasagiline mylan contains - the active substance is rasagailine . each tablet contains rasgiline tartrate equivalent to 1 mg rasgailine - the other ingredients are microcrystalline cellulose , tartric acid , maize starch , pregelatinized maize starch and talc , stearic acid . what rasaggilinemylan looks like and contents of the pack rasagleiline tablets are 11 . 5 mm x 6 mm , biconvex tablets debossed with " r " on one side and " 1 " on the other side
do not use hulio - if you are allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has a severe infection , including tuberculosis . if your doctor has told you that your child may have symptoms of infections , such as fever , wounds , feeling tired , dental problems . - if the child has moderate or severe heart failure . if you have a serious heart condition . warnings and precautions allergic reaction allergic reactions may occur with symptoms such as chest tightness , wheezing , dizziness , swelling or a rash . tell your doctor immediately if your or your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . polyarticular juvenile idiopathic arthritis in children and adolescents from 2 to 17 years old weighing 10 kg or more the usual dose is 30 mg once a day . hulio is available as 20 mg once daily . in children from 2 - 17 years of age weighing 30 kg or less the usual starting dose is 40 mg once weekly . in enthesitis - related arthritis in adults from 6 to 17 year old weighing 15 kg or 30 kg the usual dosage is 30mg once a daily . h
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may require urgent medical treatment . tell your doctor straight away if you notice any of the following serious side effects ( seen in section 4 ) since the last hulio injection : allergic reaction including heart failure severe rash or hives swollen face , hands or feet trouble breathing , swallowing , pale complexion , dizziness , persistent fever , bruising or bleeding . signs and symptoms of infection such as fever , feeling sick , wounds , dental problems , burning on urination , feeling weak or tired , coughing
what hulio contains - the active substance is adalimumab . - the other ingredients are monosodium glutumate , sorbitol , methionine , polysorbate 80 , hydrochloric acid and water for injections . what hulios looks like and contents of the pack hulIO 40 mg is a sterile solution for injection containing 40 mg of adalimab in 0 . 8 ml of solution . the solution is clear to slightly opalescent and has a rubber stopper . hullio is available in packs containing 1 , 2 , 1 sterile injection syringe , 1 syringe needle
the active substance of yellox is bromfenac . it belongs to a group of medicines called non - steroidal anti - inflammatory drugs ( nsaids ), which reduce inflammation . yellox has been prescribed for the treatment of eye inflammation following cataract surgery in adults .
do not use yellox - if you are allergic to bromfenac or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have asthma or skin allergy ( intense inflammation in your nose ). - do not use other nsaids ( e . g . acetylsalicylic acid , ibuprofen , ketoprofen or diclofenac ). this medicine may be used with topical steroids ( e. g . cortisone ) to reduce unwanted side effects . - if the patient has had bleeding problems ( such as haemophilia
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose of yellox is one drop in each eye ( s ) twice a day . the recommended daily dose is one dose in each affected eye (s ) twice daily for 2 weeks . the drops should be used on the next day following your cataract surgery . method of administration yellox is for oral use . wash your hands before using the eye drops . remove the bottle cap from the bottle . hold the bottle , pointing down , between your thumb and fingers , and
what yellox contains - the active substance is bromfenac . each ml of solution contains bromenac ( as sodium sesquihydrate ). each vial contains 33 mg of bromnac . - the other ingredients are boric acid , borax , sodium sulphite anhydrous , benzalkonium chloride , tyloxapol , povidone ( k30 ), disodium edetate and sodium hydroxide to maintain acidity levels . what yellox looks like and contents of the pack yellox is a clear yellow liquid ( solution ) supplied in a glass v
dzuveo contains sufentanil , which belongs to a group of strong painkillers called opioids . sufENTanil is used to treat sudden moderate - to severe pain in adults .
do not take dzuveo if you are allergic to sufentanil or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious lung or breathing problem . warnings and precautions talk to your doctor before taking dzuvoo if : you have any condition that affects your breathing ( such as asthma , wheezing or shortness of breath ). dzuuveo may affect your breathing during treatment . you have recently had a head injury or brain tumour . you suffer from problems with your heart and circulation such as slow heart rate , irregular heartbeat , low blood volume or low blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the single - dose administration device is for oral use only . swallow the tablet whole with a glass of water . you can take this medication with or without food . dzuveo must be taken with strong painkillers such as sufentanil 30 mg / ml . the sublingual tablet is taken with the disposable single -dose applicator . the applicator is inserted into the tongue . if the tablets dissolve in the tongue , you may experience pain relief . the tablet can be taken by mouth
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : severe breathing problems , slow and shallow breathing . if you get any of these side effects you must stop taking dzuveo and contact your doctor immediately . very common side effects ( may affect more than 1 in 10 people ): nausea , feeling sick , vomiting , being sick and feeling hot . common side side effect ( may effect up to 1 in every 10 people ) : inability or difficulty sleeping , feeling anxious or confused , dizziness , headache ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do use this product if you notice any visible signs of deterioration . do this if you are concerned that the solution is not clear and contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what dzuveo contains - the active substance is sufentanil . each tablet contains 30 mg sufantanil ( as citrate ). - the other ingredients are mannitol , dicalcium phosphate , hypromellose , croscarmellose sodium , indigo carmine , stearic acid , magnesium stearate . what dzuvello looks like and contents of the pack dzu veo is a white to off - white , round oval tablet with " d " debossed on one side and " 3 " debottled on the other side . it is supplied in
erveleada is a cancer medicine that contains the active substance apalutamide . it is used to treat prostate cancer that has spread to other parts of the body and cannot be removed with surgical treatments . it also works to treat sensitive prostate cancer which has spread beyond the original part of the male body and has not responded to surgical treatment . it works by reducing the amount of testosterone in the blood . it can also be used to prevent resistant prostate cancer from growing . erleada also works by blocking the action of androgens , which are involved in the growth and spread of the cancer . by blocking androgens from the blood ,
do not take erleada - if you are allergic to apalutamide or any of the other ingredients of this medicine ( listed in section 6 ). - if pregnant or think you may be pregnant ( see pregnancy , breast - feeding and contraception section ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . this medicine may affect the way some other medicines work . this includes : - if your child has seizures - if he / she is taking any medicines that may increase the risk of blood clots ( e . g . warfarin , acenocoumarol ). - tell your doctor if your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once a day . your doctor may increase your dose to 60 mg once daily depending on how you respond to erleada . taking this medicine by mouth is the best way to reduce the risk of side effects . taking erleade with other medicines take erlead at the same time each day . if you take more erleado than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take your tablets with food . erlea
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking erleada and see a doctor immediately if you experience any of the following symptoms : reddish , non - elevated , target - like , circular patches on the trunk , central blisters , skin peeling , ulcers of mouth , throat , nose , genitals and eyes . these serious skin rashes may be accompanied by fever and flu - like symptoms . toxic epidermal necrolysis has been reported with other similar types of serious side effects . fits ( seizure ) have been reported uncommonly ( may affect up to 1 in
what erleada contains - the active substance is apalutamide . each film - coated tablet contains 60 mg of apaluamide . - the other ingredients are colloidal anhydrous silica , croscarmellose sodium , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose , silicified microcrystine celluloise . - in addition , the film - coating contains iron oxide black ( e172 ), iron oxide yellow ( e 172 ), macrogol , polyvinyl alcohol , talc , and titanium dioxide ( e171 ). what erlead
this medicine is a radiopharmaceutical product . axumin contains the active ingredient fluciclovine . it is used to carry out scan ( a pet scan ) in adults who have previously had treatment for prostate cancer and have had other tests to check prostate specific antigen ( psa ) ( the type of protein that carries the cancer ). an axumin pet scan is performed to find out if the cancer has spread to your prostate . the scan will be done under the supervision of a doctor who is experienced in the use of radiopharms . the use in adults with this type of medicine is limited . the clinical benefit of having
do not use axumin - if you are allergic to fluciclovine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using axumin . - if your doctor has told you that you have kidney problems . - you should follow a low sodium diet . - axumin is given once a day for the duration of the axumin scan ( see section 4 for further information ). - during the scan , you will be given your usual medicines to take at the latest 60 minutes before the axum injection . - urination may occur during the time you
there are strict laws on the use , handling and disposal of radiopharmaceutical products . axumin will only be handled and given to you by people who are trained and qualified to use this medicine safely . these persons will take special care for the safe use of this medicine and will keep you informed of their actions . the nuclear medicine doctor supervising the procedure will decide the quantity of axumin to be used . the usual dose is 370 megabecquerel per kilogram of body weight . the quantity to be administered depends on the type of medicine being used . administration of axum before the procedure axumin is given into
like all medicines , this medicine can cause side effects , although not everybody gets them . in clinical studies , the following side effects were reported : very common ( may affect more than 1 in 100 people ): the medicine may cause side effect when inhaled with axumin . uncommon ( may effect up to 1 in every 100 people ) pain , rash , altered taste in the mouth , altered sense of smell . this radiopharmaceutical emits low amounts of ionising radiation which can cause cancer and hereditary abnormalities . reporting of side effects if you get any side effects talk to your nuclear medicine doctor . this includes any possible side effects not listed in
you will not have to store this medicine . this medicine is stored under the responsibility of the specialist in appropriate premises . storage of radiopharmaceuticals will be in accordance with national regulation on radioactive materials . the following information is intended for the specialist only . axumin will be stored in a safe place .
what axumin contains - the active substance is fluciclovine . axumin 1600 mg : each vial contains 1600 mg of fluciniclovine ( as besilate ). each vials of 1600 mg contains 16000 mg of axumin . axum 3200 mg : one vial of 3200mg of flociclovin ( as mesilate ) contains 3200 micrograms of 32000 microgram . - the other ingredients are sodium citrate , concentrated hydrochloric acid and sodium hydroxide ( see section 2 " axumin with sodium "). what axumin looks like and contents
azopt contains brinzolamide which belongs to a group of medicines called carbonic anhydrase inhibitors . it works by reducing pressure within the eye . azopt eye drops help to reduce high pressure in the eye , which can lead to an illness called glaucoma . the pressure in your eye increases , and this can damage your sight .
do not take azopt if you have severe kidney problems . if you are allergic to brinzolamide or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to medicines containing sulphonamides ( medicines used to treat diabetes or infections ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking azopt : if you develop the same allergy as you have if you drink too much sulphonamide . if your blood is being treated for hyperchloraemic acidosis ( see section " warnings and actions "). if any
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . azopt is used in both eyes . use azopt in both eye and eyes : 1 drop in each eye in the morning and 2 drops in the evening . use in both of eyes : use azop in both the morning , and the evening , and 1 drop of azopt each evening in the eyes . 1 drop into each of the eyes in the mornings and 2 or 3 times in the night . remove the azopt bottle from the bottle and wash your hands . remove from the cap . the cap
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with azopt : common side effects ( may affect up to 1 in 10 people ) - effects in the eye : blurred vision , eye irritation , eye pain , eye discharge , itchy eye , dry eye , abnormal eye sensation , redness of the eye . other side effects : bad taste . uncommon side effects - effects ( might affect upto 1 in 100 people ) ) -effects in the inside of theeye : sensitivity to light , inflammation or infection of the conjunctiva , eye swelling , eyelid
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and bottle after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . to protect from infections , a pack containing a single bottle should be used immediately . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what azopt contains - the active substance is brinzolamide . each ml contains 10 mg of brinzaolamide ( as benzalkonium chloride ). - the other ingredients are carbomer 974p , edetate disodium , mannitol , purified water , sodium chloride , tyloxapol , hydrochloric acid and sodium hydroxide to maintain acidity levels ( ph levels ). what azopt looks like and contents of the pack azopt is a milky liquid ( a suspension ) supplied in a 5 ml plastic ( droptainer ) bottle with a screw cap . a pack containing
the active substance of forxiga , dapagliflozin , belongs to a group of medicines called " oral medicines ". it is taken by mouth to treat diabetes by increasing the amount of sugar in your blood . it is used in adults and adolescents ( aged 18 years and over ). forxigo is used to treat two types of diabetes : type 1 diabetes that occurs when your body does not make enough insulin . forxig is used for the type 1 and 2 diabetes in which your body hardly makes enough insulin or the insulin that your body makes does not work as well as it should . diabetes occurs in people who are
do not take forxiga - if you are allergic to dapagliflozin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking forxigo : - if any of these apply to you : - feeling sick or being sick , stomach pain , excessive thirst , fast and deep breathing , confusion , unusual sleepiness or tiredness , a sweet smell to your breath , asweet or metallic taste in your mouth , a different odour to your urine or sweat , rapid weight loss . contact your doctor immediately if you experience any of any of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of forxiga for type 2 diabetes is 10 mg once a day . your doctor may increase your dose to 5 mg once daily if you have a liver problem . your dose of both forxigo and for type 1 diabetes is 5 mg twice a day , depending on your response to this medicine swallow the tablet whole with a glass of water . forxige can be taken with or without food . your blood sugar should be checked regularly during treatment with diet and exercise program . how long to
like all medicines , this medicine can cause side effects , although not everybody gets them . the most serious side effects are angioedema ( seen very rarely , may affect up to 1 in 10 , 000 people ). angioEDema may cause swelling of the face , tongue or throat , difficulties swallowing , hives and breathing problems . diabetic ketoacidosis ( seen commonly , may affects up to1 in 10 people ) is a rare but serious complication of type 2 diabetes . it may affect between 1 in 1 , 000 and 1 in 1000 people . diabeticketoacidososis may occur when you have increased levels of "
what forxiga contains the active substance is dapagliflozin . each forxigo 5 mg film - coated tablet ( tablet ) contains dapablifloin propanediol monohydrate equivalent to 5 mg dapapagllozin the other ingredients are : tablet core : microcrystalline cellulose ( e460i ), lactose ( see section 2 under ' forxigiga contains lactose '), crospovidone , silicon dioxide ( e171 ), magnesium stearate . film - coating : polyvinyl alcohol ( partially hydrolysed ), titanium dioxide ( i171 ), mac
mifamurtide works by stopping the growth of certain bacteria which are resistant to the immune system . mepact is used to treat osteosarcoma ( bone cancer ) in adults and adolescents aged 2 and 30 years . it is used when surgery is not possible to remove the tumour and is given alone or in combination with chemotherapy which stops cancer cells from growing and cancer is likely to come back .
do not take mepact : - if you are allergic to mifamurtide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines containing ciclosporin or other cineurin inhibitors ( non - steroidal - anti - inflammatory drugs ). nsaids can affect your heart or blood vessels , which may lead to blood clots ( thrombosis ), bleeding ( haemorrhage ), and inflammation of the veins ( vasculitis ). warnings and precautions talk to your doctor or pharmacist before taking mepactor
treatment mepact will be given to you by a doctor or nurse . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of mepACT is 2 mg mifamurtide once a day . your doctor will decide how many doses you need . the dose may be increased or decreased by your doctor . the maximum recommended dose is 12 mg once a week . your dose may increase or decrease by up to 24 mg depending on your mepact treatments . your chemotherapy schedule will be adjusted by your chemotherapy . the usual dose is 36 mg
like all medicines , mepact can cause side effects , although not everybody gets them . chills , fever and fatigue have been reported in patients taking mepACT ( transient ) paracetamol . if you experience fever during treatment with mep act , you should contact your doctor immediately . stomach problems ( nausea and vomiting ) and loss of appetite have been seen in patients receiving chemotherapy . tell your doctor or nurse immediately if you have continuing fever and chills . these may be signs of an infection . rash tell your physician or nurse if you get any problems breathing , wheezing or any stomach problems . very common side effects
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial and the carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vials in outer carton in order to protect from light . reconstituted suspension in sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection may be stored for up to 6 hours at 2 to 8 , but must not be frozen . do this medicine if you notice any visible sign of deterioration
what mepact contains the active substance is mifamurtide . each vial contains 4 mg of mifamanurtide ( as suspension ). after reconstitution , each ml of suspension contains 0 . 08 mg mifmurtide per ml . the other ingredients are 1 - palmitoyl - 2 - oleoyl- sn - glycero - 3 - phosphocholine ( see section 2 under ' mepacts contains lactose ') 2 - dileoyls - sn - glyco - 5 - phospho - l - serum monosodium salt ( see also section 2 "
mirvaso contains the active substance brimonidine which belongs to a group of medicines called alpha agonists . it is used on the skin and the face to reduce redness ( rosacea ) and redness of the face . rosica is a condition in which the body produces high levels of blood flow in theacial skin and enlargement ( dilution ) of the small blood vessels of the skin . mirvaso acts by blocking the blood vessels , thereby reducing the excess blood flow and reding of the area .
do not take mirvaso - if you are allergic to brimonidine or any of the other ingredients of this medicine ( listed in section 6 and section 2 " possible side effects "). warnings and precautions talk to your doctor , pharmacist or nurse before taking mirvasos : - if the medicine is injected under the skin ( for example , if you take certain medicines used to treat depression or parkinson ' s disease called monoamine oxidase ( mao ) inhibitors such as selegiline , moclobemide , tricyclic antidepressants ( such as imipramine ), tetracyclic medications
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . mirvaso is applied to the skin ( usually on the face ) once daily . this medicine is applied on the surface of your body . it should only be used on the body surfaces , such as your eyes , mouth , nose or vagina . if you have any further questions on the use of mirvasos , ask your doctor , pharmacist or nurse . how much mirvasoe mirvasoa is applied once daily on the same face . the treatment should be started with a small amount of gel (
like all medicines , this medicine can cause side effects , although not everybody gets them . uncommon side effects : severe skin irritation , inflammation , skin rash , skin pain or discomfort , dry skin , warm skin sensation , tingling , sensation of pins and needles or swelling . common side effects ( may affect up to 1 in 10 people ): worsening of rosacea . the treatment should be stopped immediately if symptoms occur ( see section 2 " warnings and precautions "). contact allergy allergic reaction including rash and rare angioedema ( a serious allergic reaction with swelling mainly of the face , mouth and tongue ). if you are given mirvas
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and tube and pump after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do away with the tube and pumps after first opening . do this if you notice any change in the appearance of the solution . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what mirvaso contains - the active substance is brimonidine . each ml of gel contains 3 . 3 mg of brimonine . each vial contains 5 mg of the active ingredient brimonate tartrate . - the other ingredients are carbomer , methylparahydroxybenzoate , phenoxyethanol , glycerol , titanium dioxide ( e171 ), propylene glycol , sodium hydroxide , purified water ( see section 2 " mirvasoa contains methylparasahydrobenzoates "). - the solvent is propyleneglycol . what mirvasos looks like and contents of
mvasi contains the active substance bevacizumab , which is a humanised monoclonal antibody ( a type of protein that recognises and attaches to a specific target in the immune system ) that is needed to defend the body from infection and cancer . bevacsizumb binds to a protein called human vascular endothelial growth factor ( vegf ), which is found in lymph vessels all over the body . the vegF protein is found on blood vessels that carry blood and nutrients such as oxygen . be vacizumsab prevents tumour growth and keeps the blood vessels open , thus increasing
do not use this medicine if you are allergic ( hypersensitive ) to bevacizumab or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic ( allergic , hypersensitive ), to chinese hamster ovary ( cho ) cell products if you or your child are pregnant . warnings and precautions talk to your doctor or pharmacist before using mvasi . if you have any of these conditions , please tell your doctor before using this medicine . if any of them apply to you , tell your physician before using it . if your child is less than 6 months of age
dose and frequency of administration your doctor will work out the dose of mvasi you will receive based on your body weight and the type of cancer you have . the usual dose is 5 mg , 7 . 5 mg or 10 mg per kg of body weight . your doctor may increase your dose to 15 mg per kilogram of your bodyweight . your dose of the mvasis will be calculated by your doctor based on the size of your tumour growing . frequency of infusion mvasic will be given once every 2 or 3 weeks . the number of infusions you receive will depend on how you respond to treatment . your physician
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with mvasi : tell your doctor straight away if you notice any of the side effects listed below . mvasis is given in combination with chemotherapy . these side effects are usually mild to moderate and usually disappear after a few days . if you are given mvasic in combination , tell your physician straight away . allergic reactions if you have an allergic reaction , including difficulty in breathing , chest pain , redness and flushing of the skin , a rash , chills or shivering , feeling sick ( nausea )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outercarton in order to protect from light . infusion solutions should be used immediately after dilution . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 8 unless dilution has taken place
what mvasi contains the active substance is bevacizumab . each ml contains 25 mg of bevaconizumb in 1 . 4 ml or 16 . 5 ml of solution . each 4 ml vial contains 100 mg of the active ingredient bevackizumumab in 1. 4 ml of water . each 16 ml vials contains 400 mg of of bevanacizumaab in 16 . 95 ml of the solution . the other ingredients are trehalose dihydrate , sodium phosphate , polysorbate 20 and water for injections . what mvasis looks like and contents of
tecartus is a gene therapy medicine used to treat mantle cell lymphoma . it is used in combination with other medicines to treat refractory mantle cell lipoma ( mcl ) in adults . it consists of your own white blood cells called autologous anti - cd19 - transfduced cd3 + cells . mantle cell cancer is a cancer that affects the immune system ( the body ' s natural defences ) and affects b - lymphocytes . mantlecell lymphoma b - lipocytes are involved in an uncontrolled way in which they accumulate in lymph tissue ( the bone marrow ) and blood . tecartus helps to remove
do not use tecartus if you are allergic to any of the ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using tecartuse if you : - are allergic or have had problems with the number of white blood cells in your blood ( lymphodepleting chemotherapy ) ( see section 3 ) - are taking white blood cell - are having autologous use ( see " other medicines and tecartuses ") tests and checks to check the function of your lungs , heart , kidney and blood pressure - are
tecartus is made from your own white blood cells . your cells will be collected and given to you by a doctor or nurse . this is done by a catheter placed in your vein ( a procedure call leukapheresis ). your white blood cell will be taken from you and your blood will be given to your doctor or a nurse . the recommended dose is 3 to 6 g of your white white blood blood cells per week . this will be repeated every 2 to 3 weeks . medicines given before tecartus treatment ( lymphodepleting chemotherapy ) the modified white blood will then be given by your doctor to you
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss your side effects with you . if you get any side effects you may need urgent medical attention . the following side effects have been reported during the tecartus infusion : very common ( may affect more than 1 in 10 people ): fever , chills , reduced blood pressure . symptoms may include dizziness , lightheadedness , fluid in the lungs . all symptoms could be signs of a condition called cytokine release syndrome . loss of consciousness ( decreased level of consciousness , confusion , memory loss ). disturbances of brain function including difficulty speaking ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). infusion bag : store in the original package in order to protect from light . diluted solution : chemical and physical in - use stability of liquid nitrogen has been demonstrated for 150 days at 2 - 10 . this medicine contains genetically modified human blood cells and human - derived material . the product is stable for 36 hours at 2 to 8 .
what tecartus contains - the active substance is autologous anti - cd19 - transfduced cd3 + cells . each patient - specific single infusion bag contains a dispersion of anti - cd19 car t cells equivalent to 68 cd3 cells per 2 ml of solution . - the other ingredients are : 106 anti - dcp3 + sodium chloride and human albumin ( see section 2 " tecartuses contains sodium "). what tecartu looks like and contents of the pack tecartub is a concentrate for solution for infusion . it is supplied as an infusion bag packed in a metal cassette . a single
januvia contains the active substance sitagliptin which belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) that lowers blood sugar levels in adult patients with type 2 diabetes mellitus . this medicine helps to increase the levels of insulin produced after a meal and decreases the amount of sugar made by the body . your doctor has prescribed this medicine to help lower your blood sugar , which is too high because of your type 2abetes . this medication can be used alone or with certain other medicines ( insulin , metformin , sulphonylureas , or gl
do not take januvia - if you are allergic to sitagliptin or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have inflammation of the pancreas ( pancreatitis ). warnings and precautions talk to your doctor or pharmacist before taking januvi : - if any of these apply to you ( or you are not sure ), talk to the doctor or nurse before taking this medicine . - if the signs of pancreatitis ( see section 4 ) include blistering of the skin or bullous pemphigoid . januvenvia may not
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 100 mg film - coated tablet 63 once daily by mouth . if you have kidney problems , your doctor may prescribe a lower dose of 25 mg or 50 mg . you should continue taking this medicine until your doctor tells you otherwise . if your doctor advises you to stop taking this medication , your dose may be reduced . if this medicine is taken with certain other medicines that lower blood sugar , it is not known how much medicine you will need to take . your doctor will work out the right
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking januvia and contact a doctor immediately if you notice any of the following serious side effects : severe and persistent pain in the abdomen ( stomach area ) which might reach through to your back , with or without nausea and vomiting , as these could be signs of an inflamed pancreas ( pancreatitis ). if you have a serious allergic reaction ( frequency not known ), including rash , hives , blisters on the skin , peeling skin , swelling of the face , lips , tongue , and throat that may cause difficulty in breathing or
what januvia contains - the active substance is sitagliptin . each film - coated tablet ( tablet ) contains sitaglptin phosphate monohydrate equivalent to 25 mg sitaglioptin . - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate , croscarmellose sodium , magnesium stearate , sodium stearyl fumarate . the tablet film - coating : poly ( vinyl alcohol ), macrogol 3350 , talc , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide . what januva looks like and contents of
xultophy helps to control blood glucose in patients with type 2 diabetes mellitus . diabetes is when your body does not make enough insulin to control the level of blood sugar . insulin degludec is a long - acting basal insulin . it helps to lower your blood sugar levels by helping your body make better use of it . liraglutide is a type of glp - 1 medicine that works by making your body produce more insulin during meals . xultophy may be used with oral medicines for diabetes xultide may be taken with oral medications for diabetes such as metformin , pioglitazone
do not take xultophy if you are allergic to insulin degludec , liraglutide or any of the other ingredients of this medicine ( listed in section 6 ). 39 if you have a sulfonylurea such as glimepiride or glibenclamide . your sulfonylation dose should be reduced to maintain your blood sugar levels . warnings and precautions talk to your doctor or pharmacist before taking xulturo if you suffer from type 1 diabetes mellitus or ' ketoacidosis '. this is a condition where your blood sugars are too high . xultury is not recommended if
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . if you have been blind or have poor eyesight , your doctor may need to adjust your dose . your doctor will check your blood sugar level before you start using xultophy 41 if you start to use xultue 42 if you stop using xulophy 8 weeks after stopping it , your blood pressure may become too low to continue to control it . how to use your medicine xultide is supplied as a pre - filled dial - a - dose pen with the dose counter and in a pack containing
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects : low blood sugar ( very common ( may affect more than 1 in 10 people ) if your blood sugar level gets low you may pass out or become unconscious . this could be a sign of serious hypoglycaemia ( which may cause brain damage ). low blood glucose is not a cure for low blood sugars . your doctor will check your bloodugar level regularly and may also tell you to stop taking xultophy . see ' low bloodugar ' in section 2 for more
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after first opening , the product may be stored at room temperature ( up to 30 ) for up to 8 weeks . after this , the medicinal product should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 21 days at 2 8 ,
what xultophy contains the active substances are insulin degludec and liraglutide . each ml contains 100 units of insulin degluudec 3 . 6 mg liragolutime in 3 ml solution . each vial contains 300 units of the active substance insulin deglbudec 10 . 8 mg liraaglunide . the other ingredients are glycerol , phenol , zinc acetate , hydrochloric acid and sodium hydroxide ( for ph adjustment ). the solvent is water for injections ( see section 2 " xultphil contains sodium "). what xultos looks
giotrif is a medicine that contains the active substance afatinib . it works by blocking two proteins called egfr [ epidermal growth factor receptor 2 ]- erbb1 and her2 [ erbb2 - erbb3 ]. these proteins are involved in the growth and spread of cancer cells . this medicine works by stopping the growth of cancer cell and slowing down their spread . this is important to help stop cancer cells from growing . this medicinal product is used to treat cancer of the lung ( non - small cell lung cancer ). giotriff is used as your first treatment in adults who have not received prior
do not take giotrif if you are allergic to afatinib or any of the other ingredients of this medicine ( listed in section 6 ) if you have low body weight ( less than 50 kg ) if your doctor has told you that you have kidney problems if you think this applies to you , tell your doctor straight away . warnings and precautions talk to your doctor or pharmacist before taking giotrinif if any of these apply to you : if you suffer from lung inflammation ( interstitial lung disease ) if any part of your lung has been removed if you know that you suffer or have had liver problems , your doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one 40 mg tablet once a day . you should take this tablet at the same time each day . if you take more giotrif than you should if you accidentally take too many tablets , contact your doctor immediately . if possible take this leaflet with you . if necessary , take this other medicine at the usual times . if this medicine is not taken with food , contact a doctor or the nearest hospital immediately . you may need to take this this medicine for 1 to 3 days before
like all medicines , giotrif can cause side effects , although not everybody gets them . the following side effects have been reported during treatment with giotrinif : diarrhoea common ( may affect up to 1 in 10 people ): diarrhoehoea ( may cause up to 2 in 10 , 000 people ): severe diarrhoee with or without fluid loss common ( might affect upto 1 in every 10 people ) low blood potassium ( may result in worsening kidney function ) diarrhoeas if you experience diarrhoeation , you should contact your doctor immediately . appropriate antidiarrhoeal treatment is not recommended . if you
what giotrif contains - the active substance is afatinib . each film - coated tablet contains 20 mg of afatinb . - the other ingredients are lactose monohydrate , microcrystalline cellulose , colloidal anhydrous silica , crospovidone , magnesium stearate . - tablet coating : hypromellose , macrogol 400 , titanium dioxide ( e171 ), polysorbate 80 . what giotrarif looks like and contents of the pack giotarif 20 mg film - coating tablets are white to off - white , round , biconvex ,
what orkambi is orkmbi contains two active substances called lumacaftor and ivacaftOR . it is a medicine used for long - term treatment of cystic fibrosis ( cf ) in patients aged 6 years and older with a mutation called f508del mutation . f508d is a protein that is found in cystic fibre conductance regulator ( cftr ) cells in the lungs . the mutation causes an abnormal cftR protein . lumacafor and / or ivacafir work together to remove the abnormal cFTr protein and replace it with lumacftor . lum
do not take orkambi if you are allergic to lumacaftor , ivacaftour or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking orkammi . if you have been told that you have the f508del mutation , your doctor may need to adjust your dose of orkababab . if any of these apply to you , tell your doctor . if your doctor has liver or kidney disease , your dose may need adjustment . your doctor will monitor the dose of okambabab and may also order abnormal
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose is 6 to 12 tablets a day . your doctor will tell you how many tablets of orkambi to take . the recommended starting dose is one 6 mg tablet a day for the first 6 weeks . your dose may be increased to 11 tablets a week . your daily dose of orkyambi is 100 mg once a day ( 2 tablets a 2 day ) for the next 12 weeks . the daily dose may also be increased . your physician will tell your doctor if
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with orkambi are usually mild to moderate . however , some patients may be more serious . if you are treated with ivacaftor , orkmbi may cause serious side effects . these effects may be due to orkibi : raised levels of liver enzymes in the blood , liver injury , pre - existing severe liver disease , or the worsening of liver function . other side effects include uncommon ( may affect up to 1 in 100 people ) the following symptoms : pain or discomfort in the upper right stomach (
what orkambi contains the active substances are lumacaftor and ivacaftum . orkammi 100 mg film - coated tablets each tablet contains 100 mg lumacftor and 125 mg ivacftum . each tablet of orkmbi 200 mg film film - coating contains 125 mg lumiacaftor or 125 mg of ivacaptor . each tablets of orkyambi 100mg film - coat contains 125mg lumacaptum and 125mg ivacrestor . the other ingredients are : orkabi 200mg film film coating contains cellulose , microcrystalline ,
what lynparza is lynparz contains the active substance olaparib . olaparaib is a type of cancer medicine known as a parp inhibitor ( poly [ adenosine diphosphate - ribose ] polymerase inhibitor ). it works by preventing mutations ( changes ) in a gene called brca ( breast cancer gene ). in cancer , parp inhibitors cause death by stopping cancer cells from working properly . it works in a similar way to an enzyme that helps repair dna . what lynparaz is used for lynparanza is used to treat adult patients with ovarian cancer called brcas ( mutated ovarian
do not use lynparza if you are allergic to olaparib or any of the other ingredients of this medicine ( listed in section 6 ). if you think this applies to you , tell your doctor before using lynparz . warnings and precautions talk to your doctor , pharmacist or nurse before using this medicine . children and adolescents do not give this medicine to children under 6 years of age . use in children and young children under 2 years of years is not recommended . other medicines and lynparaz tell your healthcare professional if you have any of these conditions : low blood cell counts ( seen in testing ). low counts of red
always take lynparza capsules exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of lynparz is 100 mg once a day . your doctor may increase your dose to 150 mg once daily . the doses of lynarza capsules are taken in combination with tablets . if you take more than one tablet of lynpalza per day , you may experience side effects of 8 mg . you should take the tablets by mouth once in the evening . if possible , take your tablet at about the same time each day . if necessary , take it at least 2 hours before
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): feeling short of breath , feeling very tired , pale skin , fast heart beat . these may be symptoms of a decrease in the number of red blood cells ( anaemia ). uncommon ( may effect up to 1 in 100 people ): allergic reactions ( hives , difficulty breathing or swallowing , dizziness ). signs and symptoms of hypersensitivity reactions are listed below . other side effects very common : may affect less than 1in 10 people : feeling sick ( nausea ) being sick ( vomiting ) feeling tired
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store below 25 . do away with any lynparza capsules that are damaged or have been frozen . lynparZA capsules may be stored at room temperature ( up to 30 ) for up to 3 days . do discard any capsules that have been stored at this temperature . do this as soon as possible and return the capsules to the refrigerator . do
what lynparza contains - the active substance is olaparib . each hard capsule contains 50 mg of olaparaib . - the other ingredients are lauroyl macrogol - 32 glycerides , hypromellose , titanium dioxide ( e171 ), gellan gum , potassium acetate , iron oxide black ( e172 ). what lynparz looks like and contents of the pack white , opaque , hard capsule with " olaparatib 50 mg " imprinted on one side and " astrazeneca logo on the other . the pack size is 112 capsules ( 4 blisters of 448 capsules
this medicine contains the active substance naloxone . nalxone is used to treat opioids such as heroin , methadone , fentanyl , oxycodone , buprenorphine and morphine . nyxoid is also used as a nasal spray for the emergency treatment of opioid overdose . opioid overdose is usually treated within 14 days . overdose may cause breathing problems and severe sleepiness . if you have an opioid overdose , you should immediately contact your doctor or get emergency medical care .
do not use nyxoid if you are allergic to naloxone or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using nyxoids . you may need emergency medical care or emergency services if you have an opioid overdose . the signs and symptoms of an opioid dose are listed below . if you think you may have an overdose , talk to a doctor , nurse or pharmacist before using this nasal spray . if it is 2 to 3 hours since you last used a new nasal spray , talk with your doctor . this medicine is not recommended
always use nyxoid nasal spray exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 . use the nasal spray in the shoulders , ears , breastbone , sternum or inside the ear . do not touch or sniff . do this with your fingernail . do the following : clear the mouth and nose of any blockages . do it in the mouth or nose . 1 . the most common symptom of breathing is the chest moving up towards the chest . if you hear breathing sounds or breath on the cheek , you should contact your doctor immediately . if
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : nyxoid may cause acute withdrawal symptoms , which may be more common in people taking opioid drugs . symptoms may include fast heart rate , high blood pressure body aches , stomach cramps , feeling sick , vomiting , diarrhoea , sweating , fever , goose bumps , shivering , trembling changes in behaviour , including violent behaviour , nervousness , anxiety , excitement , restlessness , irritability unpleasant or uncomfortable mood increased skin sensitivity difficulty in sleeping . acute withdrawal reactions may affect up to 1 in 100
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what nyxoid contains the active substance is naloxone . each nasal spray contains 1 . 8 mg of nalxone ( as hydrochloride dihydrate ). the other ingredients are trisodium citrate dihydrates , sodium chloride , hydrochloric acid , sodium hydroxide , purified water . the amount of ndaloxone in 0 . 1 ml is equivalent to a spray in a pre - filled nasal spray . nyxoids is available in a single dose container . nxoid is also available in packs containing a carton containing 2 nasal sprays in blisters . each spray contains one
what ovaleap is ovaleep contains the active substance follitropin alfa , which is a gonadotropin ( a type of hormone that is produced naturally in the body ). what ovaleape is used for ovaleaps is used to treat adult women with fsh , which are involved in the growth and development of the sacs ( follicles ) in the ovaries . it is used in women for the production of sperm ( a immature egg cell ) after treatment with a medicine called " clomifene citrate ". it is also used in adult women undergoing assisted reproductive technology procedures ( procedures to help
do not use ovaleap if you are allergic to follitropin alfa , follicle stimulating hormone or any of the other ingredients of this medicine ( listed in section 6 ) if you have a tumour in your hypothalamus or pituitary gland ( the brain ), if you know that you have large ovaries or sacs of fluids that contain the ovaries ( ovarian cysts ), if your doctor thinks that you may have unexplained vaginal bleeding , if you think you have cancer in your ovaries , womb or breasts , if any condition that makes normal pregnancy impossible , such as ovarian failure or early menopause ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use this medication is given as an injection into the tissue just under the skin ( subcutaneous injection ). if you have irregular periods , you will only be given this medicine once during the first 7 days of your menstrual cycle . the medicine will be given to you every day . the usual dose of this medicine is 75 mg . your doctor will tell you how many treatments you need . the recommended dose is 150 mg . you will be treated with this medicine for 7 days , followed by 14 days
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with ovaleap : serious side effects in women allergic reactions such as skin rash and raised itchy areas of skin . severe allergic reactions may include weakness , drop in blood pressure , difficulty breathing and swelling of the face . 37 this may affect up to 1 in 10 , 000 people . if you experience this type of reaction , your ovaleape injection should be stopped immediately . serious sideeffects in women lower stomach ache , nausea and vomiting are the symptoms of ovarian hyper - stimulation syndrome ( ohss ). this may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the cartridge after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the cartridge in the outer carton in order to protect from light . this medicine may be stored for a maximum of 3 days below 25 . do this medicine if it has been stored for more than 3 days at room temperature . once the cartridge has been removed from the refrigerator and has reached room temperature ( 28 ) it must either
what ovaleap contains the active substance is follitropin alfa . ovaleep 300 micrograms / 0 . 5 ml solution for injection : each cartridge contains 300 microlitres ( 22 microgram ) follitroin ala in 0 . 05 ml solution . ovalesap 450 microgramsis / 0. 75 ml solution : each cartridges contains 450 microlitre ( 33 microgram) follitopin alffa in 0.75 ml solution after preparation . ovaloap 900 microgramms / 1 . 5ml solution for injections : eachridge contains 900 microliters ( 66 microgram
voriconazole accord contains the active substance voriconazol . voricoazole is an antifungal medicine that works by killing or stopping the growth of the fungus that causes infections . it is used in adults and children from the age of 2 years to treat invasive aspergillosis ( a type of fungal infection caused by aspergonillus sp ). and candidaemia ( a form of fun fungal illness caused by candida sp ). in non - neutropenic patients ( patients with abnormally low white blood cells count ) to prevent candida Sp . infections . to reduce the amount
do not take voriconazole accord - if you are allergic to voricleazole or any of the other ingredients of this medicine ( listed in section 6 ). - if taking any other medicines , including herbal medicines . the medicines listed below may affect the way voricoazole accord treatment works . 46 terfenadine ( used to treat allergy ) astemizole ( used for allergy ) cisapride ( used in treating stomach problems ) pimozide ( used when treating mental illness ) quinidine ( used if you have irregular heart beat ) rifampicin ( used used to prevent
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will work out your dose based on your weight and the type of infection . the usual starting dose is 40 mg once a day . this will be increased to 40 mg twice a day for 24 hours . your dose may be increased by 400 mg once daily for 12 hours . this may be reduced to 200 mg once every 12 hours for 24 days . this dose may also be increased up to 200mg once a daily for 100 days . your first dose of treatment will be given to you in the hospital
like all medicines , this medicine can cause side effects , although not everybody gets them . if any side effects occur , they are usually mild to moderate and of a short duration . serious side effects stop taking voriconazole accord and tell your doctor straight away : rash , jaundice , changes in blood tests of liver function ( pancreatitis ). other side effects very common ( may affect more than 1 in 10 people ): visual impairment ( change in vision , blurred vision , visual color alterations , abnormal intolerance to visual perception of light , colour blindness , eye disorder , halo vision , night blindness , swinging vision , seeing sparks ,
what voriconazole accord contains the active substance is voricazole . each tablet contains 50 mg voricleazole ( as besilate ). each tablet of voricoazole accord 50 mg ( film - coated tablets ) contains 200 mg vorbiconazose ( as mesilate ) the other ingredients of vorbicazle accord 200 mg are lactose monohydrate , pregelatinised starch , croscarmellose sodium , povidone , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactosemonohydrate and triacetin
mvabea is a vaccine to protect you against ebola virus disease in the future . adults and children from 1 year of age and older who have ebola virus and who have not had a 2 - dose course of vaccinations before have ebla virus disease caused by the zaire ebolavirus or filovirus . this vaccine contains the whole ebolairus and will not give you ebola disease . warnings and precautions talk to your doctor or nurse before you are given mvabeas . vaccinations you will receive : one type of zabdeno vaccine , given 8 weeks later . mvabdena
your doctor will decide on the correct dose and duration of the vaccination course . if you have previously received the vaccine , you should not receive mvabea if you had a severe allergic reaction ( see section 6 . if a severe allergy reaction to an antibiotic called ' gentamicin ' is not recommended , your doctor will give you the vaccine instead of mvabdeno ). if you think you may have had asevere allergic reaction , talk to your doctor . warnings and precautions talk to you doctor or nurse before you receive movabea . if any of the following apply to you , tell your doctor or pharmacist before
the recommended dose of vaccine is given as a muscle ( intramuscular injection ) in the upper arm , thigh or blood vessel . the recommended dose is one dose of one dose ( 0 . 5 ml ) of vaccine containing zabdeno vaccine 8 weeks later . if you are given more mvabea vaccine than you should the second vaccine will be given as an additional dose . the first dose of the second dose is given at the end of the first cycle . if your child is given more vaccine than he / she should primary vaccination first vaccination with zab deno red cap vial ( 0 .. 5 ml ).
like all medicines , this vaccine can cause side effects , although not everybody gets them . the following side effects may happen with mvabea : very common ( may affect more than 1 in 10 people ): pain , warmth , swelling where the injection is given feeling very tired muscle ache joint pain common ( might affect up to 1 in every 10 people ) feeling sick ( vomiting ) itching where the vaccine is given uncommon ( may affects up to1 in every 100 people ): redness , skin hardness where thejection is given generalised itching . the most common side effects are : common ( likely to affect up in 1 in a 10
what mvabea contains the active substance is zaire ebolavirus 29 produced inactivated by recombinant dna technology inactivated with tai forest ebolovirus nucleoprotein marburg equivalent to 0 . 7 mg / kg . the other ingredients are : 108 antigen derived from chicken embryo fibroblast cells . this vaccine contains trace residues of gentamicin , sodium chloride , trometamol , water for injections and hydrochloric acid ( for ph adjustment ). what mvabaa looks like and contents of the pack mvagaa is a suspension for injection in a single - dose glass v
bondronat contains the active substance ibandronic acid . this belongs to a group of medicines called bisphosphonates . it is used to treat breast cancer that has spread to your bones ( called ' bone ametastases '). it helps to prevent your bones from breaking ( fractures ) and other bone problems that may need surgery or radiotherapy bondronat is used if you have a raised calcium level in your blood due to a tumour . it helps reduce the amount of calcium that is lost from your bones . this helps to stop your bones getting weaker .
do not take bondronat if you are allergic to ibandronic acid or any of the other ingredients of this medicine ( listed in section 6 ) if you have low levels of calcium in your blood . warnings and precautions talk to your doctor or pharmacist before taking bondronate if you : have a possible side effect called osteonecrosis of the jaw ( onj ) ( bone damage in the jaw ) you are taking bondroneat for the treatment of cancer or related conditions . onj can occur several months after stopping treatment . on j is a painful condition that can be difficult to treat . therefore , you should be
this medicine is given to you by a doctor or nurse who is experienced in the treatment of cancer . it is given as an infusion into your vein . your doctor will carry out regular blood tests to check how well you are being treated . your dose of bondronat will be adjusted depending on your illness . if you have breast cancer that has spread to your bones , it will usually be given 3 - 4 weeks after your last dose . this will be given as a single dose as an injection in your vein over a period of about 15 minutes . if there is a raised calcium level in your blood , it may be given once every
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following side effects you may need urgent medical treatment : rare ( may affect up to 1 in 1 , 000 people ) persistent eye pain or inflammation new pain , weakness or discomfort in your thigh , hip or groin . this may be a sign of unusual fracture of the thigh bone . very rare ( might affect up in 1 in 10 , 000 patients ) pain or sore in your mouth or jaw . these may be signs of severe jaw problems called necrosis ( dead bone tissue in the jaw bone ). ear
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . after dilution the infusion solution should be used immediately . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2ºc - 8ºc . do use this product if you notice that the solution is not clear or contains particles .
what bondronat contains - the active substance is ibandronic acid . each 2 ml vial contains a concentrate for solution for infusion that contains 2 mg ibandronat . - the other ingredients are sodium monohydrate , sodium chloride , acetic acid , sodium acetate , water for injections . what bondronAT looks like and contents of the pack the concentrate for concentrate for solutions for infusion is a white to off - white cake . the solvent is a clear , colourless liquid . bondronats is supplied in packs containing 1 or 2 vials with a bromobutyl rubber stopper .
what zeposia is zepoia belongs to a group of medicines that affect the number of white blood cells ( lymphocytes ). what zepoesia is used for zeposeia is a treatment for adults with relapsing remitting multiple sclerosis ( rrms ), a rare but active disease that affects the nerves of the brain and spinal cord . symptoms include numbness , difficulty in walking and problems with vision and balance . relapsed remitting ms is attacks on the nerve cells . the symptoms disappear for a few days or weeks , but for periods , some problems may remain . how zeposesia
do not take zeposia if you are allergic to ozanimod or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severely weakened immune system . if you had a heart attack , angina , stroke , mini - stroke or transient ischemic attack ( tia ). if severe heart failure has occurred within the last 6 months . if your heartbeats ( arrhythmia ) are irregular or abnormal . if any of these apply to you , tell your doctor before you start treatment . if the patient has severe infection such as hepatitis , tuberculosis or cancer . if he / she
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take your doctor will work out the dose of zeposia you need to take . your doctor may also check your heart rate and may prescribe you a ' treatment initiation pack ' for the first 4 weeks . the recommended dose is 0 . 23 mg ozanimod once a day . this is taken as 1 capsule once a morning . the dose may be increased to 1 mg once a afternoon . the maximum recommended dose for the second 4 weeks is 4 mg once daily . the doctor may prescribe
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : very common ( may affect more than 1 in 10 people ): slow heart rate urinary tract infection ( raised blood pressure uncommon ( may effect up to 1 in 100 people ): allergic reaction . the signs may include a rash . other side effects include : very commonly ( may affects more than one in 10 persons ): infections of the nose or nostrils , nasal cavity , mouth , throat ( pharynx ) or voice box ( larynx ). viruses and
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine in the original package in order to protect from moisture . do do not take this medicine if you notice any damage or signs of tampering to the pack . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what zeposia contains the active substance is ozanimod . zeposeia 0 . 23 mg : each capsule contains 0 . 22 mg ozanimog ( as hydrochloride ). zepoesia 0. 46 mg : one capsule contains approximately 0 . 46 mg ozimod ( as hydrometrochloride ) and zeposesia 0 , 92 mg : two capsules contain approximately 0. 92 mg ozmogromod (as hydrochlorine ). the other ingredients are microcrystalline cellulose , silica , colloidal anhydrous , croscarmellose sodium , magnesium st
what temybric ellipta is temyebric elliptic contains two active substances called fluticasone furoate and umeclidinium bromide ( vilanterol ). fluticastone furaate belongs to a group of medicines called corticosteroids ( steroids ). umecylidinia bromine and vilansterol belong to agroup of medicines known as bronchodilators . what temybarric elliptical is used for temymbric elliptetic is used to treat chronic obstructive pulmonary disease ( copd ). copd is a long -
do not use temybric ellipta - if you are allergic to fluticasone furoate , umeclidinium , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using temy bric elliptfa - if your child has asthma . warnings and precaution talk to the doctor or nurse before using this medicine : - if the child has ever had asthma . temyberric elliptea should not be used in children with asthma . - if any of your child ' s medical conditions has been previously untreated
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . try to use temybric ellipta at the start of each day and continue to use it until your doctor tells you otherwise . if you use more temybiric ellipte than you should if you have used more tembric ellipta than you need , contact your doctor immediately . symptoms of temybreric elliptoe may include a sudden attack of
like all medicines , this medicine can cause side effects , although not everybody gets them . immediate breathing difficulties if your breathing or wheezing gets worse while taking this medicine , tell your doctor straight away . pneumonia ( infection of the lung ) in copd patients the most common side effect of temybric ellipta is symptoms of a lung infection such as fever and chills . increased mucus production , change in mucus colour , increased cough and increased breathing difficulties common side effects ( may affect up to 1 in 10 people ) sore or raised patches in the mouth or throat . this may be a fungal infection ( candidiasis
what temybric ellipta contains - the active substances are fluticasone furoate , umeclidinium bromide and vilanterol . each delivered dose contains 92 micrograms of flutic asone firoate , 65 microgram of umeklidinum bromate and 55 microgram / ml of umclidinicium ( as 22 microgram per ml ) vilancerol and trifenatate . - the other ingredients are lactose monohydrate ( see section 2 under ' temy bric elliptas contains lactose '), magnesium st
zinforo is an antibiotic medicine that contains the active substance cefaroline fosamil . it belongs to a group of medicines called 'cephalosporin antibiotics '. what zinforo used for zin foro is used to treat infections of the skin and the tissues below the skin . it is also used to prevent an infection of the lungs called ' pneumonia '. how zin Foro works zininforoe works by killing certain bacteria that cause serious infections .
do not use zinforo if you are allergic to ceftaroline fosamil or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic to othercephalosporin antibiotics . if you have had previous severe allergic reactions to other antibiotics ( such as penicillin or carbapenem ). warnings and precautions talk to your doctor or pharmacist before using zin foro . if any of these apply to you , tell your doctor before using this medicine . warnings and risks talk to the doctor or nurse before using it if you : have kidney problems . have
the recommended dose of zinforo is 600 mg once a day . your doctor will tell you how many doses to give . the recommended dose is one 600 mg tablet once a week for 8 weeks . if you have some infections that you may need to stop treatment for 8 to 12 weeks , your doctor may give you a lower dose . zin foro is given as a drip into a vein ( intravenously ) over a period of 5 minutes . your dose may be increased to 60 mg once every 120 days . your physician may give an increased dose depending on how you respond to treatment . the first 5 to 14 treatments are
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following side effects you may need urgent medical treatment : sudden swelling of your lips , face , throat or tongue , a severe rash , or swallowing or breathing problems . these could be signs of a severe allergic reaction ( anaphylaxis ). diarrhoea or stool that contains blood or mucus . your doctor may decide to stop treatment with zinforo or to give you medicines to slow bowel movement . this may take up to 1 in 10 people . a blood test called a ' co
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do this to protect from light . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what zinforo contains the active substance is ceftaroline fosamil . the other ingredients are arginine . what zinFORo looks like and contents of the pack zinofo is a pale yellowish to light yellow powder for concentrate for solution for infusion in a vial . it is supplied in packs containing 10 vials .
pfizer belongs to a group of medicines used to treat epilepsy , neuropathic pain and generalised anxiety disorder ( gad ) in adults . peripheral and central neuropathicpain : pregabalin pfizer is used to relieve long lasting pain caused by damage to the nerves . a variety of diseases can cause peripheral neuropathic arthritis , such as diabetes or shingles . pain sensations may be described as hot , burning , throbbing , shooting , stabbing , sharp , cramping , aching , tingling , numbness , pins and needles . peripheral or central neuropathy pain may also be associated with mood changes , sleep
do not take pregabalin pfizer if you are allergic to pregagabalin or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking pregabil pfiser . some patients taking pregaabalin pumpfizer have reported symptoms suggesting an allergic reaction . these symptoms include swelling of the face , lips , tongue , and throat and diffuse skin rash . should you experience any of these reactions , you should contact your doctor immediately . pregibalin has been associated with dizziness and somnolence , which could increase the
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . pregabalin pfizer is for oral use . peripheral and central neuropathic pain , epilepsy and generalised anxiety disorder : the usual dose is 150 mg once a day . your doctor may increase your dose to 600 mg once daily depending on your response to pregibalin psfizer . take pregaboralin pfeizer once in the morning and once inthe evening . swallow the capsule whole with a glass of water . do not crush or chew the capsule . children and adolescents 59 take
like all medicines , this medicine can cause side effects , although not everybody gets them . very common : may affect more than 1 in 10 people dizziness , drowsiness , headache . common : might affect up to 1 in every 10 people increased appetite . feeling of elation , confusion , disorientation , decrease in sexual interest , irritability . disturbance in attention , clumsiness , memory impairment , loss of memory , tremor , difficulty with speaking , tingling feeling , numbness , sedation , lethargy , insomnia , fatigue , feeling abnormal , blurred vision , double vision , vertigo , problems with balance
what pregabalin pfizer contains the active substance is pregibalin . each hard capsule contains 25 mg , 50 mg , 75 mg , 100 mg , 150 mg , 200 mg , 225 mg or 300 mg of pregabialin . the other ingredients are lactose monohydrate , maize starch , talc , gelatine , titanium dioxide ( e171 ), sodium laurilsulphate , anhydrous colloidal silica . the printing ink contains black ink , shellac , black iron oxide ( e172 ), propylene glycol ( e1520 ), potassium hydroxide ) and the printing
xadago is a medicine that contains the active substance safinamide , which increases the levels of dopamine in the brain . this is a stimulant of the brain involved in movement . in parkinson ' s disease , the body struggles to move normally . xadago helps to control parkinson ', a condition that causes sudden swings in the ability to move . this can lead to difficulties moving . xADago is used in adults , adolescents and children aged one month and older . the medicine is used on its own in combination with levodopa ( other medicines used to treat parkinson' s disease ).
do not take xadago - if you are allergic to safinamide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking any of any of these : - monoamine oxidase ( mao ) inhibitors ( e . g . selegiline , rasagiline ), moclobemide , phenelzine , isocarboxazid , and tranylcypromine . - if treatment for parkinson ' s disease is not suitable for you - depression . - pethidine , a strong pain killer . see
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of xadago is 50 mg twice a day ( 100 mg taken by mouth ). your doctor will tell you how many tablets of xADago to take . if you have moderately reduced liver function , your doctor may prescribe a lower dose of 50 mg once a day . take xadadago with food . xadagon should be taken with or without a meal . if taking more xadado than you should if you take more tablets than you have been told to take , or if
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : hypertensive crisis ( very high blood pressure that may lead to collapse ) neuroleptic malignant syndrome ( confusion , sweating , muscle rigidity , hyperthermia ), increase level of enzyme creatine kinase in your blood ( serotonin syndrome ), confusion , hypertension , muscle stiffness , hallucinations ( hypotension ). the following side effects have been reported with the use of parkinson ' s disease in combination with safinamide and levodopa . they are usually mild to moderate and usually disappear after a few weeks . other
what xadago contains - the active substance is safinamide . each tablet contains 50 mg or 100 mg safinate . - the other ingredients are methansulfonate , microcrystalline cellulose , crospovidone type a , magnesium stearate , silica colloidal anhydrous - tablet coating contains hypromellose , macrogol , titanium dioxide ( e171 ), iron oxide red ( e172 ) what xadark looks like and contents of the pack xadagon 50 mg film - coated tablets of 7 mm diameter with metallic gloss are engraved with ' 50 ' on one
zytiga is a medicine containing abiraterone acetate that is used to treat prostate cancer that has spread to other parts of the body . zytiga increases testosterone in the blood when used to fight prostate cancer . ztiga is used in patients who have disease that has not responded to hormone therapy or who have not responded adequately to a treatment that lowers testosterone ( androgen deprivation therapy ). it is used with another medicine , prednisone . prednisolone is used for high blood pressure in adult patients whose body is not able to absorb the medicine properly and which causes fluid retention in your blood .
do not take zytiga if you are allergic to abiraterone acetate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be pregnant . warnings and precautions talk to your doctor or pharmacist before taking zytig if you have severe liver damage or prostate cancer . this medicine should not be taken with this medicine . if you know that you may have any of these conditions , tell your doctor before taking this medicine : if you suffer from liver problems such as high blood pressure , heart failure , low blood potassium . if any of those conditions apply to you , tell the doctor
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 , 000 mg once a day . you should take this tablet at the same time each day . this medicine is for oral use . swallow the tablet whole with a glass of water . do not chew or crush the tablet . take the tablet with food . it is best to take the tablets by mouth . if you take more zytiga than you should if you accidentally take too many tablets , contact your doctor immediately . if possible , take your tablets with food and drink . if more
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking zytiga and contact your doctor immediately if you experience : muscle weakness , muscle twitches , a pounding heart beat or palpitations . the level of potassium in your blood is low . your doctor may check your potassium more frequently . other side effects include : very common ( may affect more than 1 in 10 people ): fluid in your legs or feet ( signs of low blood potassium and liver function test ) high blood pressure urinary tract infection , diarrhoea common ( might affect up to 1 in every 10 people ) high fat levels in
what zytiga contains - the active substance is abiraterone acetate . each tablet contains 250 mg abirate acetate - the other ingredients are microcrystalline cellulose , croscarmellose sodium , lactose monohydrate , magnesium stearate , povidone ( k32 ), colloidal anhydrous silica , sodium laurilsulfate . see section 2 " zytigo contains lactose ". what zytig looks like and contents of the pack - zytige tablets are white to off - white , round , 9 . 5 mm in diameter . the tablets are provided
hefiya contains the active substance adalimumab . it is a medicine used for the treatment of inflammatory diseases : polyarticular juvenile idiopathic arthritis , enthesitis - related arthritis , paediatric plaque psoriasis , paedile crohn ' s disease and paediatric non - infectious uveitis . adalumab is a monoclonal antibody . monoclal antibodies attach to specific proteins in the body . ad alimumab works by blocking a protein called tumour necrosis factor ( tnfα ). tnfsα is a protein that is involved in the inflammatory diseases and
do not take hefiya if your child is allergic to adalimumab or any of the other ingredients of this medicine ( listed in section 6 ). if your or your child has a severe infection , including tuberculosis , sepsis ( blood poisoning ), or other opportunistic infections . tell your doctor if your / your child ' s doctor thinks that your / his child ' re developing unusual infections . if your/ your child ´ s doctor has told you that your or his child ¨ s child  s child has developed a weakened immune system . symptoms of infections may include fever , wounds , feeling tired , dental problems
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is : adults 40 mg twice a day ( morning and evening ) for 20 days followed by 20 days for 40 days . children and adolescents polyarticular juvenile idiopathic arthritis age and body weight how much to use adults 2 years of age and older , weighing 30 kg or more 40 mg once a day for 10 days followed thereafter by 20 mg once daily for 20 weeks . enthesitis - related arthritis age or body weight when to use children and adolescent weighing 6 kg or less ,
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . tell your doctor straight away if you notice any of the following side effects ( see section 4 , " warnings and precautions "): - after the last hefiya injection , you may experience allergic reaction ( e . g . heart failure ), severe rash , hives , swollen face , hands , feet , trouble breathing , swallowing , shortness of breath and swelling of the feet . tell a doctor straightaway if you have any of these . signs and symptoms of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre - filled syringe in the outer carton in order to protect from light . after first opening , the product may be stored at room temperature ( up to 25 ) for a maximum period of 14 days . once removed from the refrigerator for room temperature storage , your pre -filled syringe must be used within 14 days or discarded
what hefiya contains - the active substance is adalimumab . each pre - filled syringe contains 20 mg of adalumab in 0 . 4 ml solution . - the other ingredients are adipic acid , citric acid monohydrate , sodium chloride , mannitol , polysorbate 80 , hydrochloric acid and sodium hydroxide and water for injections . what hefiYA looks like and contents of the pack hefiqa 20 mg / 0 . 04 ml solution for injection is a clear to slightly opalescent , colourless to slightly yellowish solution . it is supplied in a clear type
what ritemvia is ritemv contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and dividing . what ritemvy is used for ritemvi is used to treat adults with two different types of lymphoma : a ) non - hodgkin ' s lymphoma this is an illness of the lymph tissue that affects the immune system . it affects a
do not take ritemvia if you are allergic to rituximab , other proteins that are similar to ritonuximb , or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe active infection if you suffer from a weak immune system if you suffered from severe heart failure or severe uncontrolled heart disease if you know that you have granulomatosis , polyangiitis , microscopic polyangis or pemphigus vulgaris ( see section " warnings and precautions "). warnings and risks talk to your doctor before taking ritemvi if you think you have
how much ritemvia is given your doctor will decide how much ritemvia you will receive . your doctor or nurse will monitor you for signs of this treatment . this medicine is given to you by a doctor or a nurse . if you have any side effects , your doctor may reduce your dose . how ritemv is given ritemva is given as a drip ( intravenous infusion ). medicines given before each ritemvi administration you will be given ritamvia together with other medicines ( pre - medication ) to reduce the risk of side effects . your treatment will be repeated every three weeks . how much and how
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number of
what ritemvia contains the active substance is rituximab . each ml of concentrate contains 100 mg of ritukimab ( as besilate ). each vial of concentrate contents contains 10 mg of the active ingredient in ritudimab ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what ritemva looks like and contents of the pack ritemvest is a clear , colourless solution for infusion in a glass vial . pack size of 2 .
capecitabine teva belongs to a group of medicines called " cytostatic medicines ", which stop the growth of cancer cells . capecitabate teva contains capecitibine , which itself is not a cytostatics medicine . only after being absorbed by the body is it changed into an active anti - cancer medicine . capecabine cheva is used in the treatment of colon , rectal , gastric , or breast cancers . capectabineteva is prescribed for the prevention of colon cancer after complete removal of the tumour by surgery . cape citabine may be used either alone or in
do not take capecitabine teva if you are allergic to capecitibine or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may have an allergy , ask your doctor for advice before taking this medicine . if you have had severe reactions to fluoropyrimidine therapy ( a group of anticancer medicines such as fluorouracil ) if you ( or your partner ) are pregnant or breast - feeding if you suffer from low levels of white cells or platelets in the blood ( leucopenia , neutropenia or thrombocytopenia ) if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . capecitabine should only be prescribed by a doctor experienced in the use of anticancer medicines . your doctor will prescribe a dose and treatment regimen that is right for you . the dose of capecitabiline teva depends on your body surface area ( height and weight ). the usual dose for adults is 1250 mg / m2 of body surface surface taken once a day . this is equivalent to a daily dose of 64 mg . your height should be 1 . 64 m2 taken once daily . a
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking capecitabine teva and contact your doctor immediately if you have any of these symptoms : diarrhoea : if you experience an increase of 4 or more bowel movements compared to your normal bowel movements , or any diarrhoehoea at night . vomiting : if vomiting is severe and you vomit more than once in a 24 - hour time period . nausea : if your stomach does not empty as quickly as it should . if you lose your appetite . stomatitis : if pain , redness , swelling or sores in your
what capecitabine teva contains the active substance is capecitabiline . capecitavine tevas 150 mg film - coated tablets each film - coating contains 150 mg capecitobine . the other ingredients are : capecitafine teeva 500 mg film film - coat contains 500 mg capecabine . tablet coating : lactose , microcrystalline cellulose , hypromellose , croscarmellose sodium , magnesium stearate , macrogol 400 , hyproellose, titanium dioxide ( e171 ), yellow iron oxide ( e172 ), red iron oxide red ( e 172
silodosin recordati contains silodosino recordati . it belongs to a group of medicines called alpha1a - adrenoreceptor blockers . silodosein recordat is used to lower the pressure in the prostate , bladder and urethra , where it causes smooth muscle in the tissues . this helps to control your symptoms . silosinrecordati is used for the urinary symptoms associated with benign enlargement of the prostate ( prostatic hyperplasia ), such as difficulty in starting to pass water and a feeling of not completely emptying the bladder .
do not use silodosin recordati - if you are allergic to silodosein or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using silodousin recordi - if your child is going to undergo eye surgery - if there is cloudiness of the lens ( cataract surgery ) in your child ' s eye 26 - if the child is being treated with silodocin recordat - if a child is given medicine that causes a loss of muscle tone in the iris ( the coloured part of the eye ) during a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of silodosin recordati is one capsule a day . you should take silodosein recordat for 8 hours . if you have kidney problems if you suffer from moderate kidney problems , your doctor may prescribe a lower dose . for this purpose silodosesin recordatin is taken once a day , in the morning and evening , at about the same time each day . take the capsule at about 4 hours before or at about about the time you usually take your first dose . if
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions may include swelling of the face or throat , difficulty in breathing , feeling faint , itchy skin and hives . the most common side effect of silodosin recordati is dizziness . dizziness may occur with difficulty in walking , feeling weak or dizzy . the symptoms may include dizziness and fainting . if you experience any of these , stop taking silodosiin recordat and seek medical advice straight away . complications following a cataract surgery ( eye surgery ) cloudiness of the lens of the eye has
what silodosin recordati contains the active substance is silodusin . each capsule contains 8 mg silodosein . the other ingredients are : capsule content : silodol ( e464 ), mannitol ( e421 ), magnesium stearate , sodium laurilsulfate , gelatin , titanium dioxide ( e171 ). capsule shell : silosin filmati 4 mg : siliodosin ( e463 ), mannaitol ( i421 ), aluminium stearata , magnesium stearingate , potassium laurilulfate . printing ink : gelatin , stainless dioxide ( i171 ), yellow iron oxide
kinzalmono belongs to a class of medicines known as angiotensin ii receptor antagonists . angiotENSin ii is a substance produced in your body which causes your blood vessels to narrow , thus increasing your blood pressure . kinzal mono blocks the effect of angiotenin ii so that the blood vessels relax , and your bloodpressure is lowered . kinzonmono is used to treat essential hypertension ( high blood pressure ) in adults . the high blood blood pressure is not caused by any other condition . high bloodpressure , if not treated , can damage blood vessels in several organs , which could lead sometimes
do not take kinzalmono - if you are allergic to telmisartan or any of the other ingredients of this medicine ( listed in section 6 ). - if more than 3 months pregnant ( it is also better to avoid kinzdalmono in early pregnancy see pregnancy section ). - tell your doctor if you have severe liver problems such as cholestasis or biliary obstruction ( problems with drainage of the bile from the liver and gall bladder ) or any other severe liver disease . - tell the doctor if any of these apply to you . - if your doctor has told you that you have diabetes or impaired
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . try to take the tablet at the same time each day . the tablets should be swallowed whole with some water . you can take kinzalmono with or without food . try not to take more tablets than your doctor tells you to . if you take more kinzdalmono than you should if you have taken too many tablets , contact your doctor immediately . treatment of high blood pressure the usual starting dose of kinzaline 40 mg once a day is
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious and need immediate medical attention : sepsis ( often called " blood poisoning "), is a severe infection with whole - body inflammatory response , rapid swelling of the skin and mucosa ( angioedema ). these side effects are rare ( may affect up to 1 in 1 , 000 people ). other side effects of kinzalmono common side effects ( may effect up to1 in 10 people ): low blood pressure ( hypotension ) reduction in cardiovascular events uncommon side effects : ( may impact up to one in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . once your medicine has been taken out of your refrigerator , it should be used immediately . do this if your kinzalmono tablet is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what kinzalmono contains - the active substance is telmisartan . each tablet contains 20 mg telmisantan . - the other ingredients are povidone , meglumine , sodium hydroxide , sorbitol ( e420 ), magnesium stearate . what kinzalao looks like and contents of the pack kinzalanmono 20 mg tablets are white to off - white , round and flat . kinzaloo is available in blister packs of 14 , 28 , 56 or 98 tablets . not all pack sizes may be marketed .
afstyla is a human clotting ( coagulation ) factor viii product . it contains the active substance lonoctocog alfa . afstylfa is used to treat bleeding episodes in adults with haemophilia a ( inborn factor v iii deficiency ). factor v viii is a component of blood clotting and is required to clot the blood . patients with an increased tendency to bleed have been shown to have higher levels of factor v ii in their blood than in patients with haophilia b . therefore , it is important to continue to clot until the blood is clotting again .
do not use afstyla if you have had an allergic reaction to afstylea or if you are allergic to hamster proteins 46 warnings and precautions talk to your doctor , pharmacist or nurse before using afstlera . the dose and the batch number are recorded in your treatment diary . do not use more afstila than your doctor has recommended . allergic ( hypersensitivity ) reactions are possible with afstreea . symptoms of allergic reactions may include : allergic reactions such as hives , generalised skin rash , tightness of the chest , wheezing , fall in blood pressure ( anaphyl
your treatment will be overseen by a doctor experienced in the treatment of blood clotting disorders . always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage the recommended dose of afstyla is one vial per day . dose and duration of treatment depending on your disease the site and the bleeding your clinical condition will be worked out by your doctor . reconstitution and administration general structures the powder and the solvent ( liquid ) should be mixed in a glass vial to form aseptic conditions . afstlva may be used with other medicines or sol
like all medicines , afstyla can cause side effects , although not everybody gets them . symptoms of allergic reactions allergic reactions may include hives , generalised urticaria ( itchy rash ), tightness of the chest , difficulty in breathing , wheezing , low blood pressure , dizziness , anaphylaxis ( bleeding caused by factor viii medicines ). inhibitor antibodies ( see section 2 ) may affect up to 1 in 10 people . patients who have received previous treatment with factor v iii ( more than 150 days of treatment ), the risk is uncommon ( less than 1 in 100 people ). medicines to prevent persistent bleeding may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the afstyla powder in the outer carton in order to protect from light . after reconstitution , the product may be stored at room temperature ( up to 25 ) for a maximum period of 3 days . do away with the vial and keep it in theouter carton . do this until the reconstit
what afstyla contains the active substance is loroctocog alfa . each vial contains 250 iu ( 2 . 5 mg ) of lonoctocag alfa and after reconstitution with 2 .5 mg of loroectocog as solvent , each vials contains 200 iu lonoectocag aluminium . each pack contains 1000 iu of lanoctocg alfa ( 2 , 5 mg ). after reconitution with 5 mg of injections the solution contains 400 iu iu / ml lonoCTocog aluminium . the other ingredients are : 1500 iu powder
what praxbind is praxBind contains the active substance idarucizumab . idarucaizumb is a recombal agent of the form dabigatran ( pradaxa ), a blood thinner medicine used to prevent blood clot formation . what prax bind is used for praxbinding is used to rapidlytrap dabigATran . what it is usedfor ? prax binds is used in combination with pradxa in adults who are undergoing emergency surgery or urgent procedures to control uncontrolled bleeding .
do not take praxbind if you are allergic to idarucizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a genetic disease called hereditary fructose intolerance ( haf ) ( hf ) and have taken the substance sorbitol ( a substance derived from sugar ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you think any of these apply to you , or if you notice any of them apply to your child , or you are not sure , talk to a doctor or nurse before taking the medicine . taking this type of medicine dabigat
the recommended dose is 5 mg / kg ( equivalent to 2 . 5 mg dabigatran ). this medicine is given once a day . you will be given this medicine once a week for 5 days . this medicine will be injected into a vein . you should not receive more than one dose of this medicine during your treatment . if you have problems with blood clot formation , dabigATran may be given at least 24 hours after you have received this medicine . if this medicine has not been fully effective , your doctor will decide how long you should receive this medicine and will monitor you for any changes to your treatment , including any changes
like all medicines , this medicine can cause side effects , although not everybody gets them . reporting of side effects if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . you can also report side effects directly via the national reporting system listed in appendix v . by reporting side effects you can help provide more information on the safety of this medicine .
what praxbind contains - the active substance is idarucizumab . - the other ingredients are sodium acetate trihydrate , acetic acid , sorbitol ( e420 ), polysorbate 20 and water for injections . what praxbinding looks like and contents of the pack the clear , colourless to slightly opalescent , colourfully - to slightly yellow solution is supplied in a clear glass vial with a butyl rubber stopper and an aluminium cap .
temomedac contains a medicine called temozolomide . this medicine is an antitumour agent . temomedac is used to treat specific forms of brain tumours : - in adults with newly - diagnosed glioblastoma multiforme . temormac is first given together with radiotherapy ( concomitant phase of treatment ) and then alone ( monotherapy phase oftreatment ). - in children 3 years of age and older and adult patients with malignant glioma , such as glioclastoma multipurpose or anaplastic astrocytoma . temmedac is given in combination
do not take temomedac if you are allergic to temozolomide or any of the other ingredients of this medicine ( listed in section 6 ). if you have had an allergic reaction to dacarbazine ( an anticancer medicine sometimes called dtic ). signs of allergic reaction include feeling itchy , breathlessness , wheezing , swelling of the face , lips , tongue or throat . if any of these apply to you , tell your doctor immediately . if you notice any of your signs of a severe form of allergic problem , tell the doctor immediately : feeling ity , breathless , wheezy , swelling or
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and duration of treatment your doctor will work out your dose of temomedac based on your height and weight . this is especially important if you have a recurrent tumour that has not responded to chemotherapy treatment in the past . your doctor may also give you other medicines ( anti - emetics ) to take with temomedic to prevent nausea and vomiting . if you currently have newly - diagnosed glioblastoma multiforme , treatment will be divided into two phases : treatment with radiotherapy ( con
like all medicines , this medicine can cause side effects , although not everybody gets them . if you experience a severe allergic ( hypersensitive ) reaction , including hives , wheezing or other breathing difficulty , uncontrolled bleeding , seizures , convulsions , fever , chills and severe headache , stop taking temomedac and contact your doctor immediately . temomedic treatment may cause a reduction in certain kinds of blood cells . this may cause increased bruising or bleeding , anaemia ( reduced number of red blood cells ), fever and reduced resistance to infections . the reduction in blood cell counts is usually short - lived and can lead to anaemia
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store above 30 . do away with the capsules if you notice any change in the appearance of the capsules . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what temomedac contains the active substance is temozolomide . temomedic 5 mg : each capsule contains 5 mg temozoleomide ( as temomedaf ). temomedacon 20 mg : one capsule contains 20 mg temzolomine ( as mesomedaf . temmedac 100 mg : two capsules contain 100 mg tem ozolomides ( as besilate ). temmedacon 140 mg : three capsules contain 140 mg temazolomile ( as esilate . temarthac 180 mg : four capsules contain 180 mg temizolomid ( as bisectate ). the
cialis is a treatment for adult men with erectile dysfunction , a condition where a man cannot get , or keep a hard , erect penis suitable for sexual activity . cialis helps to provide a hard erect penis for sexual performance . cialsis contains the active substance tadalafil which belongs to a group of medicines called phosphodiesterase type 5 inhibitors . calis works by stopping the blood vessels in your penis from tightening . this helps your penis to relax and relax , allowing you to have sex more easily . this will help to maintain erectile function . cileis is used to treat adult men who
do not take cialis - if you are allergic to tadalafil or any of the other ingredients of this medicine ( listed in section 6 ) - if your doctor has told you that you are taking organic nitrate or nitric oxide donors ( such as amyl nitrite ) or medicines (" nitrates ") used to treat angina pectoris (" chest pain "). warnings and precautions talk to your doctor before taking ciali . these medicines may increase the amount of nitrate in your blood . - if any of these apply to you : - if : you have serious heart disease - recently had a heart
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cialis tablets are for oral use . swallow the tablet whole with a glass of water . the tablets can be taken with or without food . the usual dose is 5 mg twice a day ( 2 . 5 mg in the morning and 2 . 75 mg in in the evening ). if you take more cialnis than you should if you have taken more cialsis than you have been told to , tell your doctor straight away . if you forget to take
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with the medicine : allergic reactions ( rashes ) ( frequency not known ) chest pain ( common ) when taking nitrates ( frequency unknown ) priapsim may cause a prolonged and possibly painful erection . if this happens , stop taking cialis and seek medical help straight away . if you get an erection that lasts more than 4 hours , contact your doctor immediately . sudden loss of vision ( frequency cannot be estimated from the available data ). other side effects very common ( may affect more than 1 in 10 people ) uncommon
what cialis contains - the active substance is tadalafil . each tablet contains 2 . 5 mg of tadalabil . - the other ingredients are : tablet core : lactose monohydrate ( see section 2 ' cialises contains lactose '), croscarmellose sodium , hydroxypropylcellulose , microcrystalline cellulose , sodium laurilsulfate , magnesium stearate . film - coating : lactate monohydrate , hypromellose , triacetin , titanium dioxide ( e171 ), iron oxide yellow ( e172 ), iron ox red ( e129 ),
enyglid is an oral antidiabetic medicine containing repaglinide , which helps your pancreas produce more insulin and thereby lower your blood sugar ( glucose ). type 2 diabetes is a disease in which your pancrea does not make enough insulin to control the sugar in your blood or where your body does not respond normally to the insulin it produces . enyglID helps control type 2abetes by helping your pancryas produce better insulin and lower the sugar that your body makes . your doctor will also tell you how to increase the amount of sugar in the blood when you exercise or change how much food you eat .
do not take enyglid if you are allergic to repaglinide or any of the other ingredients of this medicine ( listed in section 6 ). if you have type 1 diabetes . if the acid level in your blood is too low ( diabetic ketoacidosis ). if your doctor has told you that you have a severe liver disease . if you take gemfibrozil ( a medicine used to lower increased fat levels ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking eny glid if : you have liver problems . you have moderate liver 28 disease
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 0 . 5 mg once a day . swallow the tablet whole with a glass of water . the maximum recommended dose for adults is 30 mg once daily . the dose may be increased to 4 mg once every day . the daily dose for children and adolescents is 30mg once a daily . use in children and teenagers ( aged 16 years and above ) your doctor will work out the right dose for you . if you take more enyglid than you should if you accidentally take too many en
like all medicines , this medicine can cause side effects , although not everybody gets them . hypoglycaemia is the most common side effect . hypocaemia may affect up to 1 in 10 people . hypoptycaemic reactions are generally mild / moderate . hypocemic unconsciousness ( coma ) is the first serious symptom of allergy allergy . very rare ( may affect more than 1 in every 10 , 000 people ). symptoms include swelling , difficulty in breathing , rapid heartbeat , feeling dizzy and sweating . this may be the first signs of anaphylactic reaction . other side effects common ( may affects up to1 in
what enyglid contains the active substance is repaglinide . each tablet contains 0 . 5 mg or 1 mg or 2 mg repagginide . the other ingredients are microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , povidone k25 , glycerol , magnesium stearate , meglumine , poloxamer , yellow iron oxide ( e172 ), red iron oxide (< e172 ) ( see section 2 " eny glid contains lactose "). what enylid looks like and contents of the pack eny
what azacitidine mylan is azacitonidine myl is an anti - cancer agent . what azaccitidine mylon is used for azac itidine myla is used to treat adults . what it is used in adults azac citidine myel is used : when a stem cell transplantation is needed in higher - risk myelodysplastic syndromes ( mds ) such as chronic myelomonocytic leukaemia ( cmml ) or acute myeloid leukaemic ( aml ). these are diseases that affect the bone marrow , which results in normal blood cell
do not take azacitidine mylan - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azac citidine myl : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition such as heart attack or lung disease . blood test before and during treatment with
before starting azacitidine mylan , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azaccitidine myl you need . your dose of this medicine will depend on your height and weight . azacacitine mylan will be administered every 3 weeks during this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) on the skin of the thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your doctor or
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising ( which may be symptoms of liver failure ). swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( which could be symptoms or signs of kidney failure ). a fever may be a sign of an infection . low levels of white blood cells . chest pain or short
your doctor , pharmacist or nurse knows how to store azacitidine mylan properly . any unused azaccitidine myl must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . the suspension must be used within 1 hour after preparation . the azacididine myla suspension will be stored in a refrigerator ( 2 8 ). the suspension will then be stored at room temperature ( up to 8 ) for up to a maximum of 8 hours . the zacitine mylan suspension will also be stored with water for injections . the
what azacitidine mylan contains the active substance is azacinidine . one vial of powder contains 100 mg azacacitine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaccitidine . the other ingredient is mannitol ( e421 ). what azacididine myl looks like and contents of the pack azacitonidine mylon is a white powder for suspension for injection in a glass vial containing 100 mg of azacilitidine . pack sizes of 1 and 7 vials . not all pack sizes may
duotrav eye drop solution contains two active substances , travoprost and timolol . travostrost is a prostaglandin analogue in the eye . timoll is a beta blocker that reduces the amount of fluid within the eye and reduces pressure within theeye . duotraveye drops are used to treat high pressure in theeye in adults with an illness called glaucoma .
do not take duotrav - if you are allergic to travoprost , prostaglandins , timolol , beta blockers or any of the other ingredients of this medicine ( listed in section 6 ). - if your child has respiratory problems such as asthma , severe chronic obstructive bronchitis or severe lung disease ( e . g . wheeziness , difficulty in breathing , long - standing cough , breathing problems , severe hay fever , a slow heartbeat ), heart failure ( a disorder of heart rhythm ), or if your eye becomes cloudy . warnings and precautions talk to your doctor before taking duotra : - if a
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use the recommended dose is one drop in the affected eye or eyes twice a day . do not use duotrav in both eyes . how to use duetrav is for oral use . use in children and adolescents the recommended doses are one drop twice a morning , one drop once in the evening , and one drop two times a day in the morning , at about the same time each day . use dudoserav in children aged 1 year and above , and in adolescents aged 3 years and
like all medicines , this medicine can cause side effects , although not everybody gets them . the drops should be kept in the bottle and should not be swallowed . duotrav can cause very common side effects ( may affect more than 1 in 10 people ) effects of the eye eye redness . common side effect ( may effect up to 1 in every 10 people ), effects of of theeye eye surface inflammation or surface damage . eye pain , blurred vision , abnormal vision , dry eye , itchy eye , eye discomfort . signs and symptoms of eye irritation such as burning or stinging . uncommon side effects these may affect up to1 in
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do away with the blister once you have opened the blister . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what duotrav contains - the active substances are travoprost and timolol . each ml contains 40 mg travostrost and 5 mg timolole ( as timolool maleate ). - the other ingredients are polyquaternium - 1 , mannitol , propylene glycol , polyoxyethylene hydrogenated castor oil 40 mg - the ingredients are boric acid , sodium chloride , sodium hydroxide , hydrochloric acid , purified water , sodium hydrochloride and hydrochlorIC acid . what duotra looks like and contents of the pack duotrev is a liquid (
nplate ' s active ingredient is romiplostim . it is a protein used to reduce low platelet counts in patients with a condition called immune ( idiopathic ) thrombocytopenic purpura ( itp ). itp is a disease that affects your body ' s immune system . platelets are important as they help protect the blood from blood clots . very low platelets can cause bruising and serious bleeding . nplate is used to treat adults , adolescents and children aged 1 year and above who have had their spleen removed or who have chronic itp . it may be used in patients who
do not take nplate if you are allergic to romiplostim or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before taking nplate : if you have a low blood platelet count ( thrombocytopenia ) if you take n plate to reduce your platelet counts . if you suffer from blood clots . if blood clotting is not possible . if any of these apply to you , tell your doctor . if your doctor thinks you may have liver problems . if if
nplate is used in adults and adolescents aged 1 to 17 years . your doctor will decide how much nplate you need and how often you need to take nplate . nplate is given as an injection under the skin ( subcutaneous ) in adults , adolescents and children aged 1 year and above . how nplate works nplate should be injected every day . your platelet counts will be checked regularly for the first time . you will also have regular blood samples taken to count your platelets . your dose will be adjusted depending on the level of platelet count in your blood . yourplatelet count will be calculated by your
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with itp : common ( may affect up to 1 in 10 people ): headache , allergic reaction , upper respiratory tract infection common ( might affect up in 1 in every 10 people ) bone marrow disorder , increased bone marrow fibres , trouble sleeping ( insomnia ), dizziness , tingling or numbness of the hands or feet ( paraesthesia ), migraine , redness ofthe skin , flushing , blood clot in a lung artery ( pulmonary embolism ), nausea , diarrhoea , abdominal pain , ind
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do store above 30 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what nplate contains the active substance is romiplostim . nplate 125 mg powder for solution for injection contains approximately 230 mg romiplopim . each vial contains 125 mg romplostim in a deliverable amount of 0 . 25 ml solution . each single - dose vial of 0 , 25 ml contains 125mg romiplustim . every two - dose per vial , each single dose per day contains 375 mg romclostim ( as besilate ). each single single -dose vial containing 250 mg romoplostim is supplied as besildate . each two -dose per day ,
this medicine contains an active substance called glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what tovanor breezhaler is used for this medicine is used to help to make breathing easier for adult patients with breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine works by tightening these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on copd .
do not use tovanor breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using tovanOR breez inhaler - kidney problems - if your doctor has told you that you have an eye problem called narrow - angle glaucoma ( difficulty passing urine ). your doctor may decide to temporarily stop treatment with tovannor breezer . if you have any of these conditions , stop using this medicine and tell your doctor immediately : - tightness of the
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much tovanor breezhaler to use the recommended dose of this medicine is 24 capsules ( in blisters ) once a day . your doctor will tell you how many capsules to use . the maximum recommended dose is 75 capsules ( per day ). you should use this this medicine every day , at the same time each day . this medicine comes as an inhaler and capsules ( blisters ). the medicine is inhaled through inhalation powder . the capsules are inhaled using the inhaler provided in
what tovanor breezhaler contains - the active substance is glycopyrronium bromide . each capsule contains 63 micrograms glycopirroniumbromide and 50 microgramS glycopyronium . each delivered dose ( the delivered dose ) delivers the delivered delivered dose into the mouthpiece of the inhaler delivering 44 microgram glycoprronium per inhalation dose . - the other ingredients of the inhale powder are lactose monohydrate and magnesium stearate . what tovanOR breez inhaler looks like and contents of the pack tovannor breezer 44
adasuve contains the active substance loxapine and belongs to a group of medicines called antipsychotics . it works by allowing the brain to produce more dopamine and serotonin which are involved in calming effects and relieving aggressive behaviour . adasuve is used to treat acute symptoms of mild - to - moderate agitation in adults with schizophrenia and bipolar disorder . these are diseases characterised by symptoms such as ( schizophrenia ) hearing , seeing or sensing things which are not there , mistaken beliefs , incoherent speech and behaviour and emotional flatness . people with bipolar disorder may also feel depressed , guilty , anxious or tense . the most common symptoms
do not take adasuve if you are allergic to loxapine or any of the other ingredients of adasuvet ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking adasuves if you have symptoms such as wheezing or shortness of breath , lung problems like asthma , chronic obstructive pulmonary disease ( copd ), narrowing of the airways ( bronchospasm ), wheeze , cough , chest tightness or short shortnessof breath . these may be signs of 25 neuroleptic malignant syndrome ( nms ), a group of symptoms that have been reported
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 9 . 1 mg twice a day ( taken in 2 to 4 hours apart ). your doctor may increase your dose to 4 . 5 mg twice daily depending on your condition . adasuve is for oral use . you should take adasuves with food . it is best to take adasve with a meal or snack . it should be taken with or just after a meal . you can take adamsve with or without food . you may find it easier to take it with or
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following side effects : any breathing symptoms such as wheezing , cough , shortness of breath , chest tightness , irritating your airways ( asthma or copd ), light - headedness or fainting . these may be signs that your blood pressure is not being controlled as well as worsening agitation , confusion , fever and muscle stiffness . these could be signs of a severe condition called neuroleptic malignant syndrome . other side effects include : very common ( may affect more than 1 in 10
keep this medicine out of the sight and reach of children . do not use adasuve after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . do away with adasuves if you notice any visible signs of physical damage . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what adasuve contains - the active substance is loxapine . each single - dose inhaler contains 5 mg of loxapeine . one delivers 4 . 5 mg loxagine . what adasuves looks like and contents of the pack adasuva 4 . 95 mg is a white to off - white plastic inhaler , with " lox " printed on the cap and " nvr " printed in black on the body . each inhaler is provided in a sealed foil pouch . adasuvey is available in packs containing 4 . 0 mg , 1 mg or 5 mg inhalers . not all pack
what azacitidine betapharm is azacitonidine betabarm is an anti - cancer agent . it belongs to a group of medicines called ' anti - metabolites '. what azaccitidine betafarm is used for azaciticidine betaparm is for use in adults . azacididine betagarm is given to adults who have had a stem cell transplantation to treat : higher - risk myelodysplastic syndromes ( mds ) chronic myelomonocytic leukaemia ( cmml ) acute myeloid leukaemic ( aml ). aml is
do not take azacitidine betapharm - if you are allergic to azaccitidine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have advanced liver cancer . warnings and precautions talk to your doctor or pharmacist before taking azacacitine betapham : - if the patient has decreased counts of platelets , red or white blood cells . - if he / she has kidney disease . - tell your doctor if the person has liver disease . if the doctor has a heart condition that makes you prone to heart attack or lung disease . blood
before starting azacitidine betapharm , you will be given another medicine to prevent nausea and vomiting . the recommended dose is 75 mg once a day . your doctor will decide how much azacita betapham you need . your dose of this medicine will depend on your height and weight . azaccitidine betafarm is given every 3 weeks as part of this " treatment cycle " ( cycle 4 , 6 ). this medicine is given under the skin ( subcutaneously ) on the skin of the thigh , tummy or upper arm . if you have any further questions on the use of this product , ask your
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience any of the following serious side effects : drowsiness , shaking , jaundice , abdominal bloating and easy bruising ( which may be symptoms of liver failure ). swelling of the legs and feet , back pain , reduced passing of water , increased thirst , rapid pulse , dizziness , nausea , vomiting , reduced appetite , confusion , restlessness and fatigue ( which could be symptoms or signs of kidney failure ). a fever may be a sign of an infection . low levels of white blood cells . chest pain or short
your doctor , pharmacist or nurse knows how to store azacitidine betapharm properly . any unused azaccitidine betabarm must be disposed of in accordance with local requirements . this medicine is for single use only . this medicinal product does not require any special storage conditions . the suspension must be used within 45 minutes . the azacididine betafarm suspension will be prepared and diluted with water for injections . the preparation will be stored in a refrigerator ( 2 8 ). the azackitidinebetapharm suspension is prepared and mixed in water for injection and will be kept in the refrigerator ( 3 8 )
what azacitidine betapharm contains the active substance is azaccitidine . each vial contains 100 mg azacacitine . after reconstitution with 4 ml of water for injections , the reconstituted suspension contains 25 mg / ml azaciticidine . the other ingredient is mannitol ( e421 ). what azacididine betafarm looks like and contents of the pack azacitonidine betabarm is a white to off - white powder supplied in a glass vial containing 100 mg of azacilitidine .
cerdelga contains the active substance eliglustat . it is used for the long term treatment of gaucher disease type 1 in adults . gaucher dementia type 1 is inherited condition in which a substance called glucosylceramide is not removed from your body . this substance is mainly produced by the spleen , liver and bones . when eliglustate is taken with glucoslceramide , it stops the production of glucosyleceramide and helps to rebuild your affected organs . your doctor will test for this before you start taking this medicine . if you have any further questions on the use of this medicine , ask your
do not take cerdelga if you are allergic to eliglustat or any of the other ingredients of this medicine ( listed in section 6 ). if you take medicines known as moderate cyp2d6 inhibitors ( e . g . quinidine , terbinafine ) 31 if you have moderate cyc3a inhibitors ( such as erythromycin or itraconazole ). if any of these medicines affect your body ' s ability to function properly , do not take them . warnings and precautions talk to your doctor before taking cerdelg . if you think any of this applies to you , or if
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of metaboliser twice a day . the amount of metabolizer that you need is based on your body weight . the usual dose is two tablets of one tablet each day . swallow the tablets with a glass of water . if you take more cerdelga than you should if you accidentally take more tablets than you have been told to , contact your doctor straight away . if possible , take the tablet with a meal . do not take more than the recommended daily dose . if necessary ,
like all medicines , this medicine can cause side effects , although not everybody gets them . very common ( may affect more than 1 in 10 people ): headache dizziness change in taste ( dysgeusia ) palpitations throat irritation heartburn ( dyspepsia ) feeling sick ( nausea ) diarrhoea constipation abdominal pain stomach ache ( upper abdominal pain ) acid reflux disease ( gastrooesophageal reflux diseases ) bloating ( abdominal distension ) inflammation of the stomach ( gastritis ) 34 difficulty swallowing ( dysphagia ) vomiting dry mouth gas ( flatulence ) dry skin hives ( ur
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the outer carton and on the sleeve after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what cerdelga contains - the active substance is eliglustat . each capsule contains 84 mg of eliglustate . - the other ingredients are : capsule content : microcrystalline cellulose , lactose monohydrate ( see section 2 ' cerdelaga contains lactose '), hypromellose , glycerol dibehenate , gelatin , potassium aluminium silicate , titanium dioxide ( e171 ), yellow iron oxide ( e172 ), indigotine ( e132 ), shellac , black iron oxide , propylene glycol and ammonia solution . what cerdelg looks like and contents of the pack cerdelgi
the active substance in zoledronic acid hospira is zoledron acid , which belongs to a group of substances called bisphosphonates . zoledor acid works by attaching itself to the bone and slowing down the rate of bone change . it is used to prevent bone complications , e . g . fractures , in adult patients with bone metastases ( spread of cancer from primary site to the rest of the bone ). it reduces the amount of calcium in the blood in adult men when there is a tumour . tumours can accelerate normal bone change in such a way that the release of calcium from bone is increased . this
your doctor will carry out blood tests before you start treatment with zoledronic acid hospira and will check your response to treatment regularly during treatment . do not use zoledron acid hospir if you are allergic ( hypersensitive ) to zoledic acid , another bisphosphonate ( the group of substances to which zoledoral acid belongs ). warnings and precautions talk to your doctor or pharmacist before using zoledicle acid hospire : if you think any of the above applies to you , or if you have been in close contact with someone who has , or has had , a kidney problem . if you experience pain
zoledronic acid hospira must only be given by healthcare professionals trained in administering bisphosphonates intravenously ( into a vein ) and under ' iv ' administration . your doctor will recommend the best treatment for you . dehydration the recommended dose of much zoledronic acidic hospira is 4 mg / kg body weight once daily . if you have a kidney problem , your doctor may lower the dose depending on the severity of your kidney problem . zoledic acid hospir is also used to prevent and treat bone complications caused by bone metastases . your first infusion of zoledron acid hospire will be given to you by
like all medicines , zoledronic acid hospira can cause side effects , although not everybody gets them . the following side effects have been reported : common ( may affect up to 1 in 10 people ): severe kidney impairment ( will be determined by your doctor with certain specific blood tests ) low level of calcium in the blood uncommon ( may affects up to1 in 100 people ): pain in the mouth , teeth and / or jaw , swelling or non - healing sores inside the mouth ( jaw discharge , numbness or a feeling of heaviness , or loosening of a tooth ) bone damage in the jaw ( osteonecrosis ).
your doctor , pharmacist or nurse knows how to store zoledronic acid hospira properly .
what zoledronic acid hospira contains - the active substance is zoledron acid . one vial of zoledic acid contains 4 mg zoledoracid . - the other ingredients are monohydrate , mannitol , sodium citrate and water for injections . what zoledico acid hospir looks like and contents of the pack zoledicle acid hospire is a liquid concentrate for solution for infusion ' and is a clear , colourless to pale yellow to yellow to light yellow to brown solution . it is supplied in a glass vial as a clear to slightly opalescent , clear , sterile concentrate . each pack
varuby contains the active substance rolapitant . it is used to treat adults with cancer feeling sick ( nauseous ) or being sick ( vomiting ) during cancer treatment chemotherapy . how varuby works rolapit works by stopping nerve cells from working in the brain , which can cause vomiting . people who are sick ( sick ) do not have rolapiton to stop these nerve cells working properly , which may cause nausea and vomiting .
do not take varuby if you are allergic to rolapitant or any of the other ingredients of this medicine ( listed in section 6 ). if you take an herbal medicine called st john ' s wort ( hypericum performatum ). if your depression or difficulty sleeping has been reported in patients taking varubky ( see section 2 " warnings and precautions "). if you have taken this medicine for 27 days or more if you suffer from severe liver or kidney problems . if you currently take certain medicines containing rifampicin ( used to treat tuberculosis or other infections ), carbamazepine ( used for epilepsy and nerve
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 180 mg once a day for up to 90 days . swallow the tablets whole with a glass of water . you can take varuby with or without food . you may take it with or just after food . it is best to take the tablets at about the same time each day . you should take them at least 2 hours apart . this is to make sure that you are taking the tablets exactly as prescribed . your doctor may change your dose during your chemotherapy cycle . if you take more
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with varuby : very rare ( may affect up to 1 in 1 , 000 people ): symptoms of an allergic reaction may include sudden shortness of breath , swelling of the lips or tongue , change in taste , swellingof skin or tissue , sudden rash , fever and faster heartbeats . tell your doctor immediately , as you may need appropriate treatment . other side effects include : very common ( may affects more than 1 in 10 people ): headache , constipation , feeling tired uncommon ( may effect up to1 in
what varuby contains the active substance is rolapitant . each tablet contains 90 mg rolapit . the other ingredients are : tablet core : lactose monohydrate ( see section 2 under ' varubiy contains lactose '), pregelatinised starch , microcrystalline cellulose , povidone ( k - 30 ), croscarmellose sodium , colloidal silicon dioxide , magnesium stearate . film - coating : polyvinyl alcohol , titanium dioxide , macrogol , polysorbate 80 . tablet coat : blue 100 mg film - coated tablet , with a polyvinil chloride
what enerzair breezhaler is enerzaire breez inhaler contains two active substances : indacaterol and glycopyrronium - mometasone furoate indacterol and g glycopyronium belong to a group of medicines called bronchodilators . they relax the muscles in the small airways in the lungs and help to open the airways wider . they help to keep the air in the smaller airways open . they also help to lower the amount of air that gets into the small lungs . what enerzAIR breezcheler is used for enerz
do not use enerzair breezhaler if you are allergic to indacaterol , glycopyrronium , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor before using enerzir if you : have heart problems , have an irregular or fast heartbeat , have thyroid gland problems , or have diabetes , have high blood sugar , or are having seizures , have severe kidney problems , suffer from severe liver problems , and have a low level of potassium in
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhaler twice a day . the medicine should be inhaled twice a morning and once in the evening . use enerzair breezhaler every day to control your asthma and to help control your symptoms . use it at the same time each day . do not use it if you notice that the effect of enerz air breez inhaler is too weak or too weak . how to use enerzeair breezyzhalzer is for inhalation use . it is supplied
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious stop using enerzair breezhaler and see a doctor straight away if you notice any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips or face , skin rash , itching or hives . allergic reaction other side effects other side effect tell your doctor or pharmacist if you get any of these side effects : very commonly ( may affects more than1 in 10 users ): sore throat , runny nose , sudden difficulty breathing ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . store in the original package in order to protect from moisture . the capsules should be used immediately after first opening . do this if you notice any change in the appearance of the capsules . do away with the capsules if you see any change to the appearance or appearance of them . do throw away any medicines via wastewater or household waste . ask your pharm
what enerzair breezhaler contains the active substances are indacaterol ( as acetate ), glycopyrronium ( as bromide ), and mometasone furoate . each capsule contains 150 micrograms of indacate ( asacetate ), 63 microgram of glycopreyronium bromides , 50 microgram glycopyronium and 160 microgram mometsone furuate . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 114 microgram indacataterol , 58 microgram ( 3 . 0 millig
clopidogrel acino pharma gmbh contains the active ingredient clopidougrel which belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopidineogrelacino pharmá gmbhs is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombotic events ( such as stroke
do not take clopidogrel acino pharma gmbh if you are allergic ( hypersensitive ) to clopipidogle or any of the other ingredients of clopidineogrel agabababil ( see section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopidiogrelacino pharmara gmbhl . warnings and precautions talk to your doctor or pharmacist before taking any of your medicines :
always take clopidogrel acino pharma gmbh exactly as your doctor has told you . you should check with your doctor or pharmacist if you are not sure . the usual dose is one 75 mg tablet of clopridogrel aclara gmbhl per day to be taken orally with or without food . you can take cloclidogl acino pi gmb h with or just after food . if you take more clopidoogrelacino pharmh than you should contact your doctor , pharmacist or the nearest hospital emergency department because of the increased risk of bleeding . if possible
like all medicines , clopidogrel acino pharma gmbh can cause side effects , although not everybody gets them . the most common side effects are : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) rare ( affects less than 1 users in 10 , 000 ). very rare ( affecting less than1 user in 1, 000 ). contact your doctor immediately if you experience : fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . signs of liver problems
store in the original blister in order to protect from moisture . keep out of the reach and sight of children . do not use clopidogrel acino pharma gmbh after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . donot use cloplidogl acino pharma gmbhl if you notice any visible sign of damage of blister or film - coated tablets . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures
what clopidogrel acino pharma gmbh contains the active substance is clopridogrel . each tablet contains 75 mg of clopidaogrel ( as besilate ). the other ingredients are : tablet core : macrogol 6000 cellulose , microcrystalline ( e460 ) crospovidone type a castor oil , hydrogenated film - coating : macromol 6000 ethylcellulose ( e462 ) titanium dioxide ( e 171 ) what clopIDogrelacino pharmha gmb h looks like and contents of the pack clopideogrel acute
delstrigo is used to treat hiv (' human immunodeficiency virus ') infection in adults . it is used in combination with medicines called ' antiretroviral medicines '. the active substances are doravirine ( a non - nucleoside reverse transcriptase inhibitor ( nnrti ) and lamivudine ( also known as a nucleosides analogue reverse transcriptases inhibitor ( rrti ). the other active substances in delstrigo are tenofovir disoproxil ( a nucleoide analogue reverse transcriptase inhibitor , nrti ), and tenofavir .
do not take delstrigo if you are allergic to doravirine , lamivudine , tenofovir disoproxil or any of the other ingredients of this medicine listed in section 6 . if you take any of any of these , tell your doctor or pharmacist . if your doctor has told you that you are taking any of : - the following medicines : carbamazepine , oxcarbazepine ( medicines to treat tuberculosis ) - st . john ' s wort ( hypericum perforatum ), a herbal remedy used for depression and anxiety . - products containing mitotane ( a
always take delstrigo exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is a complete regimen of one tablet a day . a single tablet is sufficient for the treatment of hiv infection . the dose is 1 tablet a night . if you take certain medicines ( such as doravirine ) your doctor may tell you to take a smaller dose . medicines like this medicine swallow the tablet whole with a glass of water . you can take this medicine with or without food . if your doctor advises you to stop taking delstriga , it is important that you
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking this medicine and see a doctor immediately if you notice any of the following : very common ( may affect more than 1 in 10 people ): abnormal dreams difficulty in sleeping ( insomnia ) headache dizziness sleepiness cough nasal symptoms feeling sick ( nausea ) diarrhoea stomach pain vomiting wind ( flatulence ) hair loss rash muscle symptoms such as pain ( stiffness ) feeling tired fever blood tests showing increased levels in liver enzymes uncommon ( may effect up to 1 in 100 people ): nightmares , depression , anxiety , irritability , confusion , suicidal thoughts 45 trouble
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and the carton after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . keep the bottle tightly closed in order to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what delstrigo contains the active substances are : 100 mg doravirine , 300 mg lamivudine , 245 mg tenofovir disoproxil ( as fumarate ) the other ingredients are : tablet core : croscarmellose sodium e468 , hypromellose acetate succinate , magnesium stearate , microcrystalline cellulose e460 , silica , colloidal anhydrous , sodium stearyl fumate . a coating material : carnauba wax e903 , hyprogellose , iron oxide yellow ( e172 ), lactose monohydrate
spravato contains esketamine . it belongs to a group of medicines called anti - depressants . this medicine helps to control your depression . it also helps to reduce the symptoms of depression such as feeling sad , anxious or worthless , sleeping difficulties , change in appetite , loss of interest in favourite activities and feeling of being slowed down . spravato is used in adults who are also taking another antidepressant . it is important that you also read the package leaflets for this medicine ( see section 2 " antidepressant medicines ").
do not take spravato - if you are allergic to esketamine , ketamine or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have an aneurysm ( a weak spot in a blood vessel wall that bulges out due to bleeding in the brain ). - have recently had a heart attack . within 6 weeks of starting treatment , you may experience a temporary increase in blood pressure . serious complications in these conditions can occur , and spravo should not be used to treat them . tell your doctor before taking this medicine if you have a heart problem
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much spravato to use the spravat nasal spray is for oral use . the nasal spray device is for use in adults . use in children and adolescents the recommended dose is 1 spray ( 2 sprays ) per kg body weight . use 3 nasal spray devices per kg weight . one nasal spraydevice is for 4 to 4 days . use spravata every day for 2 weeks . use this product at the same time every day . if you use more spravatos than you should if you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with spravato : very common ( may affect more than 1 in 10 people ) feeling disconnected or having feelings and things around you feeling dizzy headache change in sense of taste feeling sleepy decreased feeling or sensitivity to touch ( especially in the mouth area ) spinning sensation ( vertigo ) vomiting nausea common ( might affect up to 1 in every 10 people ): feeling extremely happy ( euphoria ) feeling agitated feeling anxious feeling in the eyes or ears that your sense of touch are altered or mimicked irritable panic attacks change in
what spravato contains - the active substance is esketamine . each nasal spray device contains esketam hydrochloride equivalent to 28 mg esketa . - the other ingredients are citric acid monohydrate disodium edetate sodium hydroxide ( for ph adjustment ) water for injections what spravat looks like and contents of the pack spravatos is a nasal spray solution . this medicine is a clear , colourless solution for use in children . spravata is available in packs containing one single - use nasal spray handset . spreamato is available as packs containing 1 , 2 , 3 or 6 nasal
zerbboraf is an anticancer medicine that contains the active substance vemurafenib . it is used to treat melanoma that has spread to other parts of the body or cannot be removed by surgery . this type of cancer is caused by a change ( mutation ) in a gene responsible for the growth of melanoma . zelboraf targets proteins that are involved in the growth and spread of your cancer .
do not use zelboraf if you are allergic to vemurafenib or any of the other ingredients of this medicine ( listed in section 6 ) symptoms of allergic reactions may include swelling of the face , lips or tongue , difficulty breathing , rash and fainting sensation . if you think any of these apply to you , tell your doctor or nurse before using zelberaf . allergic reactions if you experience allergic reactions to zeloraf , tell the doctor or hospital pharmacist immediately . if any of those apply to your skin , tell them immediately . severe skin reactions if severe skin skin reactions occur , tell a
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 4 mg once a day for up to 8 weeks . your doctor may increase your dose to 4 mg twice a day if you experience side effects . your treatment will be continued until your doctor tells you otherwise . taking zelboraf with food and drink you should avoid eating or drinking spicy foods or drinks that contain fat or are not available in the country . if you take more zelbaf than you should if you accidentally take too many tablets , contact your doctor immediately . vomiting if
like all medicines , zelboraf can cause side effects , although not everybody gets them . serious allergic reactions swelling of the face , lips or tongue difficulty breathing rash fainting sensation stop taking zelberaf and tell your doctor immediately if you notice any of the following : radiation treatment side effects caused by radiation during zelbaraf treatment , the following may occur : radiation may affect the skin , esophagus , bladder , liver , rectum , and lungs . tell your physician immediately if your doctor notices any of these symptoms : skin rash , blistering , peeling , discoloration of the skin shortness of
keep out of the reach and sight of children . do not use zelboraf after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this after the first opening of the blister . do away with the blister if you notice it is damaged or shows signs of tampering . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what zelboraf contains the active substance is vemurafenib . each film - coated tablet contains 240 mg of vemurabenib ( as a co - precipitate of vemafenb ). the other ingredients are : hypromellose acetate succinate , colloidal anhydrous silica , croscarmellose sodium , hydroxypropyl cellulose , magnesium stearate film - coating : iron oxide , macrogol 3350 , polyvinyl alcohol , talc and titanium dioxide ( e171 ). what zelberaf looks like and contents of the pack zelb
duoplavin contains clopidogrel and acetylsalicylic acid ( asa ) and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood which clump together during blood clotting . by preventing this clumping , blood vessels relax . antiplatelets medicinal products reduce the chances of blood clots forming ( a process called atherothrombosis ). duoplavic is taken to prevent blood clumps forming in hardened arteries , a process known as atherostrombotic events ( i . e . stroke , heart attack , or death
do not take duoplavin if you are allergic to clopidogrel , acetylsalicylic acid ( asca ) or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to other products called non - steroidal anti - inflammatory products if you have painful and / or inflammatory conditions of muscles or joints if you suffer from a medical condition ( such as asthma , nasal discharge , runny nose , polyps ( a type of growth in the nose ) if your child has a medicalcondition that is currently causing bleeding such as a stomach ulcer or bleeding
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take duoplavin at the same time each day . your doctor will tell you how many tablets of your medicine to take . if you take more duoplin than you should if you have accidentally taken too many tablets , or if someone else has taken your tablets , tell your doctor immediately . if possible , take the tablet with you . if a heart attack occurs , take duaplavin immediately and contact your doctor ' s emergency department .
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any visible sign of deterioration . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what duoplavin contains duoplin 75 mg film - coated tablets each tablet contains 46 tablets of the active substances , clopidogrel , acetylsalicylic acid (asa ) 75 mg : clopridogrel ( as hydrogen sulphate ) 75mg : acetylSalicylic acids , mannitol , macrogol 6000 , microcrystalline cellulose , low substituted hydroxypropylcellulose , maize starch , hydrogenated castor oil ( see section 2 ' duopllin contains hydrogenatedcastor oil '), stearic acid and colloidal anhydrous
simbrinza contains two active substances , brinzolamide and brimonidine tartrate . brin zolamide belongs to a group of medicines called carbonic anhydrase inhibitors . brimonine tartrate belongs to an active group of medicine called alpha - 2 adrenergic receptor agonists , which reduce pressure within the eye . simbrinzza is used to treat the eyes in adults aged 18 years and older with eye conditions such as glaucoma , ocular hypertension ( high pressure in the eyes ).
do not take simbrinza if you are allergic to brinzolamide , brimonidine tartrate or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be allergic to sulphonamides if you have ever taken medicines for diabetes or infections if you take diuretics ( water tablets ) or a monoamine oxidase ( mao ) inhibitors if you do not take medicines for depression or parkinson ' s disease if you cannot take certain antidepressants if you suddenly stop taking any antidepressant medicines if you suffer from severe kidney problems if you drink too much acidity ( excess )
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . simbrinza should only be used in the eyes . avoid contact with the back of the eye or eyes . wash your hands thoroughly with soap and water ( see section 1 , " how to use simbrinusza "). remove the cap and snap collar . before using the medicine , twist off the cap . hold the bottle with your fingers . tilt your head back . pull down the eyelid with a clean finger and insert a ' pocket ' between the eyelids and the back part of the coloured
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with this medicine : if you have a reaction to the medicine ( frequency not known ): signs of an allergic reaction include severe skin reactions , rash , redness or itching all over your body and / or eyes trouble breathing , chest pain , or irregular heart beat tell your doctor immediately if you experience extreme tiredness or dizziness . the other side effects that have been reported with simbrinza are : in combination with other medicines containing brinzolamide and brimonidine . common side effects ( may affect up
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the bottle and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the bottle tightly closed in order to protect from light . if you use more simbrinza than you should if you accidentally use too much simbrinaza , tell your doctor or pharmacist . if the medicine is accidentally used , it is unlikely to cause infections . but if you forget to use simbrinia if you have
what simbrinza contains the active substances are brinzolamide and brimonidine tartrate . each ml of suspension contains 10 mg of brin zolamide ( corresponding to 2 mg of a brimonate tartrate equivalent to 1 . 3 mg of the active substance in each vial ), and brimidine is dissolved in benzalkonium chloride ( see section 2 " simbrinusza contains benzalkonaium chloride "). the other ingredients are propylene glycol , carbomer 974p , boric acid , mannitol , sodium chloride , tyloxapol , hydrochloric
what filgrastim ratiopharm is filgrastaim ratitopharm contains the active substance filgrasteim . filgrasterim is a protein produced by biotechnology in bacteria called escherichia coli . it is similar to a natural protein produced in your body called granulocyte - colony stimulating factor ( gsf ). filgrateim stimulates the bone marrow to produce new blood cells . more blood cells are needed than white cells . white cells are important as they help your body fight infection . filgrimastim can help your immune system to grow and reproduce itself . fil grastim rati
do not use filgrastim ratiopharm - if you are allergic ( hypersensitive ) to filgrasteim or any of the other ingredients of filgrateim ratinopharm . warnings and precautions talk to your doctor or pharmacist before using filgrasterim ratisopharm : - if your child has a cough , fever or difficulty breathing . this may be a symptom of a pulmonary disorder . other possible side effects of sickle cell disease 57 if your baby gets left upper abdominal pain or pain at the tip of your shoulder . this might be a sign of a spleen disorder . your doctor will
how much filgrastim ratiopharm is given the amount of filgrastaim ratisopharm you will receive will depend on your condition and on how well you respond to filgrasteim ratitarm . your doctor will tell you how many tablets of filgrimastim ratiopharm to receive . filgrateim ratiotopharm treatment will be started by a doctor who is experienced in the use of chemotherapy . the usual dose is 0 . 5 mg per kilogram bodyweight given once every 60 days . your treatment will last approximately 14 days . some disease types may be more severe . how
you must not be given filgrastim ratiopharm if you have sickle cell disease 57 you should not be treated if you get left upper abdominal pain or pain at the tip of your shoulder . this may be a sign of a spleen disorder . see section 4 . if you experience side effects , your doctor may order regular blood tests before you are given filbrastim ratiopharm . neutrophils ( a type of white blood cells ) are important in measuring the level of the number of these cells in your blood . your doctor will check this before treatment is started . other medicines and filgraste
keep out of the reach and sight of children . do not use filgrastim ratiopharm after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . donot use filgrimastim ratiopharm if the solution is cloudy or contains particles . medicines should not be disposed of via wastewater or household waste . ask your pharmacist how to dispose of medicines no longer required . these measures will help to protect the environment .
what filgrastim ratiopharm contains - the active substance is filgrasim . each ml of solution for infusion contains 60 mg of filgrasteim . filgrasterim ratisopharm 30 mg / 0 . 5 ml : each pre - filled syringe contains 30 mg filgrateim in 0 . 05 ml solution . filgrimastim ratiopharm 48 mg / 1 ml : one pre - drawn syringe containing 48 mg filGrastim in 1 ml solution for injection . - the other ingredients are sodium hydroxide , glacial acetic acid , sorbitol , poly
what riluzole zentiva is riluxole zenziva contains a substance called rilusole which belongs to a group of substances called ' dopaminergic agonists '. dopaminopamine is a substance produced by the nervous system . what rilzole zintiva is used for rilizole zertiva is given to adults with amyotrophic lateral sclerosis ( amy )- motor neurone disease ( mds ). the nerve cells that carry nerve signals help muscles to work normally , but weakness , muscle waste and paralysis occur . this is linked to the destruction of nerve cells . motor neur
do not take riluzole zentiva if you are allergic to rilizole or any of the other ingredients of this medicine ( listed in section 6 ). if you have any liver disease . if you experience increased blood levels of some enzymes of the liver called transaminases . if this applies to you , tell your doctor before taking rilzole zenta . warnings and precautions talk to your doctor or pharmacist before taking this medicine if you : have anyiver problems . have yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick ( especially if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken once daily . the tablets should be taken by mouth at about the same time each day . the maximum recommended dose for adults is 12 tablets taken once a day . if you take more riluzole zentiva than you should contact your doctor , pharmacist or your nearest hospital emergency department immediately . if possible take rilzole zenta with food . if a child swallows some tablets , contact your physician immediately . do not take a double dose to make up
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever ( increase in temperature ). riluzole zentiva may cause a decrease in the number of white blood cells . this is shown in a blood sample . white blood cell counts are important for fighting infections . if you have any of the following symptoms : yellowing of your skin or the whites of your eyes ( jaundice ), itching , feeling sick or being sick . these may be signs of liver disease ( hepatitis ). your doctor may do regular blood tests before you start rilzole z
what riluzole zentiva contains the active substance is rilusole . the other ingredients are anhydrous dibasic calcium phosphate , micro crystalline cellulose , anhydrated colloidal silica , magnesium stearate , croscarmellose sodium , hypromellose , macrogol 6000 , titanium dioxide . what rilizole zenta looks like and contents of the pack the tablets are white to off - white , round and marked with " 50 " on one side and " ril " on the other side . the tablets have a diameter of 202 mm . rilux
the active ingredient in emgality is galcanezumab , a medicine that blocks the activity of a protein called calcitonin gene ( cgrp ). migraine is a condition in which the body produces increased levels of cgrf . emgally is used to treat migraine in adults , adolescents and children aged 4 years and older . migraines have been reported in patients treated with emgals . the frequency of migraine headache is not known . emigality is used in adults to improve your quality of life .
do not use emgality if you are allergic to galcanezumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a serious cardiovascular disease warnings and precautions serious cardiovascular diseases allergic reactions emg abnorm may cause serious allergic reactions . these reactions may occur up to 40 minutes after you have had a serious allergic reaction . if you notice such signs or signs of side effects , tell your doctor straight away . see section 4 . children and adolescents emgally is not recommended for children and teenagers under 18 years of age . other medicines and emgals tell your child ' s doctor or
always use emgality exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 240 mg once daily . emgally is given as an injection under your skin ( subcutaneous injection ). you may receive your emgalis injection at home or at the same time each day . your doctor will decide how many treatments you need and how long you need to receive it . your physician will give you proper training to prepare and inject emgaly . if you have the impression that the effect of emgale is too strong or too weak , talk to your doctor
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects allergic reactions to emgality may include rash and itching . serious allergic reactions ( rare , may affect up to 1 in 1 , 000 people ) may include : difficulty breathing or swallowing , low blood pressure , dizziness or light - headedness , swelling of the neck , face , mouth , lips , tongue or throat , severe itching of the skin , a red rash or raised bumps . other side effects very common side effects ( may affect more than 1 in 10 people ) injection site pain injection site reactions may include red skin , itching
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store the blister in the original package in order to protect from light . after first opening , the product may be stored for up to 7 days below 30 . do this once a day . do away with the blister once you have established the correct storage time . do do not throw away any medicines via wastewater or household waste . ask your
what emgality contains the active substance is galcanezumab . each pre - filled pen contains 120 mg of galcaneszumumab in 1 ml solution . the other ingredients are l - histidine , l - ethidine hydrochloride monohydrate , polysorbate 80 , sodium chloride and water for injections . what emgalis looks like and contents of the pack emgally is a solution for injection in a clear glass syringe . the colour is slightly yellow . the syringe is provided in a pack of single - dose pens containing 1 , 2 or 3 pens . not all pack sizes
defitelio is a medicine that contains the active substance defibrotide . it is used to treat a condition called hepatic veno - occclusive disease ( when the blood vessels in the liver are damaged ) in adults , when blood clots are formed and cannot be removed with medicines obtained prior to a stem cell transplantation . defibrobrotide works by helping the blood vessel to open and close , so that blood clasts can form . this medicine is used in adults who have not received any other medicine .
do not use defitelio if you are allergic to defibrotide or any of the other ingredients of this medicine ( listed in section 6 ) if you have been taking other medicines to prevent blood clots ( tissue plasminogen activator warnings and precautions ) if any of these apply to you , tell your doctor before using this medicine . warnings and measures prevention of bleeding if you experience heavy bleeding ( e . g . if you need a blood transfusion or surgery ) if your doctor has told you that you have problems with blood circulation or a constant blood pressure . children and adolescents defitilio is not recommended
the treatment with defitelio will be started by a doctor who is experienced in the use of stem cells transplantation . it will be given by infusion into one of your veins ( known as an ' intravenous infusion ') or drip . the duration of this treatment is 21 days . if your symptoms do not improve after this 21 day period , your doctor may decide to reduce the dose . if you have any further questions on the use or use of this product , ask your doctor or pharmacist . children and adolescents do not give this medicine to children under 18 years of age . if a child swallows some of the medicine
like all medicines , defitelio can cause side effects , although not everybody gets them . stop taking defiteloio and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): low blood pressure common ( might affect up to 1 in every 10 people ) bleeding in general bleeding in the nose bleeding in parts of the brain bleeding in part of the gut vomiting blood bleeding in and around the lungs bleeding in blood in the urine and in the mouth bleeding in or around the skin coagulopathy ( disturbance in blood clotting ) nausea vomiting diarrhoea
keep this medicine out of the sight and reach of children . do not use defitelio after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . do do not defiteloio if you notice that the solution is cloudy or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what defitelio contains the active substance is defibrotide . each ml of solution contains 2 . 5 mg or 200 mg of defibroide . after dilution , each ml solution contains 80 mg of the active ingredient in defibriide . the other ingredients are sodium citrate dihydrate , hydrochloric acid , sodium hydroxide ( for ph - adjustment ), water for injections ( see section 2 " defitelsio contains sodium "). what defitELio looks like and contents of the pack defitelo is a clear , colourless to pale yellow concentrate for solution for infusion . it
daklinza contains the active ingredient daclatasvir . hepatitis c is an infectious disease that affects the liver caused by the hepatitis c virus . this medicine works by stopping the hepatitisc virus from multiplying in your body . this will slow down the growth of the virus in your blood . daklinz is used in combination with other medicines to treat hepatitis c infection . the other medicines that you will be taking with daklineza are : - oral , single use , with or without food . - combination with a tablet containing daclatinza may reduce the amount of the hepatitis b virus in the body .
do not take daklinza if you are allergic to daclatasvir or any of the other ingredients of this medicine ( listed in section 6 ) if you take daclinza by mouth with the following medicines : phenytoin , carbamazepine , oxcarbazepine and phenobarbital ( used to prevent epileptic seizures ) rifampicin , rifabutin and rifapentine ( antibiotics used to treat tuberculosis ) dexamethasone ( a steroid used to correct allergic and inflammatory diseases ) medicines containing st . john ' s wort ( hypericum
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of daklinza is 60 mg once a day . do not take more than this dose once a week . do this twice a day to avoid unpleasant taste . your doctor may tell you to take dakinza with some other medicines . if you take more daklanza than you should if you have taken more dailinza than your doctor tells you to , contact your doctor . if possible , take these medicines with a meal . your daily dose of taklinz
like all medicines , this medicine can cause side effects , although not everybody gets them . daklinza in combination with sofosbuvir and ribavirin has been associated with the following side effects : very common ( may affect more than 1 in 10 people ): headache fatigue common ( might affect up to 1 in every 10 people ) difficulty sleeping dizziness migraine nausea ( feeling sick ) diarrhoea abdominal pain joint pain aching or tender muscles when taking daklineza in tandem with sofiosbuvirin , the following other side effects have been associated : common ( likely to affect up in every 1 in a
what daklinza contains the active substance is daclatasvir . each film - coated tablet contains 30 mg or 60 mg of daclasvir ( as dihydrochloride ). the other ingredients are : tablet core : anhydrous lactose , microcrystalline cellulose , croscarmellose sodium , silicon dioxide , magnesium stearate . tablet coating : hypromellose , titanium dioxide , macrogol 400 , indigo carmine aluminum lake ( e132 ), yellow iron oxide ( e172 ) and 51 what daklineza looks like and contents of the pack 30 mg
proquad is a vaccine to protect against measles , mumps , rubella and chickenpox ( varicella ) viruses . when a person is given the vaccine , the immune system ( the body ' s natural defence system ) will produce antibodies against the measles , rubles , rubello and varicelluses . the antibodies help to prevent diseases caused by these viruses . proquad is used to prevent measles , measles , and rubella with chickenpox (" varicello "). the vaccine is given to infants 12 months of age and older . pro quad is used in children and adolescents ( aged 9 years and older ) who are
do not receive proquad if you are allergic to any varicella vaccine , measles , mumps or rubella vaccine , or any of the other ingredients of this vaccine ( listed in section 6 ) if you have been given neomycin if you suffer from a blood disorder or type of cancer that affects the immune system ( including treatment with medications that weaken the immunesystem ), if you receive low - dose corticosteroid therapy ( for asthma or replacement therapy ), if your child has a weakened immune system , if you know that your child is suffering from a disease ( including aids ), if he / she has congenital or hereditary
proquad is given by injection into a muscle ( subcutaneously ) under the skin ( usually in the thigh or upper arm ). injections will be given into the muscle ( usually into the thigh area ) or into the upper arm . if you have a blood clotting disorder or low levels of platelets , the vaccine should not be given under the sun . injecting under the same skin may reduce the risk of bleeding and therefore proquad should not go into a blood vessel . proquad is only given to infants and children from 9 months of age . children from 12 months of ages who have not had chickenpox or measles . pro quad
like all vaccines and medicines , this vaccine can cause side effects , although not everybody gets them . allergic reactions such as hives may occur . if these reactions occur , you may have difficulty in breathing or swallowing . if you have an allergic reaction , contact your doctor immediately . other side effects that have been reported with proquad include : uncommon ( may affect up to 1 in 100 people ): seizures ( fits ) with a fever rare ( may effect up to1 in 1 , 000 people ): bronchiolitis ( difficulty breathing , cough , unsteadiness with walking ). other side effect that have occurred with pro quad include : very common
what proquad contains the active substances are : measles virus1 , edmonston strain , 3 . 00 mg mumps virus1 ( jeryllynn™ level b ) strain , 4 . 30 mg rubella virus2 , strain , 6 . 00mg varicella virus3 , merck strain , 9 . 99 mg mrc . the other ingredients are : tissue culture : plaque - forming units ( mrc ), 1 , chickembryo cells , fibroblasts ( mcc ). powder sucrose , hydrolysed gelatin , urea , sodium chloride , sorbitol ( e420 ), monosodium glutamate
jylamvo is a substance that is absorbed by the body and is an anticancer medicine that reduces unwanted reactions . it is an immunosuppressive agent . it works by reducing the inflammatory effect jylamv is used to treat rheumatic and skin diseases : active rheumatoid arthritis ( the type of polyarthritic forms of joints ) in adults with severe juvenile idiopathic arthritis ( jia ) in children 3 years of age and older . it may be used alone or in combination with non - steroidal anti - inflammatory drugs ( nsaids ) for the treatment of inadequate o severe or disabling
do not use jylamvo if you are allergic to methotrexate or any of the other ingredients of this medicine ( listed in section 6 ) if you have a severe kidney impairment if you suffer from a liver impairment if your doctor has told you that you have blood disorders such as bone marrow hypoplasia , leukopenia , thrombocytopenia or significant anaemia 34 if you know that you may have a weakened immune system if you think you have or have ever had a serious infection such as tuberculosis or hiv if you develop ulcers in the stomach or intestines if you experience an inflammation
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . jylamvo can cause severe side effects , sometimes leading to even death . your doctor will discuss these with you and will adjust the dose and duration of the treatment . rheumatoid arthritis severe juvenile idiopathic arthritis severe psoriasis severe psoriatic arthritis jylimvo is used as a long - term treatment . jyslamvo is also used for the treatment of rheumatic and skin diseases ( jia , psorism , psoriatics ). your doctor may prescribe
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : wheeziness , difficulty in breathing , swelling of the eyelids , face or lips , rash or itching on the whole body . other possible side effects include breathing problems , feeling of illness , dry , irritating cough , shortness of breath , difficulty or breathing , chest pain ( fever ), spitting or coughing blood , serious peeling or blistering of the skin unusual bleeding ( vomiting blood ) bruising nose bleeds nausea , vomiting , abdominal discomfort , severe diarrhoea mouth ulcers , black or tarry st
keep this medicine out of the sight and reach of children . do not use the medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from light . the medicine must be used immediately in case of accidental spillage . the vial is stable for 3 hours at 25 . store in the original package in order to protect it from light and moisture . do away with any unused medicine after this period . any unused product or waste material should be disposed of in accordance with local requirements for cytot
what jylamvo contains - the active substance is methotrexate . each ml of solution contains 2 mg of methotexate . - the other ingredients are macrogol 400 , glycerol , orange flavour , sucralose , ethyl parahydroxybenzoate ( e218 ), sodium methyl parahhydroxybenzzoate , citric acid , tri - sodium citrate , purified water ( see section 2 " jylimvo contains ethyl parahydroxy benzoate and sodium methyl parahydrobenzoat "), citric acids , tri , sodium citrates , purified
what enurev breezhaler is this medicine contains glycopyrronium bromide which belongs to a group of medicines called bronchodilators . what enurevy breez inhaler is used for this medicine is used to make breathing easier for adult patients who have breathing difficulties due to a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways tighten , making breathing difficult . this medicine blocks the tightening of these muscles in the lungs , making it easier for air to get in and out of the lungs . this helps to reduce the effects of this medicine on
do not use enurev breezhaler - if you are allergic to glycopyrronium bromide or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have kidney problems . - if the doctor has given you an eye problem called narrow - angle glaucoma ( difficulty passing urine ). if this applies to you , tell your doctor before treatment with enurevo breez inhaler . if you have any further questions on the use of this product , ask your doctor or pharmacist . warnings and precautions talk to your doctor , pharmacist or
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at a temperature not above 75 ºc . you can use this medication at any time of the day , with or without food . this medicine is for inhalation use only . you must use this product when you are using an inhaler and capsules ( in blisters ) that contain the medicine ( inhalation powder ) are packed in the carton . the capsules should be swallowed whole with water . do
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects may be serious : uncommon ( may affect up to 1 in 100 people ) irregular heart beat high level of blood sugar ( hyperglycaemia ). typical symptoms are excessive thirst , hunger ( frequent urination ), rash , itching , hives , difficulty breathing or swallowing , dizziness . allergic reaction ( swelling mainly of the tongue , lips , face or throat ) angioedema ( see section 2 ). if any of the side effects gets serious , or if you notice any side effects not listed in this leaflet , please tell your
what enurev breezhaler contains - the active substance is glycopyrronium bromide . each hard capsule contains 63 micrograms glycopirroniumbromide equivalent to 50 microgram glycopyronium . the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is equivalent to 44 microgram of glycopYRronium per inhalation dose . - the other ingredients of the formulation powder are lactose monohydrate and magnesium stearate . what enurevi breez inhaler looks like and contents of the pack enurevo breezker 44 microlit
what riximyo is riximusimyo contains the active substance " rituximab ". this is a type of protein called a " monoclonal antibody ". it sticks to a target in a type called a white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and dies . how rixima works riximetyo is used for the treatment of several different conditions . rixibyo is given to adults with a ) non - hodgkin ' s lymphoma ( a disease of the lymph tissue that affects
do not use riximyo if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ). if you have a severe active infection at the moment . if you suffer from a weak immune system . if your doctor has told you that you have severe heart failure or severe uncontrolled heart disease ( granulomatosis , polyangiitis , microscopic polyangis or pemphigus vulgaris ). warnings and precautions talk to your doctor or pharmacist before using riximeryo . if any of
your doctor will decide how much riximyo you will receive and how often you will need this treatment . your doctor will check you for any side effects . rixima is given as a drip ( intra - venous infusion ). medicines given before each riximusyo administration you will be given rixamyo together with other medicines ( premedication ) to reduce the risk of side effects during your treatment . for non - hodgkin ' s lymphoma , your doctor may give you riximeyo alone rixmeyo once every 4 weeks . repeated treatment courses with riximeryo are possible .
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion , you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low
what riximyo contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient in ritiximab ( 10 mg / ml ). the other ingredients are sodium citrate , polysorbate 80 , sodium chloride , sodium hydroxide and hydrochloric acid ( see section 2 " rixima contains sodium "). what rixamyo looks like and contents of the pack riximusyo is a clear to slightly yellowish solution for infusion . it is supplied
topotecan actavis contains the active substance topotecin . topotecaan actis is used to treat small cell lung cancer that has come back after chemotherapy . it is also used to prevent advanced cervical cancer that cannot be removed by surgery or radiotherapy . in this case topotican actez treatment is combined with medicines containing cisplatin .
do not use topotecan actavis - if you are allergic to topotecaan or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using topotocan activ . your blood cell counts may be too low . your doctor may need to adjust your dose of topotican actez . if you have any kidney problems , tell your doctor before using this medicine . warnings and symptoms talk to a doctor , nurse or pharmacist before using the topotchean actv : - if severe kidney impairment or liver problems .
your doctor will determine the dose of topotecan actavis you will receive based on your age and the results of blood tests carried out before treatment . the recommended dose for treatment of adults small cell lung cancer : 1 . 5 mg per square metre of body surface area for the first 5 days of this treatment cycle . for cervical cancer : 0 . 75 mg per sq metre of surface area , for the second 3 days of that treatment cycle and for cervical disease when combined with another anticancer medicines containing cisplatin . cisplin is used if you have impaired kidney function . your doctor will work out the dose you need based
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious sideeffects : infections ( very common , may affect more than 1 in 10 people ): fever . this may be due to your general condition . local symptoms such as sore throat , burning sensation , severe stomach pain , fever , diarrhoea , or bowel inflammation ( neutropenic colitis ). topotecan actavis may reduce your ability to fight infections . lung inflammation ( rare , may effect up to 1 in 1 , 000 people ): difficulty in breathing , cough
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the expiratory date refers to the last day of that month . keep the vials in the outer carton in order to protect from light . reconstitution and dilution chemical and physical in - use stability has been demonstrated for 24 hours at 25 ± 2 and from 2 to 8 oc . the drug product solution for dilution in solutions for infusion ( nacl 0 . 9 %) glucose 5 mg / ml solution for injection
what topotecan actavis contains the active substance is topotecaan . 1 ml solution for injection contains 4 mg of topotan ( as hydrochloride ). after reconstitution 1 ml contains 1 mg of the active ingredient topotican . the other ingredients are mannitol ( e421 ), tartaric acid , hydrochloric acid and sodium hydroxide . what topotECan actis looks like and contents of the pack topottecan actalis is a white to off - white cake with grey bromobutylic stopper and aluminium seals with plastic flip - off caps and
the active substance of rivastigmine hexal is rivustigmine . rivestigmine belongs to a class of substances called cholinesterase inhibitors . in patients with alzheimer ' s dementia or dementia due to parkinson ' s disease , certain nerve cells die in the brain , resulting in low levels of the neurotransmitter acetylcholine ( a substance that allows nerve cells to communicate with each other ). rivaldigmine works by blocking the enzymes that break down acetylCHoline : acetylchlorolinescerase and butyrylcholinestersterase .
do not take rivastigmine hexal - if you are allergic to rivasta , the active substance in rivostigminehexal , or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you have a previous skin reaction called allergic contact dermatitis . warnings and precautions talk to your doctor or pharmacist before taking rivstigmine Hexal . if any of these apply to you , tell your doctor before taking the medicine . warnings , precautions and precautions tell your physician before taking : - if any member of your family has irregular or slow heartbeat
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment your doctor will tell you what dose of rivastigmine hexal to take . treatment usually starts with a low dose . depending on how you respond to treatment , the highest dose may be 6 . 0 mg / kg . your doctor may then increase your dose depending on your weight . taking this medicine take rivasta hexal every day for as long as your health allows . if you take more rivasteigminehexal than you should if you have taken more r
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often when you start your medicine or when your dose is increased . the side effects listed below are very common ( may affect more than 1 in 10 people ). feeling dizzy loss of appetite stomach problems such as feeling sick ( nausea ) or being sick ( vomiting ) diarrhoea common ( might affect up to 1 in every 10 people ) anxiety sweating headache heartburn weight loss stomach pain feeling agitated feeling tired or weak generally feeling unwell trembling or feeling confused decreased appetite nightmares uncommon ( may affects up to1 in 100 people
keep out of the reach and sight of children . do not use rivastigmine hexal after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 30 . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what rivastigmine hexal contains 64 the active substance is rivastaigmine hydrogen tartrate . the other ingredients are : hypromellose , magnesium stearate , microcrystalline cellulose , colloidal anhydrous silica , gelatin , yellow iron oxide red iron oxide ( e172 ), titanium dioxide ( e171 ), shellac . each rivastingigminehexal 1 . 5 mg capsule contains 1 . 95 mg of rivostigmine . each vial of each ritastigme hexal 3 mg capsule releases 3 mg of the active ingredient in each riast
cabometyx is a cancer medicine that contains the active substance cabozantinib . it is used to treat adults with kidney cancer ( renal cell carcinoma ) or liver cancer that has come back after a specific anticancer medicine ( sorafenib ). how cabometyx works cabomety blocks the action of proteins called receptor tyrosine kinases ( rtks ), which are involved in the development of new blood vessels . by blocking the action , these proteins can help to prevent high amounts in cancer cells . cabometx is used in adults .
do not take cabometyx 45 if you are allergic to cabozantinib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking cabomety : if you have high blood pressure if you had an aneurysm ( enlargement or weakening of a blood vessel wall ) or a tear in a blood valve wall if you suffer from diarrhoea if you recently had significant bleeding from surgery within the last month if you undergo surgical procedures ( including dental surgery ) if you know that you have inflammatory bowel disease ( such as crohn ' s
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . you should take this tablet at the same time each day . your doctor may increase your dose if you experience serious side effects . your treatment will be continued for as long as your physician continues to prescribe cabometyx . the usual starting dose is 60 mg cabomety once a day for 2 weeks . cabometx may be taken once a week for 1 hour . take the medicine at about the same times each day , with or without food . swallow the tablet
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with cabometyx and other medicines : tell your doctor straight away if your side effects become severe or persistent . tell your physician straight away : if you notice any of the following serious side effects you may need urgent medical treatment : symptoms include pain in the abdomen ( nausea ), ( feeling sick ), vomiting , constipation , fever . these may be signs of a gastrointestinal perforation ( a hole that develops in the stomach or intestine ). severe or uncontrollable bleeding . symptoms include vomiting blood , black stolls , bloody urine
what cabometyx contains the active substances are cabozantinib and malate . cabometx 20 mg film - coated tablets : each tablet contains cabozatinib ( s ) and malates . each tablet of 20 mg contains caboxantinab . cabobometyx 40 mg film coated tablets: each tablet contain cabozutinib_( s ) or malate and each tablet is 40 mg of cabozAntinib . cabostyx 60 mg film coating tablets : the active ingredients are : caboz antinib , malate , and 60 mg of Cabozantrinib . the
pemetrexed hospira is a medicine used in the treatment of cancer . pemetrexED hospira will be given to you in combination with cisplatin , another anti - cancer medicine , as treatment for malignant pleural mesothelioma , a form of cancer that affects the lining of the lung , to patients who have not received prior chemotherapy . petrexed hospira will also be given in combination to cisplin for the initial treatment of patients with advanced stage of lung cancer . your doctor will determine if pemetreed hospir is suitable for you if you have lung cancer at an
do not use pemetrexed hospira - if you are allergic ( hypersensitive ) to pemetreed or any of the other ingredients of this medicine ( listed in section 6 ). - if breast - feeding is not recommended during treatment with pemetemetrexED hospira . - if your child has recently received or is about to receive a vaccine against yellow fever . warnings and precautions talk to your doctor or pharmacist before using pemetretted hospir if you have or have had problems with your kidneys . before you receive pemetroed hospire , your doctor will check before each infusion that the amount of medicine
the dose of pemetrexed hospira is 500 mg for every square metre of your body ' s surface area . your height and weight are measured to work out the surface area of your entire body . your doctor will work out your dose based on this body surface area and will adjust your dose and duration of treatment according to your blood cell counts . when mixed with the pemetreed hospir powder 9 mg / ml ( 0 . 9 %) sodium chloride solution for injection , pemetresed hospire is given by infusion into one of your veins . the infusion will last approximately 10 minutes . when using pemetrett
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : fever or infection ( common ) with a temperature of 38ºc or greater , sweating or other signs of infection ( since you may have less white blood cells than normal which is very common ). infection ( sepsis ) may be severe and could lead to death . if you have chest pain ( common ), with a fast heart rate , pain , redness , swelling or sores in your mouth ( very common ) if you get allergic reaction such as skin rash , burning or prickling sensation , fever .
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the expiratory date refers to the last day of that month . this medicine does not require any special storage conditions . reconstituted and infusion solution : the product should be used immediately . chemical and physical in - use stability of reconstituuted and infused solutions of pemetrexed were demonstrated for 24 hours at refrigerated temperature . the reconstuted solution should be administered immediately after preparation . parenteral medicines : if you notice disc
what pemetrexed hospira contains the active substance is pemetreed . pemetrxed hospiras 100 mg : each vial contains 100 milligrams of pemetereed ( as pemetretted disodium hemipentahydrate ). pemetoxed hospiry 500 mg : one vial of 500 milligram of pememetrexED ( as peemetrexede disodium semipenthydrate ) contains 1 , 000 milliggrams of pererexed . after reconstitution , the solution contains 25 mg / ml of petrexed ( without
ganfort contains two active substances called bimatoprost and timolol . both help to reduce pressure in the eye . bimAToprost belongs to a group of medicines called prostamides , which work together by blocking a prostaglandin analogue . timololine belongs to medicines called beta - blockers . ganfort is used to lower pressure in your eye . it is a clear , watery liquid that is injected into the eye by your eye doctor . gansfort is for use in adults , adolescents and children aged one month and above . it can be used in the adult eye or in the
do not use ganfort eye drops : - if you are allergic to bimatoprost , timolol , beta - blockers or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has respiratory problems such as asthma or severe chronic obstructive bronchitis - if he / she has severe lung disease - if the child has wheeziness or difficulty in breathing - if they have long - standing cough - if his / her child has heart problems - if their child has low heart rate - if there is a history of heart block or heart failure warnings and precautions talk to your doctor
always use ganfort exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how to start treatment - the bottle is for single use only . - do not put ganf into your neck . - use the bottle at the same time each day . - step 5 . 1 . wash your hands . do not touch your head . 2 . pull down your eyelid , which is covered by a small pocket . 3 . gently squeeze the bottle . - gently squeeze your eye during treatment . 4 . remove the lid from your eye . 5 . gently press down on the eye with
like all medicines , ganfort can cause side effects , although not everybody gets them . the drops can cause the following side effects when given with ganart ( multi - dose or single - dose ). very common side effects ( may affect more than 1 in 10 people ) the eye redness . common side effect ( may affects up to 1 in 9 people ) 100 the eye burning , itching , stinging , irritation of the conjunctiva ( the transparent layer at the back of the eye ), sensitivity to light , eye pain , sticky eyes , dry eyes , feeling of something in the eye , small breaks in the surface of
keep this medicine out of the sight and reach of children . do not use ganfort after the expiry date which is stated on the carton and on the blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . ganf is for single use only . if you notice that the solution is not clear or contains particles , contact your doctor or pharmacist for advice . do away with the blister and keep the blister tightly closed in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how
what ganfort contains - the active substance is bimatoprost ( 0 . 3 mg / ml ) timolol . each bottle contains 5 mg of timolole maleate in 6 . 8 ml . - the other ingredients are benzalkonium chloride ( a preservative ), sodium chloride , sodium phosphate dibasic heptahydrate , citric acid monohydrate , purified water , hydrochloric acid and sodium hydroxide . what ganFort looks like and contents of the pack gan fort is a clear to slightly yellow , clear , colourless to pale yellow eye - shaped , round
gefitinib mylan contains the active substance gefitinib . this protein is produced by biotechnology in cancer cells . gefinib melan is used to treat adults with non - small cell lung cancer . this cancer is a disease in which malignant ( cancer ) cells form in the tissues of the lung .
do not take gefitinib mylan if you are allergic to gefitoninib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before taking gefinib melan if : you have any other lung problems . some lung problems can be serious . gefnitinib yourlan should not be used if you have problems with your liver . gekitin ib mylan should be used in children and adolescents under 18 years of age . other medicines and gefilitinib tell your doctor or pharmacist if you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 250 mg antacids taken once daily on an empty stomach ( see section 2 , " gefitinib mylan contains sodium "). take gefnitinib melan at about the same time each day . if you have trouble swallowing the tablets , you can take them with or without food . do not take any other liquids . take the tablets with water . do this at least 20 minutes before or at the same times each day , with or at least at the beginning
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor straight away if you notice any of the following serious side effects you may need urgent medical treatment : allergic reaction ( symptoms include swollen face , lips , tongue or throat , difficulty to swallow , hives , nettle rash , difficulty breathing , serious breathlessness , sudden worsening breathlessness with a cough or fever ). these may be signs of an inflammation of the lungs called ' interstitial lung disease '. uncommon ( may affect up to 1 in 100 people ) gefitinib may cause severe skin reactions which affect your body . the signs
what gefitinib mylan contains - the active substance is gefinib . each film - coated tablet contains 250 mg of gefib . - the other ingredients are lactose monohydrate , microcrystalline cellulose , crospovidone ( type a ), povidon ( k30 ), sodium laurilsulfate , magnesium stearate . - in the tablet coating are polyvinyl alcohol , macrogol 4000 , titanium dioxide ( e171 ), red iron oxide ( e172 ) and yellow iron oxide red ( e 172 ). what gefitoninib melan looks like
reblozyl contains the active substance luspatercept which is used to treat myelodysplastic syndromes ( mds ). mds is a group of many different blood and bone marrow disorders in which certain types of red blood cells become abnormal . signs and symptoms can be a low red blood cell count ( anaemia ) which can be caused by the lack of redblood cell transfusions . reblozey is used in adults to treat anaemia in patients with mds who cannot receive red bloodcell transfusions ( erythropoietin therapies ) in patients who have beta - thalass
do not take reblozyl if you are allergic to luspatercept or any of the other ingredients of this medicine ( listed in section 6 ) if you think you may be pregnant ( see pregnancy section ). warnings and precautions talk to your doctor before taking this medicine if you have thalassaemia ( a condition where your spleen removed ) or have had a blood clot . your doctor may recommend hormone replacement therapy if you had a previous blood clot and / or preventive measures ( including medicines used to prevent a blood clot ). if you suffer from high blood pressure , your doctor will decide whether reblzyl is
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . your doctor will carry out blood tests before you start using reblozyl . reblzyl is given as an injection under the skin . the dose depends on how much you weigh . the injections should be given in a single dose of 1 . 0 mg / kg of body weight . your dose will be adjusted by your doctor . this dose may be adjusted if your blood pressure is raised . use in children and adolescents reblblozell is used to treat myelodysplastic syndrom
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you have difficulty in walking or speaking , dizziness , loss of balance and coordination , numbness or paralysis in the face , leg or arm , or blurred vision . these may be symptoms of a stroke . blood clots swelling in the area around the eyes , face , lips , mouth or tongue throat allergic reactions , rashes 36 reporting of side effects 36 if you get any side effects talk to your doctor or pharmacist . this includes any possible side effects not listed in this leaflet . very common
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the vial label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , reblozyl may be stored at room temperature ( up to 8 ) for up to 25 hours and then refrigerated for up 24 hours at 2 8 . do away with any unused medicinal product or waste material . do throw away any medicines via wastewater or household waste . these measures will help protect the environment
what reblozyl contains the active substance is luspatercept . each ml of solution contains 25 mg or 75 mg of luspormcept . after reconstitution , each ml contains 50 mg of the active ingredient luspaterscept . the other ingredients are excipients , citric acid monohydrate , sodium citrate 80 , sucrose , hydrochloric acid ( for ph adjustment ), sodium hydroxide ( for pct adjustment ). what rebl ozyl looks like and contents of the pack reblizyl is a white to off - white powder . rebluzyl 25 mg powder for solution for
fotivda contains the active substance tivozanib , which is a protein kinase inhibitor . tiv ozanib works by stopping the growth of the cancer by stopping cancer cells from growing and forming new blood vessels . fotivd is used in adults with advanced kidney cancer when other treatments ( alpha or interleukin - 2 ) have not helped to stop your disease or have not worked .
do not take fotivda if you are allergic to tivozanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have been told that you have a problem with your heart . if you drink alcohol excessively ( either every day or only from time to time ). if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor before taking fotiveda if : you have high blood pressure . fotivada will not lower your blood pressure ; your doctor will measure your blood blood pressure using a medicine . fotalda will only lower yourblood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of fotivda is 1340 mg for 21 days , taken as 7 capsules once a day . you will take 1 capsule in the morning and 1 capsule once a morning . you may take 4 capsules in the evening . if you take more fotvda than you should if you have taken too many capsules , you may experience unacceptable side effects . severe side effects may occur during fotrevda therapy . the usual daily dose of the fotidda is 890 mg for
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects high blood pressure ( this side effect can occur commonly in people over the age of 2 ). tell your doctor immediately if you have high bloodpressure . symptoms may include severe headaches , blurred vision , shortness of breath , changes in your mental state , feeling anxious , confused or disorientated . your doctor may want to monitor your blood pressure more closely while you are taking fotivda . high blood hypertension is not treated with a medicine to treat your high blood blood pressure . if you take more fotvda than you should
what fotivda contains the active substance of fotive is tivozanib . each tablet contains 890 mg of tiv ozanib ( as tivzanib hydrochloride monohydrate ). the other ingredients are : tablet core : ( 890mg tivuzanib ), mannitol ( e421 ), magnesium stearate , gelatin , titanium dioxide ( e171 ), indigo carmine ( e132 ), yellow iron oxide ( e172 ), propylene glycol ( for strong ammonia solution ), titanium dioxide , tartrazine aluminium lake ( e133 ), shellac , propylenegly
stribild contains two active substances : elvitegravir ( an antiretroviral medicine known as an integrase inhibitor cobicistat , which is a booster ( pharmacokinetic enhancer ) of the activity of elvitesgravira emtricitabine ( an antiviral medicine called a nucleoside reverse transcriptase inhibitor ( nrti ) tenofovir disoproxil ( an antitroviral medication called a nucleotide reverse transcriptases inhibitor ) stribild is given as a single tablet regimen for the treatment of human immunodeficiency virus ( hiv
do not take stribild if you are allergic to elvitegravir , cobicistat , emtricitabine , tenofovir , ten ofovir disoproxil or any of the other ingredients of this medicine ( listed in section 6 ). during treatment , you should not take any medicine containing tenofoviir disopyroxil . your doctor will monitor your kidney function and may change your dose of these medicines . if you have been told by your doctor that you have alfuzosin ( an enlarged prostate gland ), amiodarone , quinidine ( used to
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . adults and adolescents 12 to less than 18 years of age : the recommended dose is 35 mg once daily by mouth . your doctor may change your dose , or temporarily stop your medicine . your dose may be adjusted , or your doctor will stop the treatment temporarily . your healthcare professional will tell you which medicines to take . you should also tell your doctor if you take : oral supplements ( such as antacids or laxatives containing minerals such as magnesium , aluminium , calcium , iron , zinc ) 4 times a day
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . when treating hiv infection , it is not always possible to tell whether the unwanted effects are caused by stribild or by the hiva disease itself . serious side effects are possible . tell your doctor immediately if you experience any of the following : lactic acidosis
what stribild contains the active substances are elvitegravir , cobicistat , emtricitabine and tenofovir disoproxil . each stribil film - coated tablet contains 150 mg elvitesgravira , 150 mg cobicista , 200 mg emtracitabin , 245 mg tenofovegravor disoproxil and 300 mg ten ofovir dissoproxel fumarate . each tablet contains 136 mg tenorovir . the other ingredients are croscarmellose sodium , hydroxypropyl cellulose ,
zyprexa contains the active substance olanzapine . zyprexa belongs to a group of medicines called antipsychotics and is used to treat the following conditions : schizophrenia , a disease with symptoms such as hearing , seeing or sensing things which are not there , mistaken beliefs , unusual suspiciousness , and becoming withdrawn . people with this disease may also feel depressed , anxious or tense . moderate to severe manic episodes , a condition with symptoms of excitement or euphoria . zzyprex has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olan zapine treatment
do not take zyprexa - if you are allergic ( hypersensitive ) to olanzapine or any of the other ingredients of this medicine ( listed in section 6 ). an allergic reaction may be recognised as a rash , itching , a swollen face , swollen lips or shortness of breath . - if your doctor has told you that you have eye problems such as certain kinds of glaucoma ( increased pressure in the eye ). warnings and precautions talk to your doctor or pharmacist before taking zypxa . zypitxa is not recommended for elderly patients with dementia because it may have serious side effects .
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of zyprexa tablets is one tablet a day . your doctor may increase your dose to 5 to 20 mg once a day depending on your symptoms . how to take zydosexa take your zypxa tablets at the same time each day . swallow the tablet whole with a glass of water . you can take your tablets with or without food . zypyxa coated tablets are for oral use . swallow your tablet whole . do not chew or crush the
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you experience : unusual movement ( a common side effect that may affect up to 1 in 10 people ) mainly of the face or tongue ; blood clots in the veins ( an uncommon side effect which may affect upto 1 in 100 people ) especially in the legs ( symptoms include swelling , pain , and redness in the leg ), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing . if you notice any of these symptoms seek medical advice immediately ; a combination of fever , faster breathing , sweating
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . zyprexa may pose a risk to the environment . do this by asking your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment
what zyprexa contains the active substance is olanzapine . each zyPrexa tablet contains 2 . 5 mg , 5 mg or 7 . 5mg , 10 mg , 15 mg or 20 mg . the other ingredients in your zypxa tablet pack are lactose monohydrate , hyprolose , crospovidone , microcrystalline cellulose , magnesium stearate , hypromellose , titanium dioxide ( e171 ), carnauba wax . the different zypyxa tablet strengths are : - zy prexa 2 . 25 mg , 7 . 25mg and
what prolia is prolia contains denosumab , a protein ( monoclonal antibody ) that is similar to another protein that is produced naturally in the body . it is used to prevent bone loss in adult patients with osteoporosis when treatment is not suitable . prolia helps to make bone stronger and keeps it free of oestrogen . it reduces the amount of oesterrogen that makes bones fragile . after the menopause , oestrogens level drops and bones become thin and fragile . what osteopORosis is osteoporeosis is caused by the lack of testosterone produced by the body and is
do not use prolia if you have low calcium levels in the blood ( hypocalcaemia ). if you are allergic to denosumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using prolia . if you think any of these apply to you , tell your doctor straight away . warnings and symptoms talk to a doctor or nurse straight away if you develop a skin infection with symptoms such as a swollen , red area of skin , usually in the leg , which feels hot and tender . cellulitis with symptoms of fever . these symptoms may be
what prolia is prolia contains one pre - filled syringe with 60 ml of solution for injection ( injection every 6 weeks ). it is given as a single injection under the skin ( subcutaneous ) in the front of your thighs , abdomen or upper arm . prolia can be used with or without stickers . you should continue to take calcium and vitamin d supplements while you are taking prolia . how prolia works prolia should be injected by a doctor or nurse . it is very important that you follow the instructions for use given to you by your doctor or pharmacist . if you have any questions about how prolias works
like all medicines , this medicine can cause side effects , although not everybody gets them . stop taking prolia and see a doctor immediately if you develop skin infections ( cellulitis ). if you get any of these symptoms while taking prolium : swollen , red area of skin , usually in the leg , which feels hot and tender . symptoms may include fever . stop using prolia if you have pain in the mouth and / or jaw , swelling or non - healing of sores in themouth or jaw ( discharge , numbness , feeling of heaviness or loosening of a tooth ), as these could be signs of bone damage in the
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the label and carton after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . your pre - filled syringe may be removed from the refrigerator and left at room temperature ( not above 25 ) for a single period of maximum three months . after the injection , the pen may be stored at room temperatures ( not below 25 ) or below 30 for
what prolia contains - the active substance is denosumab . 1 ml solution contains 60 mg of denosumaab in 60 ml . - the other ingredients are acetic acid , glacial , sodium hydroxide , sorbitol ( e420 ), polysorbate 20 and water for injections . what prolia looks like and contents of the pack prolia is a clear to slightly opalescent , colourless to slightly yellow solution for injection in a pre - filled syringe with a needle guard .
what ambirix is ambirrix is a vaccine used to protect adults and children from 1 to 15 years of age against two diseases : hepatitis a and hepatitis b . infection : the hepatitis a virus causes the liver to become swollen and inflamed . the virus is caused by the virus in faeces , serum or saliva . symptoms usually occur 3 to 6 weeks after infection . if you feel sick , have a fever , aches , pains , feel very tired , dark urine , pale faececes or yellowish skin or eyes ( jaundice ). the severity and type of symptoms can vary from person to person .
you must not be given ambirix if you are allergic to ambirax or any of the other ingredients of this vaccine ( listed in section 6 ). signs of an allergic reaction may include itchy skin rash , shortness of breath and swelling of your face or tongue . if you have an allergic response to any vaccine . if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or nurse before you are given ambira if you : have ever had hepatitis a or hepatitis b diseases if you get a severe infection with a high temperature . the vaccine should be given at the same time every week
your doctor or nurse will give you ambirix as an injection into a muscle in the upper arm . ambirux will be given into a vein . the injection will be injected into the thigh muscle . you will receive a total of two injections . the injections will be administered within 12 months . the first injection will usually be given at least six months apart . the second injection will normally be given between 6 and 12 months after the first . your doctor may decide to give extra doses to prevent future booster dosing . you may be given two injections at the same time to help prevent the diseases .
like all medicines , this vaccine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : allergic and anaphylactic reactions . the signs may include a rash , itchy , blistering , swelling of the eyes and face , difficulty in breathing or swallowing , a sudden drop in blood pressure and loss of consciousness . other side effects reported in clinical trials with ambirix were : very common ( may affect more than 1 in 10 people ): headache loss of appetite feeling tired or irritable pain and redness
what ambirix contains 26 the active substance is hepatitis a virus . 1 ml solution contains 720 micrograms of elisa units ( equivalent to 0 . 5 mg / ml ). the other ingredients are : hepatitis b surface antigen 20 microgram ( e433 ) human diploid ( mrc ), cells , aluminium hydroxide , hydrated in 0 . 05 ml , saccharomyces cerevisiae , aluminium phosphate in 0. 4 ml , sodium chloride and water for injections . what ambirax looks like and contents of the pack suspension for injection in a pre - filled syringe . ambirood is a white
what bexsero is bex sero is a meningococcal group b vaccine . what bexero is used for bex serumo is given to adults , adolescents and children from 2 years of age with disease caused by the neisseria meningitidis group b bacteria . these bacteria are often involved in the causes of infections ( such as meningitis , inflammation of the brain and spinal cord ) and sepsis ( blood poisoning ). the vaccine works by helping your body to produce its own protection ( antibodies ) against the disease .
do not use bexsero if you are allergic to any of the ingredients of this vaccine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using bex sero if : you have a severe infection with a high temperature ( over 38 ). vaccination should be postponed until you have recovered from a minor infection such as a cold . your doctor may decide to delay vaccination if you have haemophilia or any other problem that may prevent your blood from clotting properly . you are using blood thinners ( anticoagulants ) as part of treatment to improve the immune system ( ecul
bexsero will be given to you by a doctor or nurse . the recommended dose is 5 micrograms injected into the muscle of the thigh or upper arm . injections will be repeated every 2 to 5 weeks . you will receive three injections of the vaccine . your doctor will decide whether you need an additional injection ( booster ). the first injection will be administered at least 2 months apart . the interval between injections will usually be 1 month . your physician will decide if you need the intervalbetween injections . children and adolescents from 2 months of age onwards the interval of injections will depend on the age of the child . children from 15 to
like all vaccines , this vaccine can cause side effects , although not everybody gets them . stop using bexsero and see a doctor immediately if you notice any of the following side effects : very common ( may affect more than 1 in 10 people ): pain / tenderness at the injection site , redness of the skin at the site of injection , swelling of theskin at the place of injection site hardness of the area of the injection area . if any of these side effects occur , stop using this vaccine and tell your doctor . common ( might affect up to 1 in every 10 people ) fever , loss of appetite , tenderness
what bexsero contains the active substances are recombinant neisseria meningitidis group b nhba fusion protein 1 , 2 , 3 , 50 micrograms recombinant nisseria maningitis group b noada protein 1 and 2 , 2 and 3 50 microgasm recombinant neurisseria meingitidas group b fhbp fusion protein 2 and 2 and three 50 micros protein 3 produced in outer membranevesicles ( omv ) recombinant noisseria meningitidis type b strain total protein for thepora p ( p ) ( see section 2 ) 25 1 produced
nitisinone mdk contains the active substance nitisinon . this medicine is used to treat a rare disease called hereditary tyrosinemia ( hty ) in adults , adolescents and children aged 1 year and above . in this disease your body does not make enough of the amino acid tyrosine ( amino acids are substances that are naturally present in the body ). nitisine works by reducing the amount of tyrosinine and the harmful substances it produces . this means that tyrosate is eliminated from the body by low tyrosines and phenylalanine ( another amino acid ).
do not take nitisinone mdk - if you are allergic to nitisine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine . pregnancy and breast - feeding nitis inone mdks may affect the eyes , especially during nitisinfone treatment . if you get red eyes or if you notice any change in the colour of your eyes , tell your doctor immediately . your doctor may recommend an eye examination . if possible , you should contact your doctor if you have eye problems due to inadequate dietary control . see section 4 for
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . treatment with this medicine will be started by a doctor who is experienced in the treatment of the disease ( hereditary tyrosinemia type 1 ). the recommended dose is 1 capsule for every kg of body weight taken orally once a day , taken orally with or without food . the dose may be increased to 20 capsules once a daily . in this patient population , the dose is based on body weight . swallow the capsules whole with a small amount of water or formula diet . if you take more nitisinone md
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . store nitisinone mdk in the original package in order to protect from light . once removed from the refrigerator , nitisinaone mdks can be stored for a maximum of 2 weeks at a temperature not above 25 . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no
what nitisinone mdk contains the active substance is nitisinoone . nitis inone mdks 2 mg hard capsules : each capsule contains 2 mg nitisine . nitesinone dk 5 mg hard capsule : each capsules contains 5 mg nisinone . each capsule of nitishinone mdyk 10 mg hard gelatin : each hard capsule contains 10 mg nitesine . the other ingredients are gelatin , titanium dioxide ( e171 ), black iron oxide ( e172 ), shellac glaze . what nitisinnone mdK looks like and contents of the pack nitisinfone mdky
docetaxel accord contains the active substance docetaxal . docetxel belongs to the group of anti - cancer medicines called taxoids . docnetaxel accord has been prescribed by your doctor for the treatment of breast cancer , special forms of lung cancer ( non - small cell lung cancer ), prostate cancer , gastric cancer and head and neck cancer : - for the diagnosis of advanced breast cancer alone , docetixel could be administered either alone or in combination with doxorubicin , or trastuzumab , or capecitabine . - for early breast cancer with or without
do not use docetaxel accord - if you are allergic ( hypersensitive ) to docetxel or any of the other ingredients of docetixel accord ( listed in section 6 ) - if white blood cells are low - if your liver is not working properly - if there is a severe liver disease warnings and precautions before you are given docetAXel accord , you will have blood tests to check that you have enough blood cells and sufficient liver function to receive docetacord . white blood cell disturbances may cause fever and infections . tell your doctor immediately if you have abdominal pain , tenderness , diarrhoea
docetaxel accord will be given to you by a healthcare professional . the dose will depend on your weight and your general condition . your doctor will calculate your body surface area in square meters ( m² ) and will determine the dose you should receive . method and route of administration docetaxell accord will usually be given by infusion into one of your veins . the infusion will last approximately one hour during which you will be in the hospital . frequency of administration you should usually receive your infusion once every 3 weeks . your blood tests will be taken at regular intervals to check your generalcondition . docetAXel accord may be given
like all medicines , this medicine can cause side effects , although not everybody gets them . your doctor will discuss these with you and will explain the potential risks and benefits of your treatment . the most commonly reported adverse reactions of docetaxel accord are reduction in the number of red blood cells and white blood cells , alopecia , nausea , vomiting , sores in the mouth , diarrhoea and tiredness . the severity of adverse events of docelaxel alone may be increased when docetxel is given in combination with other chemotherapeutic agents . during the infusion , allergic reactions ( may affect up to
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial after exp . the exp date refers to the last day of that month . do store below 25 . store in the original package in order to protect from light . the vial and the infusion bag should be used within 6 hours of dilution . do away with the vials and the vouches . do this after the time you have been told by your doctor . do do not freeze . infusion the infusion solution should be mixed with non - pvc bags 48 hours
what docetaxel accord contains - the active substance is docetxel . each ml of concentrate for solution for infusion contains 20 mg docetel . 1 vial of concentrate contains 20mg docetixel . 4 vials of concentrate contain 80 mg docelaxel . 8 vials ( 1 vials ) of concentrate containing 160 mg docotaxel - the other ingredients are polysorbate 80 , ethanol anhydrous ( see section 2 " docetacord contains ethanol an hydrous "), citric acid anhydrated ( see " docelaccord contains sodium "). what docet
intuniv contains the active substance guanfacine . this medicine belongs to a group of medicines that affect the electrical activity of the brain . this medicinal product works by reducing the activity of impulsive and hyperactive parts of the body . this means that the effect of this medicine is increased . intuniv is used to treat ' attention deficit hyperactivity disorder ' ( adhd ) in adults who are not adequately controlled with current stimulant medication . current medication is not controlling adhd symptoms . the medicine is used in combination with a treatment programme consisting of psychological therapy , educational therapy and social therapy . intunaiv is indicated in
do not take intuniv if you are allergic to guanfacine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking this medicine if you have low or high blood pressure . heart problems tell your doctor if you suffer from heart problems . you may have fainted recently if you had thoughts or feelings of suicide or if you know you have any other psychiatric conditions ( withdrawal symptoms ). increased heart rate . high bloodpressure . this medicine should not be used if you think you have these problems . children and adolescents intunv is not recommended for children
your treatment will be started by a doctor experienced in the treatment of adolescent behavioural disorders . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet once a day . your doctor will start your treatment with 1 tablet once daily . your dose will be gradually increased over the course of 1 day . the dose will gradually be increased over a period of time . your treatment will usually be started with 0 . 05 mg / kg of bodyweight once daily , depending on your weight . your daily dose will then be gradually decreased . your first dose of
like all medicines , this medicine can cause side effects , although not everybody gets them . if you feel unwell , talk to your doctor or pharmacist . your doctor may need to adjust your dose or stop your medicine temporarily . serious side effects tell your doctor straight away if you notice any of the following serious side side effects : feeling drowsy ( feeling dizzy ) hypotension ( slow heart beat ( bradycardia ), feeling faint and loss of concentration ( syncope ), a serious withdrawal side effect from high blood pressure with symptoms such as headaches , feeling confused , nervousness , agitation and tremors ( hypertensive encephal
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister pack after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . the tablets should be used within one week after first opening of the blister pack . do this to protect from moisture . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what intuniv contains the active substance is guanfacine hydrochloride . each prolonged - release tablet contains 1 mg of guanFacine . each extended - release dose contains 2 mg of Guanfacin . each long - release episode contains 3 mg of the active ingredient guanfuine hydro chloride . each sustained - release dosage contains 3mg of guinfacine . every extended -release episode contains 4 mg of of guaconfacine ( see section 2 ). the other ingredients are hypromellose 2208 , methacrylic acid - ethyl acrylate copolymer , lactose monohydrate
ecalta contains the active substance anidulafungin . it is used to treat adults and children ( from 1 to 18 years old ) with a type of fungal infection that affects the blood or other internal organs called invasive candidiasis . the infection is caused by fungal cells called candida that are cut off and grown in the laboratory . ecalta belongs to a group of medicines called echinocandins . these medicines prevent serious fungal infections caused by the lack of fungo - fungal cell walls . ecalda is used when fungalcells have incomplete or defective cell walls , which makes them
do not use ecalta if you are allergic to anidulafungin , other echinocandins , caspofungin acetate or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using ecaltra if you have problems with liver function . if you suffer from liver problems , your doctor may reduce the dose of your treatment or may give you anaesthetics . your doctor will monitor your condition during and after treatment with ecaltree . if an allergic reaction occurs , such as itching , wheezing , blot
the treatment will be given to you by a doctor or nurse . the recommended dose is 200 mg / 100 mg given once a week . the dose is 1 dose in the morning and 1 dose per day in the evening . adults ( 18 years of age and older ) the recommended starting dose is 3 . 0 mg / 200 mg given twice a week , given once in the mornings and once in a day in in the afternoon . the doctor may increase the dose to 1 . 5 mg / day ( 100 mg / kg ) depending on the patient ' s weight . ecalta is given as slow infusion ( a drip into a vein
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any of the following serious side effects : - threatening allergic reactions , including difficulty breathing or wheezing or an existing rash . ecalta can cause serious sideeffects , including convulsion ( seizure ), flushing , rash , pruritis ( itching ), hot flush , hives , sudden contraction of the muscles , wheezed , coughing or difficulty of breathing other side effects very common side effects ( may affect more than 1 in 10 people ): low blood potassium ( hypokalaemia ), diarrhoea ,
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . the reconstituted solution may be stored at room temperature ( up to 25 ) for up to 48 hours . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 48 hours at 2 8 . do away with the reconfituted product
what ecalta contains - the active substance is anidulafungin . each vial of powder contains 100 mg of anidulinafungan . - the other ingredients are mannitol , polysorbate 80 , tartaric acid , sodium hydroxide and hydrochloric acid 30 . what ecaltas looks like and contents of the pack ecaltfa is supplied as a box containing 1 vial containing 100 mg concentrate for solution for infusion . the powder is white to off - white .
adenovi contains the active substance rurioctocog alfa pegol , which is a copy of pegylated human coagulation factor viii ( human cogulation factor iii ). factor v iii is necessary for the blood to form clots and stop bleedings . in patients with haemophilia a , factor v viii is not produced in the body . adynovi is used for the treatment and prevention of bleeding in adults and adolescents 12 years of age and older with haemaophilia b , an inherited bleeding disorder caused by lack of factor v ii .
do not use adynovi - if you are allergic to rurioctocog alfa pegol or octocog aluminium or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is allergic to any of these ingredients . warnings and precautions talk to your doctor or pharmacist before using adynov : - if the child has had an anaphylactic reaction ( a severe , sudden allergic reaction ) to adyno . allergic reactions may include rash 95 , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing ,
treatment with adynovi will be started by a doctor experienced in the treatment of haemophilia . adynov is used for treatment of bleeding . adnovi is used as the replacement therapy for patients who have had their previous treatment with adnovovov . adynaovi is a life - long treatment . always use this medicine exactly as your doctor has told you . check with your doctor if you are not sure . prevention of bleeding the recommended dose of adynova is 40 mg once a day or 50 mg once daily for 2 weeks . prevention and treatment of blood - related bleeding the dose of adsynovi
like all medicines , this medicine can cause side effects , although not everybody gets them . sudden allergic reactions ( anaphylactic ) may occur within minutes of the injection . early symptoms of allergic reactions may include rash , hives , wheals , generalised itching , swelling of lips and tongue , difficulty in breathing , wheezing , tightness in the chest , feeling of being unwell , dizziness and loss of consciousness . if severe symptoms of difficulty in breath or fainting occur , prompt emergency treatment is immediately available . patients who have received previous treatment with factor viii ( more than 150 days of treatment ) inhibitor antibodies
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . the powder vial may be stored at room temperature ( up to 30 ) for a maximum of 3 days . do this medicine if it is stored at a temperature not above 30 and it is not used within 3 days or it may be discarded . do
what adynovi contains the active substance is rurioctocog alfa pegol ( pegylated human coagulation factor viii produced by recombinant dna technology ). each powder vial contains 250 , 500 , 1000 or 2000 iu ruricoctocag alfapegol . the solvent vial is 5 ml of sterilised water for injections . the other ingredients are mannitol , trehalose dihydrate , histidine , glutathion , sodium chloride , calcium chloride dihydrates , tris ( hydroxymethyl ) aminomethane , polysorbate
rekovelle contains follitropin delta , a follicle stimulating hormone that belongs to a group of hormones called gonadotropins . gonadotropicins are involved in female fertility and are present in assisted reproduction programs , in vitro fertilisation ( ivf ) and intracytoplasmic sperm injection . they are produced by the ovaries and are involved with the development of many egg sacs .
do not use this medicine if any of the following apply to you . if you are not sure , talk to your doctor or pharmacist before using rekovelle . warnings and precautions talk to the doctor or nurse before using this medicine : if you have a problem with your fertility problems . if your doctor thinks you may be allergic to follicle stimulating hormone or any of those other ingredients of this medicine ( listed in section 6 ). if you develop a tumour in the uterus , ovaries , breasts , pituitary gland or hypothalamus . if any or all of the above apply to your ( or you are unsure ), talk
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the rekovelle dose will be given as your first treatment cycle . your doctor will tell you how many injections of anti - Müllerian hormone to give . your ovaries will be stimulated by stimulation with gonadotropins in your blood . your dose will depend on your body weight . your physician will take a blood sample during the last 12 months to check how well your medicine is working . the dose will vary depending on your condition and how well it is working for you . your bodyweight will
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects caused by hormones that are used to treat infertility have been reported . this medicine may cause a high level of activity in the ovaries ( ovarian hyperstimulation syndrome ). symptoms include pain , discomfort and swelling of the abdomen , nausea , vomiting , diarrhoea , weight gain and difficulty breathing . if you notice any of these symptoms , seek medical advice straight away . a side effect that may affect up to 1 in 10 people is headache . nausea ( ovarianhyperstimulation syndrome ) pelvic pain and discomfort ( ovarian origin tiredness
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . after reconstitution , the solution may be stored at room temperature ( up to 25 ) for up to 3 days . if not used immediately , in - use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 3 days at 28 to 25 . after the treatment any unused
what rekovelle contains the active substance is follitropin delta . each multidose cartridge contains 12 mg of follitroin delta in 0 . 36 millilitre of solution . after dilution , each ml of solution contains 33 . 3 mg of the active ingredient follitrotin delta ( as besilate ). the other ingredients are phenol , polysorbate 20 , l - methionine , sodium sulphate decahydrate , disodium phosphate dodecahydrates , concentrated phosphoric acid , sodium hydroxide and water for injections . what rekole looks like and contents
the active substances of revinty ellipta are fluticasone furoate and vilanterol . each inhalation of revindy elliptoe contains flutic asone fureate and 92 mg vilancerol . the 22 mg / 22 mg inhalation contains flitantasonefuroate 184 mg and vilterol 22 mg . the 92 / 22mg inhalation is for adult patients with chronic obstructive pulmonary disease ( copd ). asthma in adults and adolescents 12 years of age and older weighing 184 mg or more : the 184 / 22 inhalation dose is based on body weight . for
do not take revinty ellipta if you are allergic to fluticasone furoate , vilanterol or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking revintchy ellipta . if you have liver disease , tell your doctor straight away if you notice any of these side effects . if your doctor has moderate or severe liver disease . the lower strength of revintty ellipta 92 / 22 mg tablets should be used instead of the usual strength . if any of your medical conditions apply to you , tell the doctor straightaway
always use this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . asthma the recommended dose for asthma is one inhalation twice a day ( one inhalant each day ). this is one dose in the morning and one inhaler in the evening . for asthma the dose is one spray twice a morning ( one tablet each day ) with fluticasone furoate and one dose each day ( two tablets each day ), with vilanterol . copd the recommended starting dose for copd is one and a half inhalations twice a daily (
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions to ellipta are rare ( may affect up to 1 in 1 , 000 people ). if you experience any of the following symptoms while taking ellipta stop taking this medicine and contact your doctor immediately : skin rash , hives , redness swelling , mainly of the face and mouth ( angioedema ), becoming very wheezy or coughing , having difficulty in breathing , feeling weak or light headed ( which may lead to collapse or loss of consciousness ) immediate breathing difficulties if you have immediate breathing problems while taking revinty ellipt
what revinty ellipta contains the active substances are fluticasone furoate and vilanterol . each 92 micrograms inhalation delivers 92 microlitres of flutic asone firoate and 22 microlitre of vilancerol and trifenatate . each 184 microgramS inhalation provides 184 microliters of flilitasonefuroate , 22 micrometre of trifenedatate and 184 micrometres of vivanterol and 140 microlitr ( see section 2 " revintey ellipta is for inhalation use "). the other
atripla contains three active substances used to treat human immunodeficiency virus ( hiv ) infection : efavirenz , a non - nucleoside reverse transcriptase inhibitor ( nnrti ), emtricitabine , a nucleosides reverse transcriptases inhibitor ( tnrtis ), tenofovir , a nucleotide reverse transcript enzyme inhibitor ( netrti ). these active substances are all taken together with antiretroviral medicines . they work by interfering with the normal working of an enzyme ( reverse transcriptasing ) that is essential for the virus to reproduce itself . atri
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet taken by mouth once a day . atripla should be taken on an empty stomach at least 1 hour before or 2 hours after food . some side effects ( such as dizziness and drowsiness ) have been reported . if you take more atripola than you should if you have taken more atrippla than your doctor tells you to , contact your doctor immediately . if possible , take your tablets with food . atripla can be taken with
during hiv therapy there may be an increase in weight and in levels of blood lipids and glucose . this is partly linked to restored health and life style , and in the case of bloodlipids sometimes to the hiv medicines themselves . your doctor will test for these changes . like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects lactic acidosis ( excess lacticacid in the blood ) is rare ( may affect up to 1 in 1 , 000 people ). if you experience any serious side effect , stop taking atripla and contact your doctor immediately . serious other side
what atripla contains the active substances are efavirenz , emtricitabine and tenofovir disoproxil . each atriblea film - coated tablet contains 600 mg efavairenz and 200 mg emtracitabin , corresponding to 245 mg tenofoviir disopicroxil ( as fumarate ). the other ingredients are croscarmellose sodium , hyprolose , magnesium stearate , microcrystalline cellulose , sodium laurilsulfate ( see section 2 " atribla contains sodium "). the tablet
orgalutran contains the active substance ganirelix . it belongs to a group of medicines called anti - gonadotrophin . it is a synthetic version of the natural gonadonrophin releasing hormone ( gnrh ). how orgalutra works gnrh regulates the release of gonadotropins by the body . this is called follicle stimulating hormone . gonadadotrophicins play an important role in the growth and development of follicles in the ovaries . follicles are small round sacs that contain the egg cells . they release the immature egg cells and live in the follicles .
do not use orgalutran - if you are allergic to ganirelix or any of the other ingredients of this medicine ( listed in section 6 ). - if hypersensitive to gonadotrophin releasing hormone ( gnrh ), a gnrh analogue . - if your child has a moderate or severe kidney or liver disease . - are pregnant . warnings and precautions talk to your doctor or pharmacist before using orgaluchran allergic reactions . if you develop an active allergic condition , your doctor may recommend additional monitoring and treatment . allergic reactions if you experience allergic reactions ( generalised , hives , urticaria ),
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . orgalutran is only given to you by a doctor who is experienced in the treatment of assisted reproduction techniques ( i . e . in vitro fertilisation ( ivf ), ovarian stimulation , follicle stimulating hormone ( fsh ), corifollitropin on day 2 or 3 of each cycle . orgdalutran should be injected under the skin ( subcutaneously ) every 5 to 6 weeks . your doctor will decide how long you should be treated with orgaluitran . your dose will
like all medicines , this medicine can cause side effects , although not everybody gets them . a side effect that may affect more than 1 in 10 people is local skin reactions ( redness and swelling ). if the local reaction disappears after 4 hours , see section 4 . uncommon ( may affect up to 1 in 100 people ) headache nausea ( malaise ) rare ( may affects up to one in 10 , 000 people ) allergic reactions rash facial swelling , difficulty breathing ( dyspnoea ) swelling of face , lips , tongue , and / or throat , difficulty in breathing or swallowing ( angioedema , anaphylaxis )
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and syringe after exp . the exp date refers to the last day of that month . syringes should be stored in a refrigerator ( 2 - 8 ). do not freeze . store in the original package in order to protect from light . store the syringed in the outer carton in order for clear , particle - free solutions to be administered . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use .
what orgalutran contains - the active substance is ganirelix . each vial contains 0 . 5 ml of acetic acid . - the other ingredients are mannitol and water for injections ( for the ph ) and sodium hydroxide ( for acetic acids ). what orgalUTran looks like and contents of the pack orgaluitran is a clear , colourless aqueous solution for injection . the solution is clear and colourless . it is intended for subcutaneous administration . the needle is inserted into a dry natural rubber / latex . orgalustran is available in packs containing 1
what blitzima is blitzima contains the active substance rituximab , a " monoclonal antibody ". it sticks to a target in a type of white blood cell called " b - lymphocyte ". when ritukimab sticks to the target , it stops the cell from growing and dividing . what blitzima used for blitzima has been prescribed for the treatment of : a ) non - hodgkin ' s lymphoma this is a disease of the lymph tissue that affects the immune system . it affects a type a of white cell called b - lipocytes . blitzima can be used alone or with
do not use blitzima - if you are allergic to rituximab , other proteins that are derived from ritukimab or any of the other ingredients of this medicine ( listed in section 6 ) - if your child has a severe active infection - if he / she has a weak immune system - if his / her child has severe heart failure or severe uncontrolled heart disease - if they have granulomatosis , polyangiitis , microscopic polyangis or pemphigus vulgaris warnings and precautions talk to your doctor before using blitzima if your or your child : has a hepatitis infection .
how blitzima is given your doctor will decide how much blitzima you will receive and for how long . this treatment will be given to you by a doctor or nurse who is experienced in the use of this medicine . if you have any side effects , your doctor may decide to reduce your dose . how blitzima will be administered blitzima comes as a drip ( intravenous infusion ). medicines given before each blitzima administration you will be treated with blitzima together with other medicines ( pre - medication ) to reduce the risk of side effects . your doctor or healthcare professional will decide on the most appropriate course of your treatment . for non -
like all medicines , this medicine can cause side effects , although not everybody gets them . most side effects are mild to moderate . however , some may be serious and require treatment . rarely , some of these reactions have been fatal . infusion reactions during the first 24 hours of the infusion you may experience fever , chills , shivering , pain at the infusion site , blisters , itching , sickness , nausea , tiredness , headache , breathing difficulties , blood pressure raised , wheezing , throat discomfort , tongue or throat swelling , itchy , runny nose , vomiting , flushing , palpitations , heart attack , low number
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the vial in the outer carton in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what blitzima contains the active substance is rituximab . each 10 ml vial contains 100 mg of ritukimab in 10 ml . each 50 ml vials contains 500 mg of the active ingredient in ritiximab ( 10 mg / ml ). the other ingredients are sodium chloride , tri - sodium citrate dihydrate , polysorbate 80 and water for injections . what blitzima looks like and contents of the pack blitzima is a clear , colourless solution for infusion . it is supplied in 2 ml glass vials containing 50 ml . packs of 1 vial . not all pack
roactemra contains the active substance toilizumab , a type of monoclonal antibody ( a type in the body ) that attaches to a specific target in the brain called interleukin - 6 ( interlek ) and blocks its action . this is a target protein that is found in many parts of the body and helps to reduce the inflammation in your body . roactemrea can help to reduce symptoms such as pain and swelling in your joints . roactoremra reduces the damage to the cartilage and bone in your bones caused by the disease . roacticemra is used to treat
do not use roactemra if you are allergic to tocilizumab or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active , severe infection . during the infusion with roactiemra , you may experience allergic reactions such as chest tightness , wheezing , severe dizziness , light - headedness , swelling of the lips and skin rash . these reactions are usually mild to moderate and go away within a few days . tell your doctor immediately if you feel unwell . warnings and precautions talk to your doctor or nurse before using roactremra : if you develop
the doctor or nurse will give you roactemra by infusion into a vein ( intravenous infusion ). your doctor or a nurse will decide on the correct dose based on your body weight . the treatment with roacterera will be started as follows : 8 weeks - 4 weeks - 8 weeks roactiemra will normally be given as 4 mg once a day as a drip in the vein ( intravenous infusion ) over a period of 2 hours . roactemera will usually be given every 8 weeks for as long as your doctor continues to prescribe it . this means that it is given every 12 weeks for up
like all medicines , roactemra can cause side effects , although not everybody gets them . the following side effects have been reported in the post marketing setting in adults and children 3 years of age and older : roactemnra may cause serious side effects ( may affect up to 1 in 10 people ). allergic reactions such as difficulty with breathing , chest tightness , light - headedness , rash , itching , hives , swelling of the lips , tongue or face . serious infections such as fever and chills , mouth or skin blisters , stomach ache signs and symptoms of liver toxicity ( may occur in up to1 in
keep this medicine out of the sight and reach of children . do not use after the expiry date which is stated on the outer carton and the vial label after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what roactemra contains the active substance is tocilizumab . each 4 ml vial contains 80 mg of tociluzumab in 20 ml . each 10 ml vials contains 200 mg of of tocizumumab ( 20 mg / ml ). each 20 ml vray contains 400 mg of the active ingredient in tocilixumab , 20 mg per ml . the other ingredients are sucrose , polysorbate 80 , disodium phosphate dodecahydrate , sodium dihydrogen phosphate dihydrate and water for injections . what roactemetra looks like and contents of the
what onbrez breezhaler is onbrex breez inhaler contains the active substance indacaterol which belongs to a group of medicines called bronchodilators . these relax the muscles in the walls of the small air passages in the lungs . what onbreez breezcheler is used for onbrezer is used to make breathing easier in adults with a lung disease called chronic obstructive pulmonary disease ( copd ). in copd the muscles around the airways relax , making breathing difficult . this medicine works by relaxing these muscles in your lungs , making it easier for air to get in and out
do not use onbrez breezhaler - if you are allergic to indacaterol or any of the other ingredients of this medicine ( listed in section 6 ). - if your asthma is not controlled with onbreez breez inhaler . - if any of these apply to you , tell your doctor . warnings and precautions talk to your doctor or pharmacist before using onbrezer : - if the patient has heart problems , epilepsy , thyroid gland problems , thyrotoxicosis ( diabetes ). treatment with on brez breezyzhalER should be stopped immediately if you get tightness of the chest , coughing ,
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose is one 150 microgram capsule once a day . your doctor may increase your dose to 300 microgram once a week depending on how you respond to the treatment . your inhaler will be used for 24 hours . how onbrez breezhaler is used onbreez breez inhaler is provided as an inhaler and capsules ( in blisters ) containing the medicine are packed in a carton . the medicine is inhaled using inhalation powder . the onbrex breez
what onbrez breezhaler contains - each onbrex breez inhaler 150 micrograms inhaler contains 150 microlitres of indacaterol ( as indacateol maleate ). - the other ingredients are lactose and the capsule is made of gelatin . - eachonbrez bronzhalER 300 microgram s inhaler 300 microlitre inhaler includes 300 micrometres of of indiacaterol , as indaconateol femaleate . - the ingredients are made of lactoseand the capsule contains gelatin . what onbreez breezeler looks like and contents of
clopidogrel hcs contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopridogrel clcs is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombisation , which can lead to atherotrombotic events (
do not take clopidogrel hcs - if you are allergic to clopridogrel or any of the other ingredients of this medicine ( listed in section 6 ). - if your bleeding is not being controlled with food or drink . - if a medical condition is currently causing bleeding such as a stomach ulcer or bleeding within the brain . - have severe liver disease . if any of these apply to you , tell your doctor before taking clopIDogrel clcs . warnings and precautions the warning and precautions of clopidineogrel ccs are as follows : - if bleeding is being controlled by food or alcohol
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel hcs per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl hcs ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel hcs contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopide ( as hydrochloride ). the other ingredients are ( see section 2 ' clopIDogrel hexcs contains hydrogenated castor oil '): tablet core : microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 and hydrogenatedcastor oil in the tablet core ; film - coating : polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow
feccroja contains the active substance cefiderocol . it is an antibiotic medicine that belongs to a group of antibiotics called " cephalosporins ". antibiotics are used to fight bacteria that cause infections . fetcroja is used to treat infections caused by bacteria that you have not previously treated with other antibiotics .
do not use fetcroja if you are allergic to cefiderocol or any of the other ingredients of this medicine ( listed in section 6 ). if you think you may be allergic , ask your doctor for advice . warnings and precautions talk to your doctor or pharmacist before using fetcroj if you have ever had a severe allergic reaction to certain antibiotics ( such as penicillins or carbapenems ). if this happens , tell your doctor straight away . if you experience severe skin peeling or swelling of the hands , face , feet , lips , tongue or throat that may cause difficulty swallowing or breathing , stop using
this medicine is given to you by a doctor or nurse as an infusion ( a drip ) into a vein . it is usually given every 3 weeks . it may be given every 2 weeks . your doctor will decide how often you should receive fetcroja treatment . your dose will be decided by your doctor . your response to the treatment will depend on the type of infection you have and on whether you have any pain . the fetcroja infusion will be given into a separate vein . if you have kidney problems if you suffer from kidney problems , your doctor may decide to reduce your dose of fetcroJA . if your dose is
like all medicines , this medicine can cause side effects , although not everybody gets them . serious side effects tell your doctor straight away if you notice any of the following serious side side effects you may need urgent medical treatment : severe allergic reaction : sudden swelling of your lips , face , throat or tongue , a severe rash or other severe skin reactions , difficulty swallowing or breathing . if you have this reaction , you may have diarrhoea , stools , blood or mucus . treatment may be stopped or medicines may slow bowel movement . other side effects if you get any of these side effects : very common ( may affect more than 1 in
what fetcroja contains the active substance is cefiderocol sulfate tosylate . each vial contains 1 mg cefirocol . the other ingredients are sucrose , sodium chloride and sodium hydroxide . what fetcroJA looks like and contents of the pack fetcrojoe is a white to off - white powder for concentrate for solution for infusion . it is supplied in packs containing 10 vials .
depocyte is used to treat adults with lymphomatous meningitis . lymphomatinous menenitis is a condition in which tumour cells form the membranes around the brain and spinal cord . depocyte is prepared from the blood of lymphoma tumour cell cells .
do not use depocyte - if you are allergic to cytarabine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor , pharmacist or nurse before using depocyte if you have a meningeal infection . severe neurological side effects when using depocytes , symptoms of the nervous system may include convulsions , pain , numbness , tingling , blindness , visual disturbances . if you experience any of these symptoms , stop using depoly and tell your doctor . taking any dexamethasone tablets at the same time may increase the risk of unwanted effects .
treatment of cancer in the lumber sac will be overseen by a doctor who is experienced in the use of depocyte . depocyte will be given to you by a healthcare professional . the recommended dose is one vial of 1 mg or 5 mg of dexamethasone 5 mg / ml . each depocyte dose will be monitored by your doctor to detect any side effects . the dose of depocytes depends on the body surface area ( temperature ) and on the dose you receive . the usual dose is 22 mg / kg or 30 mg / m2 . after withdrawing depocyte from the vial , proper precautions should be taken to
like all medicines , this medicine can cause side effects , although not everybody gets them . you may experience side effects more often during your treatment . the following side effects have been reported : very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ): very common : not known ( frequency cannot be estimated from the available data ) very common adverse events where depocyte is administered in combination with other chemotherapeutic agents common ( effects 1 to less than 10 users per 10
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the vial label after exp . the exp date refers to the last day of that month . depocyte should be stored in a refrigerator ( 2 - 8 ). do not freeze . depocytes should be used within 4 hours after preparation . do this if depocyte has not been stored correctly . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what depocyte contains - the active substance is cytarabine . each ml of suspension contains 10 mg cytarbine . one vial of 5 ml solution contains 50 mg cytabine ( as besilate ). - the other ingredients are cholesterol , triolein , dioleoylphosphatidylcholine , dipalmitoylophosphatideglycerol , sodium chloride , water for injections . what depocyte looks like and contents of the pack depocyte is a solution for injection . it is supplied as a 5 ml clear glass vial , ready to use solution for a
what bemrist breezhaler is bemist breez inhaler contains two active substances , indacaterol and mometasone furoate . indacterol belongs to a group of medicines called bronchodilators . it relaxes the muscles in the small airways in the lungs , making it easier for air to get in and out of the lungs . mometsone fruate belongs to an important group of medicine called corticosteroids . it is used to reduce the swelling and irritation ( inflammation ) in the smaller airways , which can lead to breathing problems . cortic
do not use bemrist breezhaler - if you are allergic to indacaterol , mometasone furoate or any of the other ingredients of this medicine ( listed in section 6 ). - if any of these apply to you , tell your doctor before using bemist breez inhaler . - if your doctor thinks you may be allergic . - tell your physician if you have heart problems , such as an irregular or fast heartbeat . - you have thyroid gland problems . - have diabetes , high blood sugar , seizures or low level of potassium in your blood . - suffer from severe liver problems . warnings
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . bemrist breezhaler capsules should be used every day . you should use the medicine every day , at the same time of the day . this will help you to remember to use it . it will also help you remember to take it . if your asthma is not being controlled well enough , it will be easier to control your symptoms . how to use bemist breez inhaler bemrid breezhhaler is for inhalation use . it is supplied as an inhaler and
like all medicines , this medicine can cause side effects , although not everybody gets them . some side effects can be serious . tell your doctor immediately if you experience any of the following : very common ( may affect more than 1 in 10 people ): difficulty breathing or swallowing , swelling of the tongue , lips , or face , skin rash , itching and hives . allergic reaction uncommon ( may effect up to 1 in 100 people ): swelling of either the tongue or lips , face or throat ( angioedema ). other side effects other sideeffects include : very commonly ( may affects more than1 in 10 users ): sore throat , runny
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . this medicine does not require any special temperature storage conditions . the capsules should be kept in the original blister in order to protect from light . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what bemrist breezhaler contains the active substances are indacaterol ( as acetate ) and mometasone furoate . bemist breez inhaler 125 micrograms / 62 . 5 microgram inhaled contains 173 microgram indacate and 150 microgram of indacatesol ( corresponding to 80 microgram mometsone furuate ). the delivered dose ( the dose that leaves the mouthpiece of the inhaler ) is 125 microlitres ( equivalent to 173 microlitre indacatersol ) and 150 to 160 microgrammometason furoates
zyllt contains clopidogrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). zyllt is taken to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombogenesis , which can lead to atherotrombotic events ( such as stroke , heart attack , or death ).
do not take zyllt if you are allergic to clopidogrel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking zylltt . warnings and precautions talk to your doctor or pharmacist before taking any of your zyllts : if you think you may be at increased risk of bleeding if you : have a risk of internal bleeding such a stomach ache or a blood
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of zyllt per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of zllt ( 4 tablets of 75 mg ) once at the start of treatment . then , the recommended daily dose is one one 75
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what zyllt contains the active substance is clopidogrel . each film - coated tablet contains 75 mg of clopridogrel ( as hydrogen sulphate ). the other ingredients are : tablet core : lactose ( see section 2 under ' zyllT contains lactose '), microcrystalline cellulose , pregelatinised maize starch , macrogol 6000 and hydrogenated castor oil in the film - coating , hypromellose ( e464 ), titanium dioxide ( e171 ), red iron oxide ( e172 ), talc and propylene glycol in thefilm - coating . what zyll
lamivudine teva contains the active substance lamivudin . lamivuda teva is used to treat long term ( chronic ) hepatitis b infection in adults . lamivaludineteva is an antiviral medicine that works by stopping the hepatitis b virus from multiplying . it belongs to a group of medicines called nucleoside analogue reverse transcriptase inhibitors ( nrtis ). hepatitis b is a virus that infects the liver . long term (" chronic " infection can lead to liver damage . lamlivudine preva reduces the amount of hepatitis b in your body . this results in a reduction in liver damage and
do not take lamivudine teva - if you are allergic to lamivuda or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions 28 lamividine tevas , like other similar medicines , can cause serious side effects , including liver disease , hepatitis c . if you become overweight , your doctor may need to change your dose . you will have blood tests periodically during treatment with your medication ( see section 4 " warnings and risks "). if you take more lamivuine tev than you should if you have taken more lamidudine than you were told to , tell
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage your doctor lamivudine teva is used to treat your hepatitis b infection . it is important that you continue to take it until your infection is gone . if you have any further questions on the use of this medicine , ask your doctor , pharmacist or nurse . how much to take the usual dose of lamivuda teva varies depending on your condition and on the condition of your kidneys . your doctor may prescribe lamivuine together with another medicine containing lamivude . the usual starting
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with lamivudine teva in patients with other conditions linked to hepatitis b . the side effects that have been observed during therapy for hepatitis b are listed below . the most common side effects reported during lamivudaine clinical trials were tiredness , respiratory tract infections , throat discomfort , headache , stomach discomfort , pain , nausea , vomiting , diarrhoea and increases in liver enzymes . these are usually mild and usually disappear after a few days . if you notice any of these symptoms , stop taking lamivude
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . lamivudine teva should be used immediately after first opening . do this if you notice that the solution is not clear or contains particles . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help to protect the environment .
what lamivudine teva contains - the active substance is lamivuda . each film - coated tablet contains 100 mg of lamivUDine . - the other ingredients are microcrystalline cellulose , sodium starch glycolate ( type a ), magnesium stearate . tablet film - coating : hypromellose , titanium dioxide ( e171 ), macrogol , polysorbate 80 , iron oxide yellow ( e172 ), iron oxide red ( e 172 ). what lamivudsine teeva looks like and contents of the pack orange , biconvex film - - coated tablets , debossed
nespo ( an anti - anaemic ) is used to treat your anaemia . anaemia occurs when your blood does not contain enough red blood cells . the symptoms include fatigue , weakness and shortness of breath . it is used when the natural hormone erythropoietin cannot be taken . erythroietin works by blocking the growth of your kidneys and so reduces the number of red blood cell cells . it can also be used when darbepoetin alfa cannot be used . chronic renal failure ( symptomatic anaemia ) chronic renal fail is caused by kidney failure . kidney failure occurs when the
do not use nespo if you have high blood pressure or are taking other medicines . if you are allergic to nesco ( darbepoetin alfa ) or r - huepo . warnings and precautions talk to your doctor or pharmacist before using nespos if you suffer from high bloodpressure or are using medicines for sickle cell anaemia . epileptic fits ( seizures ), convulsions or seizures have been reported in patients with liver disease . drugs used to treat anaemia may cause an allergy to latex . the needle that connects the pre - filled syringe with the pre filled syring
your doctor will carry out blood tests before you start nespo . your doctor will check your haemoglobin level regularly . the usual starting dose is 10 mg . your dose will be adjusted by your doctor if a haemogl level between 10 and 12 mg / m2 is maintained . the pre - filled syringe can be given directly into a vein . patients with chronic renal failure the usual dose is a single injection under the skin or into a veins ( intravenous ). your doctor may change the dose if your anaemia is not controlled with nespos . the dose will depend on your body weight . the recommended dose is
like all medicines , nespo can cause side effects , although not everybody gets them . the following side effects have been reported with nespos : 471 common ( may affect up to 10 in 100 people ): high blood pressure ( hypertension ) fluid retention ( oedema ) uncommon ( may effect up to 1 in 100 , 000 people ): blood clots ( thrombosis ) pain in the area injected rash , redness and / or the skin rare ( may affects up to1 in 10 , 000 users ): serious allergic reactions : sudden life - threatening allergic reactions ( anaphylaxis ) swelling of the face ,
keep out of the reach and sight of children . do not use nespo after the expiry date which is stated on the carton and on the syringe label after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep your syringe in the original package in order to protect from light . after first opening , use within 30 days . do away with the syringes and discard after 7 days . nespos should not be used if you notice any visible change in the appearance of the solution . medicines should not pose a risk to the
what nespo contains the active substance is darbepoetin alfa . each ml of solution for injection contains 10 , 15 , 20 , 30 , 40 , 50 , 60 , 80 , 100 , 130 , 150 , 300 or 500 iu of the active substances darbasepoetein ala . the other ingredients of nespos are sodium phosphate monobasic , sodium phosphate dibasic ( e470b ), sodium chloride , polysorbate 80 and water for injections . what nespol looks like and contents of the pack nespi is a clear , colourless
macugen is a solution for use in the eye called pegaptanib . this medicine works by stopping abnormal formation of new blood vessels in the lens . macugen is used for the treatment of adults with macular degeneration . people with this disease have vision loss caused by damage to a part of the retina ( macula ) that lines the front part of their eye . the macula is the thin layer that lines up the front of the eye . macula , the macular part of your eye , is the eye ' s largest blood vessel . abnormal blood vessels grow in the retina and the macul . these new blood
do not use macugen if you are allergic to pegaptanib or any of the other ingredients of this medicine ( listed in section 6 ). if you have an active or suspected infection in your eye . warnings and precautions talk to your doctor or pharmacist before using macugen . if you think you may have an infection or bleeding in the eye , stop using macug injection and contact your doctor immediately if you experience any of or combination of the following symptoms : eye pain , increased discomfort , worsening eye redness , blurred or decreased vision , increased sensitivity to light , small particles in your vision , or other changes to the colour of
mugen will be given to you by a doctor or nurse . your doctor or pharmacist will give you macugen as a single injection into your eye . it is given every 6 weeks or 9 weeks . the injection will be injected into the vitreous part of your eye ( the front part of the eye ). macugen must not be used if you are being treated with antibiotic eye drops . your eye doctor will clean your eyes with some local anaesthetic (umbing medicine ) to prevent any pain where the injection is given . if you think you may be allergic to antibiotic eyedrops , your doctor will check your eye and tell
like all medicines , this medicine can cause side effects , although not everybody gets them . serious allergic reaction ( anaphylactic reaction ) angioedema of which symptoms include breathing difficulty , wheezing , swollen mouth , face , hands or feet , itching skin , fainting , rapid pulse , stomach cramps , nausea , vomiting and diarrhoea . the frequency of these side effects is not known . an infection in the internal portion of the eye has been reported during macugen treatment . the symptoms are described in section 2 under " warnings and precautions " for patients with these symptoms . other side effects very common ( may
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do use the medicine immediately if you notice any change in the appearance of the tablets . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what macugen contains - the active substance is pegaptanib . each single dose pre - filled syringe contains 0 . 3 mg of pegaptenib in 90 ml solution . - the other ingredients are sodium chloride , monobasic sodium phosphate monohydrate , dibasicodium phosphate heptahydrate , sodium hydroxide , hydrochloric acid ( for ph adjustment ) and water for injections . see section 2 . what macugen looks like and contents of the pack macugen solution for injection in a single dose pack is supplied in a pouch . each pack contains a pre -filled syringe of 0
pivance contains the active substance palifermin , which is produced by biotechnology in the laboratory of escherichia coli . palifermine works by stopping the growth of epithelial cells in the mouth and digestive tract and by blocking their growth in the tissues below the skin . paliformin is used to treat oral mucositis ( soreness , dryness or inflammation of the mouth ) as a side effect that can be treated with treatments for your blood cancer . if your bloodcancer is not being treated with chemotherapy , radiotherapy or autologous hematopoietic stem cell transplantation ( a procedure
do not take kepivance if you are allergic to palifermin , escherichia coli derived proteins or any of the other ingredients of this medicine ( listed in section 6 ). children and adolescents do not give this medicine to children and teenagers under 18 years of age . other medicines and kepivalance tell your doctor or pharmacist if you take , have recently taken or might take any other medicines . kepvelance may be taken with heparin . if you have recently been given heparrin , tell your physician . pregnancy and breast - feeding kepipivance is not recommended if you plan to
how kepivance is given your doctor will decide how much kepivanance you will receive . your doctor or nurse will decide the dose you will need . your dose will depend on your condition and your general condition of cancer treatment . the recommended dose of kepivalance is 60 mg per kilogram body weight . your healthcare professional will give you kepvelance as an intravenous injection into a vein . how often will you be given kepiveance ? kepllance is administered to you three days before chemotherapy ( chemotherapy and radiotherapy ) in three different clinical trials . you will be given chemotherapy andrad
like all medicines , this medicine can cause side effects , although not everybody gets them . common ( may affect up to 1 in 10 people ): side effects include skin rash , itching , redness ( pruritus and erythaema ), an increase in the thickness in the mouth or tongue , change in colour of the mouth , generalised swelling ( oedema ), swelling of hands , ankles or feet , pain , fever and aching joints ( arthralgia ), altered taste , raised levels of lipase and amylase levels in the blood , and decreased levels of digestive enzymes in theblood . treatment may be
what kepivance contains - the active substance is palifermin . each vial contains 6 . 25 mg of paliferin . - the other ingredients are mannitol , sucrose , l - histidine , polysorbate 20 and diluted hydrochloric acid . what kepvelance looks like and contents of the pack kepiverance is a white powder supplied in a vial . each carton contains 6 vials .
cinacalcet accordpharma contains the active ingredient cinacalcit which reduces the levels of calcium and phosphorous in the blood . it is used to treat problems with organs called parathyroid glands . parathyroids are four small glands in the neck , which are connected to the thyroid gland . cinocalcate accordphara is used : to treat secondary hyperparathyroidism in adults with serious kidney disease who are not on dialysis because they cannot eliminate the excess of waste products that are made from them . to reduce the level of calcium in the bloodstream ( hypercalcaemia ),
do not take cinacalcet accordpharma - if you are allergic to cinacealcate or any of the other ingredients of this medicine ( listed in section 6 ). - if there are low levels of calcium in your blood . your doctor will monitor your blood calcium levels regularly while you are taking cinocalcut accordpha . warnings and precautions talk to your doctor or pharmacist before taking crinacal cet accordPHarma : - if any of these apply to you , tell your doctor before taking this medicine . - if your doctor has told you that you have a history of
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet a day . cinacalcet accordpharma must be taken orally with or without food . cinnacalcitpharma can be taken with or shortly after food . the tablets must be swallowed whole with water . your doctor will take regular blood samples during treatment to monitor the progress of secondary hyperparathyroidism . the usual starting dose of cinacealcut accordphara is 30 mg once a day ( one tablet in the morning and one
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : numbness or tingling around the mouth , muscle aches , cramps or seizures , as these may be signs that your calcium levels are too low ( hypocalcaemia ). swelling of the face , lips , mouth , tongue or throat that may cause difficulty in swallowing or breathing ( angioedema ). very common ( may affect more than 1 in 10 people ): nausea and vomiting . if you notice any of these side effects seek medical advice immediately . common ( might affect up to 1 in every
what cinacalcet accordpharma contains - the active substance is cinacealcep . each film - coated tablet contains 30 mg , 60 mg or 90 mg cinaconalcip ( as hydrochloride ). - the other ingredients are cellulose , microcrystalline - crospovidone - magnesium stearate , hypromellose , titanium dioxide ( e171 ), triacetin , indigo carmine aluminum lake ( e132 ), iron oxide yellow ( e172 ). what cinacyalcel accordpharmaceutical looks like and contents of the pack ciniac
jentadueto contains two active substances called linagliptin and metformin . linaglptin belongs to a class of medicines called dpp - 4 inhibitors ( dipeptidyl peptidase - 4 inhibitor ) metformins and belongs to the class of substances called biguanides . they work together to lower blood sugar levels in adult patients with a type of diabetes called ' type 2 diabetes mellitus '. this medicine works by helping your body make better use of insulin . this medicine can be used alone or with certain other medicines used to treat diabetes ( such as sulphonylureas , emp
do not take jentadueto : if you are allergic to linagliptin , metformin or any of the other ingredients of this medicine ( listed in section 6 ). if you have severely reduced kidney function . if you suffer from uncontrolled diabetes with severe hyperglycaemia ( high blood glucose ), nausea , vomiting , diarrhoea , rapid weight loss . this can lead to lactic acidosis . the most common form of lacticacidosis is ketoacidosis . keto acidosis is a condition in which substances called ' ketone bodies ' accumulate in the blood and which can lead sometimes to diabetic pre
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of jentadueto is one tablet twice a day . if you currently take metformin or individual tablets of linagliptin or metformatin , take the tablet twice daily . do not take this other medicine if you have an upset stomach . the dose of 5 mg linaglptin or 2 , 000 mg metformina hydrochloride should be taken once daily . your doctor will tell you how many tablets of jentinueto to take . if this medicine does
like all medicines , this medicine can cause side effects , although not everybody gets them . some symptoms need immediate medical attention . stop taking jentadueto and contact a doctor immediately if you experience any of the following symptoms : low blood sugar ( hypoglycaemia ) trembling , sweating , anxiety , blurred vision , tingling lips , paleness , mood change or confusion . hypoglycemia is very rare ( may affect up to 1 in 10 , 000 people ). the most serious side effect reported with jentadaeto plus sulphonylurea is due to the combination jentadoueto plus insulin . j
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . store in the original package in order to protect from moisture . do this medicine if you notice any visible sign of tampering . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what jentadueto contains - the active substances are linagliptin and metformin hydrochloride . each jentadinueto 2 . 5 mg / 850 mg film - coated tablet contains 2 . 25 mg linaglioptin and 850 mg metformine hydrochlorides . - the other ingredients are arginine , copovidone , magnesium stearate , maize starch , silica , colloidal anhydrous , hypromellose , titanium dioxide ( e171 ), talc , propylene glycol . what jentadaeto looks like and contents of the pack jentadoeto
edurant contains the active substance rilpivirine . edurant is used to treat human immunodeficiency virus ( hiv ) infection in adults , adolescents and children aged 12 years and older . it belongs to a group of hiv medicines called non - nucleoside reverse transcriptase inhibitors ( nnrtis ). edurants is used in combination with hiv medications to treat adults and adolescents aged 12 months and older who are infected by hiv . edhurant is not a cure for hiv unless you have been taking hiv medicine before . your doctor will discuss with you which combination of
do not take edurant : - if you are allergic to rilpivirine or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking edurent : - you are taking any of any of : - the following medicines : - carbamazepine , oxcarbazepine ; phenobarbital ; phenytoin ; medicines used to treat some bacterial infections ( e . g . tuberculosis ); omeprazole , esomeprazole ; lansoprazole or pantoprazoles ; rabeprazoles
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 1 tablet once a day . children and adolescents ( aged 18 years and above ) the recommended doses of edurant are : 1 . rifabutin ( a medicine used to treat some bacterial infections ) edurants contains less than 1 mmol / ml of rifibutin . your doctor will tell you how much edurent you need to take . 2 . an antacid ( a medication used to prevent diseases ). the acid in the stomach is made up of aluminium
like all medicines , this medicine can cause side effects , although not everybody gets them . tell your doctor immediately if you have : headache , nausea , difficulty falling asleep , insomnia , dizziness , or changes in your routine liver tests ( transaminase ), increase in cholesterol and pancreatic amylase in your blood , abnormal dreams , rash , stomach pain , depression , tiredness , vomiting , drowsiness , decreased appetite , sleep disorders , stomach discomfort , depressed mood , dry mouth 36 low white blood cell and / or platelet count , decrease in haemoglobin in your body , triglycerides , lipase , bilirub
what edurant contains the active substance is rilpivirine . each tablet contains rilpalpiviraine hydrochloride . each film - coated tablet contains 25 mg of ril pivirrine . the other ingredients are : tablet core : lactose monohydrate , croscarmellose sodium , povidone k30 , polysorbate 20 , silicified microcrystalline cellulose , magnesium stearate . film - coating : lactate monohydrate and hypromellose 2910 ( e464 ). tablet coating : 6 mm ( diameter ), titanium dioxide ( e171
avandamet tablets are two different medicines , rosiglitazone and metformin . these two medicines are used to treat type 2 diabetes in adults . people with type 2abetes either don ' t make enough insulin to control their blood sugar levels or don 'T respond normally to insulin . rosigllitazONE and met formin work together by helping the insulin they make work better . this helps your body make better use of its blood sugar . avandamel is also used in combination with a sulphonylurea ( another type of diabetes medicine ) to treat high blood sugar in adults and adolescents
follow all your doctor ' s instructions carefully . check with your doctor , pharmacist or nurse if you are not sure . how to treat your diabetes : avandamet must not be used : if you have been prescribed avandamanet if you : are allergic ( hypersensitive ) to rosiglitazone , metformin or any of the other ingredients of avandammet ( listed in section 6 ) have had a heart attack have severe angina have heart failure have had heart failure in the past have severe breathing difficulties have liver disease have diabetic ketoacidosis ( a complication of diabetes causing rapid weight loss
always take avandamet tablets exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended starting dose is 2 mg rosiglitazone ( equivalent to 1000 mg metformin ). this dose is taken once a day , at about the same time each day . your doctor may increase your dose to 1 mg once a week , at least every 8 weeks . the maximum dose is 4 mg rosciglitizone ( corresponding to 1000mg metforma ). thisdose is taken twice a day . if you take more avandamanet
like all medicines , avandamet can cause side effects , although not everybody gets them . allergic reactions to avandamanet can include raised and itchy rash ( hives ) swelling mainly of the face or mouth ( angioedema ), which may cause difficulty in breathing collapse . if you get any of these symptoms , stop taking avandandamnet and contact your doctor straightaway . lactic acidosis ( build up of lactic acids in the blood ( lacticacidosis is a common side effect in patients taking metformin , especially if they have severe kidney disease ). symptoms of lact acidosis include
keep out of the reach and sight of children . do not use avandamet after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . this medicine does not require any special storage conditions . do this if you notice any change in the appearance of the tablets . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what avandamet contains the active substances are rosiglitazone and metformin . avandamanet tablets come in different strengths . each tablet contains 1 mg rosIGlitazon ( 500 mg metforma ) and 2 mg rosciglitasone ( 500mg metforman ). each tablet also contains 2 mg of rosigllitazione ( 1000 mg met formin ). each dose contains 4 mg of rsig litazone ( 1000mg met formformin ). the other ingredients are sodium starch glycollate , hypromellose , microcrystalline cellulose
clopidogrel mylan contains clopidigrel and belongs to a group of medicines called antiplatelet medicinal products . platelets are very small structures in the blood , which clump together during blood clotting . by preventing this clumping , antiplatelets medicinal products reduce the chances of blood clots forming ( a process called thrombosis ). clopiderel myl is taken by adults to prevent blood clumps ( thrombi ) forming in hardened blood vessels ( arteries ), a process known as atherothrombisation , which can lead to atherotrombotic events ( such
do not take clopidogrel mylan 31 if you are allergic to clopiprel or any of the other ingredients of this medicine ( listed in section 6 ). if you have a medical condition that is currently causing bleeding such as a stomach ulcer or bleeding within the brain . if you suffer from severe liver disease . if any of these apply to you , tell your doctor before taking clopridogrelmylan . warnings and precautions talk to your doctor or pharmacist before takingclopidoggingrel myl : if you think you may be at increased risk of bleeding such a medicalcondition that puts you at
always take this medicine exactly as your doctor or pharmacist has told you . check with your doctor , pharmacist or nurse if you are not sure . the recommended dose , including for patients with a condition called ' atrial fibrillation ' ( an irregular heartbeat ), is one 75 mg tablet of clopidogrel mylan per day to be taken orally with or without food , and at the same time each day . if you have experienced severe chest pain ( unstable angina or heart attack ), your doctor may give you 300 mg of clapidogl mylan ( 4 tablets of 75 mg ) once at the start
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor immediately if you experience : - fever , signs of infection or extreme tiredness . these may be due to rare decrease of some blood cells . - signs of liver problems such as yellowing of the skin and / or the eyes ( jaundice ), whether or not associated with bleeding which appears under the skin as red pinpoint dots and /or confusion ( see section 2 ' warnings and precautions '). - swelling in the mouth or skin disorders such as rashes and itching , blisters of theskin . these could be the signs of
what clopidogrel mylan contains the active substance is clopridogrel . each film - coated tablet contains 75 mg of clopide ( as hydrochloride ). the other ingredients are microcrystalline cellulose , colloidal anhydrous silica , crospovidone ( type a ), macrogol 6000 , hydrogenated castor oil ( see section 2 " clopIDogrelmylan contains hydrogenatedcastor oil "), polyvinyl alcohol , titanium dioxide ( e171 ), red iron oxide ( e172 ), yellow iron oxide , talc and macrogl 3000 . what
doptelet belongs to a group of medicines called thrombopoietin receptor agonists . doptelet is used to treat chronic liver disease with low platelet count ( thrombolocytopenia ), in adults , in a medical procedure to reduce the risk of bleeding . it works by reducing the number of platelets . platelets are blood cells that are needed in the blood to clot and prevent bleeding .
do not use doptelet - if you are allergic to avatrombopag or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor thinks that you may have a risk of blood clots in the veins or arteries . this is because doptelets may increase the risk of formation of bloodclots in patients with a history of cancer . - if the contraceptive birth control pill is not suitable for you ( or you are not sure ), ask your doctor . - when hormone replacement therapy is not recommended . - recently had surgery or if you have been injured . warnings and precautions 23 -
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the usual dose for your procedure is one 5 mg tablet once a day . your doctor may increase your dose to one 8 mg tablet twice a day depending on your response to doptelet . your dose of doptelets may be increased by 20 mg , 40 mg , 60 mg or more per day . the maximum recommended dose is one 60 mg tablet per day for 5 days . your physician will monitor your platelet counts regularly during this period . if you take more doptethan than you should if you
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with doptelet : very common ( may affect more than 1 in 10 people ): feeling tired uncommon ( may effect up to 1 in 100 people ): low red blood cell count ( anaemia ) blood clot in the portal vein ( a blood vessel that transports blood from the liver to the intestines ) upper abdominal pain , swelling bone pain muscle aches and fever reporting of side effects if you get any side effects talk to your doctor , pharmacist or nurse . this includes any possible side effects not listed in this leaf
what doptelet contains - the active substance is avatrombopag . each film - coated tablet contains avatormbopg maleate equivalent to 20 mg of avatrambopab . - the other ingredients are lactose monohydrate ( see section 2 under ' doptelets contains lactose '), microcrystalline cellulose , crospovidone type b [ e110 ], silica , colloidal anhydrous , magnesium stearate . - coating : vinyl alcohol , talc , macrogol 3350 , titanium dioxide ( e171 ), iron oxide yellow ( e172 ).
rapiscan belongs to a group of medicines called ' coronary vasodilators '. it works by widening the heart arteries , thus increasing heart rate and thereby increasing the flow of blood into the muscles of the heart . rapiscan is used for the following types of heart scan : ' myocardial perfusion imaging '. the scan contains a radioactive substance called a ' radiopharmaceutical '. these images are taken using a machine to measure the muscles in the heart using a readmill . a scan is taken to measure a small amount of radiopharma from the body into a vein . it is given by your doctor or nurse by
do not take rapiscan if you have slow heart rate , high degree heart block , sinus node disease , or a pacemaker that does not work properly . if you experience chest pain ( unstable angina ) during treatment , especially if you suffer from low blood pressure ( hypotension ) or heart failure . if your doctor thinks you may be allergic to regadenoson or any of the other ingredients of rapiscin ( listed in section 6 ). warnings and precautions talk to your doctor before taking rapiscen if any of these apply to you : if you are not sure , talk to a doctor or pharmacist before taking
rapiscan will be given to you by a doctor or nurse who is experienced in the treatment of your heart and blood pressure . it will be injected into a vein ( intravenously ) over a period of 400 minutes . a 5 ml solution the injection will be administered over a minimum of 5 minutes . the dose may be administered up to 10 minutes depending on your weight . your doctor will also give you an injection of sodium chloride 9 mg / ml ( 0 . 9 %) solution for injection ( intravenous ) over the course of 5 hours . if you are given more rapiscan than you should if you have received more rap
like all medicines , rapiscan can cause side effects , although not everybody gets them . the side effects are usually mild to moderate and usually disappear after the rapiscin injection has been given within 30 minutes of any treatment . tell your doctor immediately if you notice any of the following side effects : sudden stopping of the heart , which may be a sign of damage to the heart ( heart block ), a disorder of theheart ' s electrical signal , rapid heart beat low blood pressure , fainting , mini strokes , weakness of the face and inability to speak . rapiscans may cause a stroke or cerebrovascular accident .
viagra contains the active substance sildenafil which belongs to a group of medicines called phosphodiesterase type 5 ( pde5 ) inhibitors . it works by helping the blood vessels in your penis relax , allowing blood to flow into your penis when you get sexually excited . viagra will only help you to get an erection if you are sexually stimulated . viag is a treatment for adult men with erectile dysfunction ( impotence ) who cannot get , or keep a hard , erect penis suitable for sexual activity .
do not take viagra - if you are allergic to sildenafil or any of the other ingredients of this medicine ( listed in section 6 ). - if your doctor has told you that you are taking medicines called nitrates , which could lead to a dangerous fall in your blood pressure . these medicines are used to treat angina pectoris ( " chest pain "). if you have any questions about the medicines , ask your doctor . - if the doctor has given you nitric oxide donors such as amyl nitrite , which can lead to an increased risk of a dangerous drop in yourblood pressure . - when you
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 50 mg once a day . viagra film - coated tablets are for oral use . viaga orodispersible tablets are also for oral consumption . swallow the tablets whole with a glass of water . do not crush or chew the tablets . taking viagra with food viagra will help you to get an erection when you are sexually stimulated . if you take more viagra than you should if you accidentally take too many tablets , contact your doctor straight away . if possible take viagra
like all medicines , this medicine can cause side effects , although not everybody gets them . the side effects reported with viagra are usually mild to moderate . the most serious side effects that have been reported with the use of viagra include : an allergic reaction ( may affect up to 1 in 100 people ). symptoms include sudden wheeziness , difficulty in breathing , dizziness and swelling of the eyelids , face , lips or throat . if you get chest pains , you may be in a semi - sitting position and you may need to take nitrates to control your chest pain . prolonged and sometimes painful erections ( may occur rarely ,
what viagra contains - the active substance is sildenafil . each tablet contains 25 mg of sildenedafil ( as the citrate salt ). - the other ingredients are : tablet core : microcrystalline cellulose , calcium hydrogen phosphate ( anhydrous ), croscarmellose sodium , magnesium stearate , hypromellose , titanium dioxide ( e171 ), lactose monohydrate , triacetin , indigo carmine aluminium lake ( e132 ). what viagra looks like and contents of the pack viagra film - coated tablets have a rounded - diamond shape and are marked with "
sifrol contains the active substance pramipexole and belongs to a group of medicines known as dopamine agonists , which stimulate dopamine receptors in the brain . stimulation of the dopamine receptors triggers nerve impulses in thebrain that help to control body movements . sifrol is used to treat the symptoms of primary parkinson ' s disease in adults , adolescents and children aged one month and older . it is used in combination with levodopa to treat parkinson '. the symptoms are moderate to severe primary restless legs syndrome .
do not take sifrol - if you are allergic to pramipexole or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor before taking sifol if you have any medical conditions or symptoms , such as kidney disease . hallucinations ( seeing , hearing or feeling things that are not there ). most hallucinations are visual . dyskinesia ( abnormal , uncontrolled movements of the limbs ). if you suffer from advanced parkinson ' s disease , you may be given levodopa to treat dyskineia . warnings and symptoms talk to the doctor before you are given s
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose of sifrol for parkinson ' s disease is 3 tablets per day . during the first week , take 1 tablet of sufrol 0 . 088 mg ( 0 . 264 mg / 1 tablet ) once a day . thereafter , take one tablet of the 0 .088 mg ( 1 . 264 μg / 1 tablets ) once daily . your doctor may increase your dose to 0 . 800 mg ( 2 tablets ) twice a day if your symptoms return but do not stop taking tablets .
like all medicines , this medicine can cause side effects , although not everybody gets them . evaluation of these side effects is based on the following frequencies : very common ( may affect more than 1 in 10 people ) common ( might affect up to 1 in 100 people ) rare ( may affects up to1 in 1 , 000 people ) very rare ( might affects upto 1 in10 , 000 patients ) not known ( frequency cannot be estimated from the available data ) if you have parkinson ' s disease , you may experience the following side effects : - dyskinesia ( abnormal , uncontrolled movements of the limbs ), dizziness , nausea
what sifrol contains the active substance is pramipexole . each tablet contains 0 . 088 mg , 0 . 18 mg , or 0 . 35 mg , corresponding to 0 . 7 mg pramipxole as 0 . 125 mg , 1 mg , 2 mg , 3 mg , 4 mg , 5 mg , 6 mg , 8 mg , 10 mg , 15 mg , 20 mg , 30 mg , 40 mg , 50 mg , 60 mg , 100 mg , 90 mg , 200 mg , 300 mg , 400 mg , 500 mg , 600 mg , 800 mg , and 1 mg pramsipexol
emadine is a medicine used for the treatment of seasonal allergic conjunctivitis of the eye . it is used to prevent allergic conditions from occurring in the eye , and to reduce the allergic reaction . allergic conjustivitis may occur with exposure to some materials ( allergens ) that may cause allergic reactions such as itching , redness and swelling on the surface of your eye . if you notice any of these , tell your doctor immediately . do not try to cover up any of the effects . if any of them do not improve , tell the doctor immediately , or contact your doctor . if your doctor thinks that you do not
do not use emadine - if you are allergic to emedastine or any of the other ingredients of this medicine ( listed in section 6 ). - if your child is more than 3 years old . warnings and precautions talk to your doctor or pharmacist before using emadmine . children and adolescents do not give this medicine to children and young children under 3 years of age because benzalkonium chloride is present in the blood in children and children under the age of 6 . no clinical trials have been performed in this age group . other medicines and emadines tell your doctor if you have kidney or liver problems . em
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to use adults use in adults use for 3 weeks . use in children and adolescents use in the eye only . this medicine is for oral use . use only in your eyes . use within 3 weeks of the first dose . children and adolescent use in adolescents use for children and teenagers use in infants and adolescents 1 year and above use in adult use in all age groups . children 2 years and above 1 year of age use in this age group use in combination with other eye drops . do not use em
like all medicines , this medicine can cause side effects , although not everybody gets them . the effects are usually mild to moderate and will usually disappear after a few weeks or months . if the drops are used too often , tell your doctor straight away . common side effects ( may affect up to 1 in 10 people ) effects in the eye : eye pain , itchy eye and eye redness . uncommon side effects in adults ( may effect up to1 in 100 people )effects in the back of the eye ( corneal disorder ): abnormal eye sensation , increased tear production , tired eyes , eye irritation , blurred vision , cornealing
keep out of the reach and sight of children . do not use emadine after the expiry date which is stated on the carton and blister after exp . the exp date refers to the last day of that month . do store below 25 . do this to protect from infections . do do not throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what emadine contains - the active substance is emadastine 0 . 5 mg / ml . - the other ingredients are difumarate , benzalkonium chloride , trometamol , sodium chloride , hypromellose , purified water , hydrochloric acid , sodium hydroxide to maintain acidity levels and ph levels . what emadrine looks like and contents of the pack emadarine is a liquid ( a solution ) supplied in a 5 ml or 10 ml plastic ( drop -tainer ) bottle with a screw cap . not all pack sizes may be marketed .
levetiracetam is an antiepileptic medicine ( a medicine used to treat seizures in epilepsy ). levetir acetam actavis is used : on its own in adults and adolescents from 16 years of age with newly diagnosed epilepsy , to treat a certain form of epilepsy . epilepsy is a condition where the patients have repeated fits ( seizures ). levantiracetams is used for the epilepsy form in which the fits initially affect only one side of the brain , but could thereafter extend to larger areas on both sides of the body ( partial onset seizure with or without secondary generalisation ). leveiracetamm has been
do not take levetiracetam actavis - if you are allergic to leveturacetam , pyrrolidone derivatives or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking levetiraacetamactavis - tell your doctor if you have kidney problems - tell his / her if you notice any slow down in the growth or unexpected puberty development of your child . anti - epileptics should be used in children and adolescents . levetiralacetam actsavis has been associated with thoughts of harming or killing themselves . tell your
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one tablet of levetiracetam actavis twice a day , in the morning and in the evening . monotherapy dose in adults and adolescents from 16 years of age and older : one tablet once a day ( 1 , 000 mg ) for 3 weeks . your doctor will tell you the dose of leveriraceta actavis to take . in children and adolescents aged 2 years and older the recommended starting dose is 1 , 500 mg once a week . after therapy dose in children
like all medicines , this medicine can cause side effects , although not everybody gets them . contact your doctor or the nearest emergency department immediately if you experience : weakness , feel light - headed or dizzy or have difficulty breathing , as these may be signs of a serious allergic ( anaphylactic ) reaction . swelling of the face , lips , tongue and throat ( quincke ' s oedema ). flu - like symptoms , with a rash on the face or an extended rash with a high temperature , increased levels of liver enzymes seen in blood tests and a decrease in a type of white blood cell 56 ( eosinoph
what levetiracetam actavis contains the active substance is levetiraacetam . levetairacetamactavis 250 mg : each film - coated tablet contains 250 mg of levetoracetam ( as levetaracetam ). levetieracetam actingavis 500 mg : one film - coating contains 500 mg of the active ingredient levetiralacetam. leveteracetam actedavis 750 mg : every film - covered tablet contains 750 mg of one film- coated tablet levetirusacetam , as leveriraceta actavis 1 , 000 mg : the active substances are :
incruse ellipta contains the active substance umeclidinium bromide , which belongs to a group of medicines called bronchodilators . incruse ellipta is used to treat adults with chronic obstructive pulmonary disease ( copd ). copd is a long - term condition in which the airways in the lungs become blocked . this makes breathing difficulties difficult . difficulties in breathing can also result in tightening of the muscles around the airway . this medicine works by tightening these muscles in the air passages in the back of the lungs , making it easier for air to get in and out of the air
do not use incruse ellipta 27 if you are allergic to umeclidinium or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have asthma . incruruse ellipta should not be used in patients with asthma . talk to a doctor or nurse before using incruSE ellipta if you : have heart problems . have an eye problem called narrow - angle glaucoma ( an enlarged prostate , difficulty passing urine , or a blockage in your bladder ). have severe liver problems . immediate breathing
always use this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is one inhalation once a day . you should use this this medicine for 24 hours at the same time each day . use incruse ellipta every day . if you use more incruense ellipta than you should if you have used more inculse elliptas than you need , contact your doctor immediately . symptoms of using too much of this medicine may include a sudden attack of breathlessness or wheezing . if this attack occurs , you may need a quick - acting reliever
like all medicines , this medicine can cause side effects , although not everybody gets them . allergic reactions allergic reactions are uncommon ( may affect up to 1 in 100 people ). if you experience any of the following symptoms while taking incruse ellipta , stop taking this medicine and seek medical help immediately : itching skin rash , hives and redness 29 common side effects ( may effect up to1 in 10 people ): faster heart beat painful and frequent urination . these may be signs of a urinary tract infection . common cold infection of nose , throat cough , feeling of pressure , pain in the cheeks and forehead . these could be signs for
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and on the label of the inhaler after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 - 8 ). do not freeze . keep the inhalcer in the sealed tray in order to protect from light . after first opening of the sealed tray , the inhalard should be used within 6 months . once the inhaluer has been opened , the seal should be put back in the tray and discarded . do this after 30 . do away
what incruse ellipta contains - the active substance is umeclidinium bromide . each delivered dose contains 55 micrograms umecylidinia . each dose delivers 65 microgramms umechloridinIUM bromides . - the other ingredients are lactose monohydrate ( see section 2 under ' incrusemipta contains lactose '), magnesium stearate . what incrusey ellipta looks like and contents of the pack incrute ellipta is an inhalation powder . the ellipta inhaler is supplied in a grey plastic body with a light green mouthpiece
what nucala is nucal contains the active substance mepolizumab , which is a monoclonal antibody . this type of protein is designed to recognise and bind to specific proteins in the body . what nucalan is used for nucalya is used to treat severe asthma in adults , adolescents and children aged 6 years and older . severe asthma affects many eosinophils ( a type of white blood cell that helps the airways to open ) and affects the lungs . in eosinaophilic asthma , the most common form of asthma nucalo is used in adults to prevent asthma
do not use nucala if you are allergic to mepolizumab or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before using this medicine if you have worsening asthma 58 if you experience asthma - related side effects , your doctor may decide to reduce the dose or stop nucla . if your asthma is not controlled with nucalan , your asthma may get worse . talk to a doctor or go to the nearest hospital straight away if you think any of these apply to you . warnings and symptoms talk to the doctor or nurse before using nuc
nucala is given under the skin ( subcutaneous injection ). adults and adolescents 12 years of age and older : the recommended dose is 100 mg once a day . children and adolescents 1 year of age or older : your doctor will decide the dose that is right for you . the dose will be given by injection into the pre - filled pen . if you have any further questions on the use of nucala , ask your doctor . duration of treatment with nucal your doctor may decide to stop the treatment with a low dose . your doctor should continue to monitor your asthma symptoms and may decide if you should continue treatment with
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects may happen with nucala : allergic reactions allergic or allergic - like reactions may occur very commonly ( may affect more than 1 in 10 people ) after the injection . sometimes symptoms can be severe and include symptoms such as chest tightness , cough , difficulty breathing fainting dizziness feeling lightheaded ( due to a drop in blood pressure ) swelling of eyelids , face , lips , tongue or mouth hives rash tell your doctor immediately if you have a reaction similar reaction to nucal . other side effects include : very
keep out of the reach and sight of children . do not use nucala after the expiry date which is stated on the carton and on the pre - filled pen after exp . the exp date refers to the last day of that month . store in a refrigerator ( 2 8 ). do not freeze . keep the pre filled pen in the outer carton in order to protect from light . after first opening , use within 7 days . do away with the pre- filled pen once you have established the date of opening . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you
what nucala contains - the active substance is mepolizumab . 1 ml solution contains 100 mg of mepoluzumab ( as besilate ). - the other ingredients are sucrose , sodium phosphate dibasic heptahydrate , citric acid monohydrate , polysorbate 80 , edta disodium dihydrate and water for injections . what nucal looks like and contents of the pack nucalo is supplied as a pack containing 1 vial , a multipack containing 3 vials , and 1 vials . not all pack sizes may be marketed .
what ninlaro is ninlar is a cancer medicine that contains the active substance ixazomib , a ' proteasome inhibitor '. what it is used for ninlara is used to treat a cancer of the bone marrow called multiple myeloma . ixezomib is used in cell survival to stop myelomas cells from growing because it contains a lot of proteins called proteasomes . how ninlalo works when used in adults , it is given to you by your doctor . how it works in adults and children with multiple myelooma , ninlAR is given in combination with lenalid
do not take ninlaro if you are allergic to ixazomib or any of the other ingredients of this medicine ( listed in section 6 ). warnings and precautions talk to your doctor or pharmacist before taking ninlar if any of these apply to you . if you have any of those conditions : if you think you may be taking this medicine , tell your doctor . warnings and symptoms talk to a doctor or nurse before taking the tablets . if any part of the following apply to your child , tell the doctor or hospital pharmacist as soon as possible : if they are not sure , talk to the doctor , pharmacist
you must not take ninlaro if you have multiple myeloma . always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . how much to take the recommended dose of ninlar is one capsule of lenalidomide ( a medicine that helps to lower the level of inflammatory hormone in the body ). the recommended starting dose of one capsule is one tablet of ninlvaro ( one tablet ) once a day on the same day of the week . for the first 3 weeks , the recommended daily dose is 4 capsules of lenidomide 25 mg ( one
like all medicines , this medicine can cause side effects , although not everybody gets them . very common serious side effects ( may affect more than 1 in 10 people ): low platelet counts ( thrombocytopenia ) nose bleeds that can easily bruise nausea , vomiting , diarrhoea numbness , tingling or burning of the hands or feet ( peripheral neuropathy ) swelling of the legs or feet (> peripheral oedema ) skin rash ( itchy , often on the upper part of the body ). rare side effects these may affect up to 1 in 1 , 000 people : severe skin rashes , red
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the blister and carton after exp . the exp date refers to the last day of that month . do store below 30 . store the capsule in the original package in order to protect from moisture . do this medicine only if you notice any damage to the pack . do away with any unused medicine packaging after the first opening . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what ninlaro contains the active substance of ninlar is ixazomib . each capsule contains 2 . 3 mg ixezomib and 3 . 3mg ixzomib citrate . the other ingredients are microcrystalline cellulose , magnesium stearate , talc . the capsule shell contains gelatin , titanium dioxide ( e171 ), red iron oxide ( e172 ), shellac , propylene glycol , potassium hydroxide , black iron oxide . the printing ink contains : - the capsule content contains : ixar 3 mg / ixabine ( 3 mg ) ix
do not use palforzia if you are allergic to peanuts or arachis hypogaea . warnings and precautions talk to your doctor , pharmacist or nurse before using palfORzia . children and adolescents from 4 to 17 years of age should not receive treatment for peanut allergy because the medicine contains traces of peanut ( desensitisation ). palfiorzia does not reduce the risk of allergic reactions . palforbzia is not used to treat food allergies . talk to a doctor , nurse or pharmacist before usingpalforzeria .
do not take palforzia if you are allergic to peanut or soya . if your asthma is severe , you may have a problem swallowing . if you have long term problems with your digestive system such as a severe mast cell disorder or severe or life - threatening anaphylaxis . if this happens , you must contact your doctor within 60 days of stopping treatment . warnings and precautions talk to your doctor or pharmacist before taking palferzia . if any of the above apply to you , tell your doctor before taking the first dose of palfurzia : if you notice any of these symptoms : peanut
always take this medicine exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . dosage and frequency of administration if you have allergy , allergic reactions ( anaphylaxis ) have been reported in patients receiving palforzia . your doctor will determine the dose you need and will determine for how long you should take palferzia and how often you should continue to take it . initial doseescalation and up - dosing steps are given to you by your doctor . your physician will determine how long your treatment with palfourzia needs to last . if you take
like all medicines , this medicine can cause side effects , although not everybody gets them . the following side effects have been reported with palforzia : severe allergic reactions : if you have any of the following symptoms while taking palfofzia , stop taking the medicine and seek medical help immediately : - trouble breathing - throat tightness - feeling offulness - trouble swallowing or speaking - changes in voice - dizziness or fainting - severe stomach cramps , pain , vomiting , diarrhoea , severe flushing or itching of the skin palfORzia may cause problems with the stomach and digestive system ( e
keep this medicine out of the sight and reach of children . do not use this medicine after the expiry date which is stated on the carton and the vial label after exp . the exp date refers to the last day of that month . do store below 25 . do this medicine if you notice any hard lumps of powder or if the solution is discoloured . do throw away any medicines via wastewater or household waste . ask your pharmacist how to throw away medicines you no longer use . these measures will help protect the environment .
what palforzia contains the active substance is palfofen . each 0 . 5 mg capsule contains 1 , 10 or 20 mg of the active substances . the other ingredients are microcrystalline cellulose , colloidal anhydrous silica and magnesium stearate palfiorzia 100 mg oral powder in capsules with opening microcrycrystallinine celluloses , colloid anhydrated silica , and magnesiumstearatepalforza 300 mg oralpowder in sachet microcrystine cellulos , collir anhydrate silica, and magnesium unstearate . the active
zerne belongs to a group of substances called benzodiazepine - related medicinal products . it contains hypnotic actions . zerene is used to treat sleeping problems in adults . it is used during treatment to help you sleep . if you have problems sleeping , you should contact your doctor .
do not take zerene : if you have hypersensitivity ( an allergy ) to zaleplon or any of the other ingredients of zerenea sleep apnoea syndrome ( which may occur for short periods ) if you suffer from severe kidney or liver problems if you are suffering from myasthenia gravis ( which causes you to feel very weak , tired muscles , severe breathing , chest problems ) if any of these apply to you , tell your doctor . children and adolescents do not give this medicine to children under 18 years of age because it has not been studied in this age group . zeren has not
always take zerene exactly as your doctor has told you . check with your doctor or pharmacist if you are not sure . the recommended dose is 10 mg once a day . if you have difficulty falling asleep , take your capsule straight away . if your doctor tells you to take zerne , you should not take more than the recommended dosage . if the dose is 65 mg once daily . if there is mild to moderate liver problems , you can take zera once daily for up to 65 days . if this is not enough , you may take 5 mg once weekly . if mild tomoderate liver problems are not enough or you
like all medicines , zerene can cause side effects , although not everybody gets them . tell your doctor immediately if you notice any other changes in your health . the frequency of possible side effects listed below is defined using the following convention : 36 very common ( affects more than 1 user in 10 ) common ( affecting 1 to 10 users in 100 ) uncommon ( affects 1 to10 users in 1 , 000 ) very rare ( affects less than 1 users in 10 , 000 ). very rare : very rare , affects less 1 user per 10 ,000 but very rare cases : very common (> affects less to 1 user of 10 , 500 )
what zerene contains - the active substance is zaleplon 5 mg . - the other ingredients are : microcrystalline cellulose , pregelatinised starch , silicon dioxide ( e171 ), sodium lauryl sulphate , magnesium stearate . - printing ink : shellac , lecithin , simethicone , yellow iron oxide ( e172 ). what zeren looks like and contents of the pack zerenea 5 mg is an intense dark blue powder with a light brown cap and a light green body . zerenes 5 mg are available in blisters of 7 , 10 or 14
